
<html lang="en"     class="pb-page"  data-request-id="16e1df26-65a5-4f3d-8b7b-a4629daeec3c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2009.52.issue-22;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm900524b;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease Featuring a 2-Amino-1,3-thiazole as a P4 Carbamate Replacement" /></meta><meta name="dc.Creator" content="M. Emilia  Di Francesco" /></meta><meta name="dc.Creator" content="Gabriella  Dessole" /></meta><meta name="dc.Creator" content="Emanuela  Nizi" /></meta><meta name="dc.Creator" content="Paola  Pace" /></meta><meta name="dc.Creator" content="Uwe  Koch" /></meta><meta name="dc.Creator" content="Fabrizio  Fiore" /></meta><meta name="dc.Creator" content="Silvia  Pesci" /></meta><meta name="dc.Creator" content="Jillian  Di Muzio" /></meta><meta name="dc.Creator" content="Edith  Monteagudo" /></meta><meta name="dc.Creator" content="Michael  Rowley" /></meta><meta name="dc.Creator" content="Vincenzo  Summa" /></meta><meta name="dc.Description" content="Our laboratories recently reported the discovery of P2−P4 macrocyclic inhibitors of HCV NS3/4A protease, characterized by high levels of potency and liver exposure. Within this novel class of inhib..." /></meta><meta name="Description" content="Our laboratories recently reported the discovery of P2−P4 macrocyclic inhibitors of HCV NS3/4A protease, characterized by high levels of potency and liver exposure. Within this novel class of inhib..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 26, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm900524b" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm900524b" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm900524b" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm900524b" /></link>
        
    
    

<title>Novel Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease Featuring a 2-Amino-1,3-thiazole as a P4 Carbamate Replacement | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm900524b" /></meta><meta property="og:title" content="Novel Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease Featuring a 2-Amino-1,3-thiazole as a P4 Carbamate Replacement" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0010.jpeg" /></meta><meta property="og:description" content="Our laboratories recently reported the discovery of P2−P4 macrocyclic inhibitors of HCV NS3/4A protease, characterized by high levels of potency and liver exposure. Within this novel class of inhibitors, we here describe the identification of a structurally diverse series of compounds featuring a 2-amino-1,3-thiazole as replacement of the carbamate in P4. Optimization studies focused on structural modifications in the P3, P2, and P1 regions of the macrocycle as well as on the linker chain and resulted in the discovery of several analogues characterized by excellent levels of enzyme and cellular activity. Among these, compound 59 displayed an attractive pharmacokinetic profile in preclinical species and showed sustained liver levels following oral administration in rats." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm900524b"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm900524b">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm900524b&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm900524b&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm900524b&amp;href=/doi/10.1021/jm900524b" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 7014-7028</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm9005077" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901133z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease Featuring a 2-Amino-1,3-thiazole as a P4 Carbamate Replacement</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=M.+Emilia++Di+Francesco">M. Emilia Di Francesco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gabriella++Dessole">Gabriella Dessole</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emanuela++Nizi">Emanuela Nizi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paola++Pace">Paola Pace</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Uwe++Koch">Uwe Koch</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrizio++Fiore">Fabrizio Fiore</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Pesci">Silvia Pesci</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jillian++Di+Muzio">Jillian Di Muzio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edith++Monteagudo">Edith Monteagudo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Rowley">Michael Rowley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincenzo++Summa">Vincenzo Summa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A., Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +39 0691093563. Fax: +39 06 91093654. E-mail: <a href="/cdn-cgi/l/email-protection#d6bbb7a4bfb7b3bbbfbabfb789b2bfb0a4b7b8b5b3a5b5b996bbb3a4b5bdf8b5b9bb"><span class="__cf_email__" data-cfemail="94f9f5e6fdf5f1f9fdf8fdf5cbf0fdf2e6f5faf7f1e7f7fbd4f9f1e6f7ffbaf7fbf9">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm900524b&amp;href=/doi/10.1021%2Fjm900524b" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 7014–7028</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 26, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 April 2009</li><li><span class="item_label"><b>Published</b> online</span>26 October 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 November 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm900524b" title="DOI URL">https://doi.org/10.1021/jm900524b</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7014%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DM.%2BEmilia%2BDi%2BFrancesco%252C%2BGabriella%2BDessole%252C%2BEmanuela%2BNizi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D22%26contentID%3Djm900524b%26title%3DNovel%2BMacrocyclic%2BInhibitors%2Bof%2BHepatitis%2BC%2BNS3%252F4A%2BProtease%2BFeaturing%2Ba%2B2-Amino-1%252C3-thiazole%2Bas%2Ba%2BP4%2BCarbamate%2BReplacement%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7028%26publicationDate%3DNovember%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm900524b"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1697</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm900524b" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease Featuring a 2-Amino-1,3-thiazole as a P4 Carbamate Replacement&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;M.&quot;,&quot;last_name&quot;:&quot;Emilia Di Francesco&quot;},{&quot;first_name&quot;:&quot;Gabriella&quot;,&quot;last_name&quot;:&quot;Dessole&quot;},{&quot;first_name&quot;:&quot;Emanuela&quot;,&quot;last_name&quot;:&quot;Nizi&quot;},{&quot;first_name&quot;:&quot;Paola&quot;,&quot;last_name&quot;:&quot;Pace&quot;},{&quot;first_name&quot;:&quot;Uwe&quot;,&quot;last_name&quot;:&quot;Koch&quot;},{&quot;first_name&quot;:&quot;Fabrizio&quot;,&quot;last_name&quot;:&quot;Fiore&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Pesci&quot;},{&quot;first_name&quot;:&quot;Jillian&quot;,&quot;last_name&quot;:&quot;Di Muzio&quot;},{&quot;first_name&quot;:&quot;Edith&quot;,&quot;last_name&quot;:&quot;Monteagudo&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Rowley&quot;},{&quot;first_name&quot;:&quot;Vincenzo&quot;,&quot;last_name&quot;:&quot;Summa&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;7014-7028&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm900524b&quot;},&quot;abstract&quot;:&quot;Our laboratories recently reported the discovery of P2−P4 macrocyclic inhibitors of HCV NS3/4A protease, characterized by high levels of potency and liver exposure. Within this novel class of inhibitors, we here describe the identification of a structurally diverse series of compounds featuring a 2-amino-1,3-thiazole as replacement of the carbamate in P4. Optimization studies focused on structural modifications in the P3, P2, and P1 regions of the macrocycle as well as on the linker chain and resulted in the discovery of several analogues characterized by excellent levels of enzyme and cellular activity. Among these, compound 59 displayed an attractive pharmacokinetic profile in preclinical species and showed sustained liver levels following oral administration in rats.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900524b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900524b" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900524b&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900524b" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900524b&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900524b" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm900524b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900524b&amp;href=/doi/10.1021/jm900524b" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm900524b" /></input><a href="/doi/pdf/10.1021/jm900524b" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm900524b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm900524b%26sid%3Dliteratum%253Aachs%26pmid%3D19856919%26genre%3Darticle%26aulast%3DDi%2BFrancesco%26date%3D2009%26atitle%3DNovel%2BMacrocyclic%2BInhibitors%2Bof%2BHepatitis%2BC%2BNS3%252F4A%2BProtease%2BFeaturing%2Ba%2B2-Amino-1%252C3-thiazole%2Bas%2Ba%2BP4%2BCarbamate%2BReplacement%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D22%26spage%3D7014%26epage%3D7028%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900524b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Our laboratories recently reported the discovery of P2−P4 macrocyclic inhibitors of HCV NS3/4A protease, characterized by high levels of potency and liver exposure. Within this novel class of inhibitors, we here describe the identification of a structurally diverse series of compounds featuring a 2-amino-1,3-thiazole as replacement of the carbamate in P4. Optimization studies focused on structural modifications in the P3, P2, and P1 regions of the macrocycle as well as on the linker chain and resulted in the discovery of several analogues characterized by excellent levels of enzyme and cellular activity. Among these, compound <b>59</b> displayed an attractive pharmacokinetic profile in preclinical species and showed sustained liver levels following oral administration in rats.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78274" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78274" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Hepatitis C virus (HCV<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: HCV, hepatitis C virus; HCC, hepatocellular carcinoma; PEG-IFN-α, pegylated interferon alpha; SVR, sustained virological response; NS, nonstructural; RCM, ring closing metathesis; FBS, fetal bovine serum; NHS, normal human serum; SAR, structure−activity relationship.</p></div>) infection is a major cause of liver disease and represents a serious burden to global health care that is likely to increase over the coming years. It is estimated that approximately 170 million people, ca. 3% of the worldwide population, are currently infected with HCV, and 3−4 million new cases are reported every year.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In the majority of cases, HCV infection leads to chronic hepatitis, which in turn can evolve into cirrhosis and ultimately hepatocellular carcinoma (HCC).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> HCV infection is believed to be responsible for 50−76% of all cases of liver cancer and is the leading cause of liver transplantation.<a onclick="showRef(event, 'ref1 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref3">(1, 3)</a> The current standard of care for HCV is based on a combination of pegylated interferon alpha (PEG-IFN-α), a protein that stimulates the immune system, and ribavirin, a nucleoside that augments the antiviral action of IFN-α by a not yet completely elucidated mechanism.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> However, the current therapy suffers major limitations due to significant side effects and limited response rate. Only about 50% of the treated population achieves sustained virological response (SVR) depending on patient characteristics and viral genotype, with particularly low response rates for patients infected with genotype 1 virus, the most prevalent in Europe, North America, and Japan.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The discovery of novel, more efficacious, and better tolerated therapies for the treatment of HCV infection is therefore a medical problem that needs urgent attention.</div><div class="NLM_p">HCV, which replicates mainly in the liver, is a positive single-stranded RNA virus of approximately 9.6 kilobases that encodes a polyprotein precursor of about 3000 amino acids. The latter is processed by cellular and viral proteinases to produce structural and nonstructural (NS) proteins.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The virally encoded NS3 protease plays an essential role in the viral cycle being responsible for processing of the nonstructural portion of the polypeptide and has long been recognized as a validated target for antiviral intervention.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> More recently, NS3 has also been associated with silencing of the host’s immune response, further raising its relevance as a therapeutic target.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> NS3 is a bifunctional protein that harbors a canonical serine protease catalytic triad (Asp-His-Ser) and a helicase/ATP-ase domain.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Formation of a heterodimeric complex with the NS4A cofactor is essential for maximum protease efficiency and anchoring to the endoplasmatic reticulum. The unusually shallow substrate binding cleft requiring extensive substrate−protein interactions has posed significant challenges to the development of effective small molecule inhibitors of NS3/4A. The discovery that N-terminal hexapeptide cleavage products are competitive inhibitors of NS3/4A<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> opened new avenues to drug discovery and ultimately resulted in the identification of BILN-2061 (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), a non covalent P1−P3 macrocyclic NS3/4A inhibitor that first achieved clinical proof of concept (POC).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> While the development of <b>1</b> was stopped due to significant side effects, several other inhibitors have since then progressed through late stage clinical investigations, including both covalent reversible inhibitors such as telaprevir (VX-950)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and boceprevir (SCH503034),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and noncovalent ones like TMC435350<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and ITMN-191.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Inhibitors of HCV NS3/4A protease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900524b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Among the strategies explored to improve the pharmacologic properties of the initial peptide leads, several macrocyclic analogues have been investigated as β-strand mimetics. Molecular modeling and NMR studies suggested hydrophobic contacts between the P4 and the P2 residues, inspiring the design of bis-arylether macrocycles.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Subsequently combination of distinct P4−P2 macrocyclic cores with ketoamide warheads resulted then in several potent NS3/4A inhibitors spanning from the P4 to the P2′ sites.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Recently, our laboratories reported the discovery of a novel class of potent macrocyclic inhibitors bearing an aliphatic chain linking the P4 carbamate and the P2 moiety, here exemplified by compound <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The design of these analogues derived from molecular modeling studies of <b>1</b> docked within the full length NS3/4A protease, which highlighted how the space between the helicase domain and the protease might accommodate a connection of the spatially close P2 and P4 residues. Further optimization of the macrocyclic scaffold, including bioisosteric replacement of the P1 carboxylic acid moiety with a cyclopropylacylsulfonylamide,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> resulted in the identification of numerous potent and selective inhibitors of NS3/4A protease.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Noticeably, several of them offered remarkably high liver exposure following oral administration in preclinical species, a key feature in any potential treatment for HCV infection.<a onclick="showRef(event, 'cit18a'); return false;" href="javascript:void(0);" class="ref cit18a">(18a)</a> Further optimizations led to the discovery of MK-7009 (<b>3</b>), which demonstrated excellent preclinical in vivo efficacy in infected chimpanzee and is currently in phase II clinical trials.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">This paper describes efforts toward the identification of a structurally diverse series of P2−P4 macrocyclic inhibitors with comparable potency and liver exposure. In particular, we set out to explore modifications of the P4 carbamate moiety and, on the basis of previous examples in which five-membered heterocyclic rings have been used as ester and amide bioisosters,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> we hypothesized that five-membered amino-heterocycles could be a suitable replacement for the carbamate group. We reasoned that such modification, by restricting the flexibility of the macrocyclic backbone, could further reduce the peptide-like character of these macrocyclic inhibitors and therefore have a favorable impact on their in vivo profile while retaining high inhibitory potency against NS3/4A. To support our initial hypothesis, we modeled carbamate <b>2</b> in the context of the full length NS3 structure<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and superimposed it with analogue <b>4</b>, containing a 2-amino-1,3,4-oxadiazole moiety, and with analogue <b>5</b>, featuring a 2-amino-1,3-thiazole in P4 (parts a and b of Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, respectively).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Molecular model of carbamate <b>2</b> (green) superimposed with oxadiazole <b>4</b> (a, blue) and thiazole <b>5</b> (b, yellow) in the context of NS3-4A active site (gray)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and helicase domain (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900524b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We were pleased to observe that in both cases the proposed macrocyclic inhibitors showed a very favorable overlap with the corresponding carbamate analogue, with only minimal effect on the overall conformation. In particular, despite the replacement of the P4-carbamate with a five-membered heterocyclic ring, the network of key intermolecular hydrogen bonds involving the carbonyl and amino groups of the P3 residue with the protein backbone (Ala 157) appeared unperturbed.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Additionally, the proposed replacement of the P4-carbamate with an amino-heterocycle did not appear to produce an unfavorable steric clash with His 528, a residue proposed by previous studies to be involved in specific helicase−inhibitor interactions.<a onclick="showRef(event, 'cit18a'); return false;" href="javascript:void(0);" class="ref cit18a">(18a)</a></div><div class="NLM_p last">In this paper, we report the studies that led to the identification of the 2-amino-1,3-thiazole moiety as a suitable replacement of the P4 carbamate group in the context of macrocyclic inhibitors of NS3/4A and describe the development of a series of novel inhibitors characterized by nanomolar cellular potency and desirable pharmacokinetic properties in preclinical species.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60777" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60777" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the initial macrocyclic analogues containing a 2-amino-1,3,4-oxadiazole and a 2-amino-1,3-thiazole in P4 is outlined in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, respectively. In both cases, we started our investigations by introducing the unsubstituted isoquinoline residue in P2 to allow direct comparison with carbamate <b>2</b> and we selected a ring closing metathesis (RCM) as the key macrocyclization step.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Oxadiazole Derivative <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900524b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) EDCI·HCl, Boc-NHNH<sub>2</sub>, DCM; (ii) TFA, DCM. (b) Dioxane. (c) (i) POCl<sub>3</sub>, 80 °C; (ii) LiOH, THF/H<sub>2</sub>O. (d) TBTU, DCM. (e) Zhan 1 catalyst, 1,2-DCE, 80 °C. (f) (i) Pd/C, H<sub>2</sub>, EtOH; (ii) LiOH, THF/H<sub>2</sub>O; (iii) <b>13A</b>, TBTU, DIPEA, DMF.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Thiazole Derivative <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900524b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CH<sub>2</sub>N<sub>2</sub>, Et<sub>2</sub>O, then aq HBr, 0 °C. (b) NaSCN, CH<sub>3</sub>CN. (c) Methyl valinate, dioxane, 50 °C. (d) (i) LiOH, THF, H<sub>2</sub>O; (ii) <b>10A</b>, EDCI·HCl, HOBt, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, DCM. (e) (i) <b>10A</b>, TBTU, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, DMF; (ii) HCl, dioxane. (f) (i) Fmoc-SCN, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, DCM, 0 °C, then 20% piperidine in MeOH. (g) <b>14a</b>, dioxane, 60 °C. (h) (i) Zhan 1 catalyst, 1,2-DCE, 80 °C. (l) (i) Pd/C, H<sub>2</sub>, MeOH; (ii) LiOH THF, H<sub>2</sub>O; (iii) <b>13A</b>, TBTU, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, DMF.</p></p></figure><div class="NLM_p">Synthesis of oxadiazole <b>4</b> commenced with conversion of 4-pentenoic acid into the corresponding hydrazide <b>6</b> by coupling with <i>tert</i>-butyl hydrazine carboxylate and subsequent <i>N</i>-Boc deprotection. Reaction of <b>6</b> with the valine derived isocyanate <b>7</b><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> afforded the oxadiazole precursor <b>8</b>, which upon treatment with POCl<sub>3</sub> promoted the desired intramolecular cyclization to give, after hydrolysis, the required functionalized 1,3,4-oxadiazole <b>9</b>. Coupling of the latter with the isoquinoline-proline derivative <b>10A</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> produced the macrocyclization precursor <b>11</b>, which upon treatment with the RCM catalyst Zhan 1<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> in 1,2-dichloroethane gave efficiently and selectively the desired macrolactam ester <b>12</b> as the <i>E</i>-stereoisomer. Hydrogenation of the double bond, hydrolysis of the methyl ester, and coupling of the resulting carboxylic acid with aminoacylsulfonamide <b>13A</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> completed the synthesis of the targeted oxadiazole macrocyclic derivative <b>4</b>.</div><div class="NLM_p">A similar approach was used for the synthesis of the thiazole derivative <b>5</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Accordingly, 4-pentenoyl chloride was treated sequentially with diazomethane and aqueous HBr to give the corresponding α-bromo-methyl ketone <b>14a</b>. The latter was further progressed to isothiocyanate <b>15</b> by reaction with NaSCN. Moderate heating of <b>15</b> in the presence of methyl valinate afforded smoothly the required 1,3-thiazole-intermediate <b>16</b>. Disappointingly, upon activation with EDCI·HCl, the corresponding carboxylic acid underwent a facile intramolecular cyclization to give the bicyclic derivative <b>17</b>, thus preventing further elaboration into the targeted macrocycle. Undeterred by these results, we sought an alternative synthetic route by assembling the P2−P3-dipeptide intermediate <b>18</b> first, followed by further elaboration of its terminal P3-amino group to install the required aminothiazole moiety. Also in this case, elaboration of the macrocycle proved to be quite challenging due to facile intramolecular reaction of the P3 amino group with the proline methyl ester of <b>18</b>. Ultimately, the issue was overcome by liberating the terminal amino group in carefully controlled conditions and in the presence of an excess of Fmoc-thioisocyanate, thus preventing the undesired lactam formation. Removal of the Fmoc protecting group then afforded thiourea <b>19</b>, which was reacted with the previously prepared α-bromo-methyl ketone <b>14a</b> to yield the required aminothiazole core. RCM macrocyclization of <b>20a</b> proceeded smoothly to give <b>21a</b> as a mixture of <i>E</i>:<i>Z</i> stereoisomers (ca. 4:1 ratio). Further functional group manipulations as previously described afforded then aminothiazole <b>5</b>.</div><div class="NLM_p">Having identified reliable synthetic routes to access efficiently both the aminoxadiazole and the aminothiazole analogues, a modular synthetic approach was developed allowing different regions of the macrocyclic cores to be explored in a systematic manner. The key intermediates were assembled in a convergent manner as depicted in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, yielding analogues <b>47</b>−<b>60</b> efficiently. The appropriate proline residues <b>10</b>, carrying the P2 heterocyclic fragments <b>A</b>,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a><b>B</b>,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and <b>C</b>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> were coupled with one of the selected P3 amino acid building blocks <b>22a</b>−<b>e</b> and elaborated to the corresponding thioureas <b>23</b>−<b>30</b> by means of the previously described transformations. The latter were then converted to the aminothiazole derivatives <b>31</b>−<b>38</b> by treatment with the appropriate α-bromo-methylketones <b>14a</b>−<b>c</b>, each of different chain lengths and optionally bearing a <i>gem</i>-dimethyl substituent. Macrocyclization by RCM reaction and optional reduction of the linker olefin by hydrogenation gave intermediates <b>39</b>−<b>46</b>. In turn, following methyl ester hydrolysis, the latter could finally be coupled with either unsaturated or saturated P1 fragments <b>13A</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> or <b>13B</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> to give the targeted analogues <b>47</b>−<b>60</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Modular Approach to the Synthesis of Macrocyclic Aminothiazole Analogues <b>47</b>−<b>60</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900524b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) EDCI·HCl, HOBt, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, DCM; (ii) HCl/dioxane. (b) Fmoc-SCN, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, DCM, 0 °C, then 20% piperidine in MeOH. (c) <b>14a</b>−<b>c</b>, dioxane, 60 °C. (d) Zhan 1 catalyst, 1,2-DCE, 80 °C. (e) Pd/C, H<sub>2</sub>, MeOH; (f) (i) LiOH, THF, H<sub>2</sub>O; (ii) <b>13A</b> or <b>13B</b>, EDCI·HCl, HOBt, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, DCM. (g) (COCl)<sub>2</sub>, cat. DMF, DCM. (h) CH<sub>2</sub>N<sub>2</sub>, Et<sub>2</sub>O; then aq HBr, 0 °C; <i>E</i>-db = <i>E</i>-double bond; sat = saturated.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68363" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68363" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All the compounds prepared were evaluated in an enzymatic assay using the genotype 1b NS3/4A enzyme, and results are reported as <i>K</i><sub>i</sub> values.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The cellular activity was determined using a subgenomic 1b replication assay (replicon),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> where compounds were tested both in the presence of 10% fetal bovine serum (FBS) and in the more physiological conditions represented by the use of 50% normal human serum (NHS). Initial pharmacokinetic evaluation of the analogues focused on concentration in liver and plasma exposure levels in rats after a single oral dose (5 mg/kg). Selected compounds were further evaluated with a full pharmacokinetic analysis in rat.</div><div class="NLM_p">Evaluation of analogues <b>4</b> and <b>5</b> in vitro confirmed that a five-membered amino-heterocycle could be a very effective replacement of the P4 carbamate. Oxadiazole <b>4</b> proved in fact to be a potent enzyme inhibitor, with a <i>K</i><sub>i</sub> = 0.9 nM (entry 2, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), and showed submicromolar activity in the replicon, with EC<sub>50</sub> = 80 nM in the presence of 10% FBS. In addition, <b>4</b> retained interesting levels of cellular activity with 50% NHS (EC<sub>50</sub> = 180 nM), albeit with a 4-fold loss in comparison with <b>2</b> (EC<sub>50</sub> = 46 nM). Oral administration of <b>4</b> in Sprague−Dawley rat at 5 mg/kg resulted in detectable but lower levels of plasma exposure compared to <b>2</b> (AUC = 0.1 μM·h and AUC = 0.27 μM·h for <b>4</b> and <b>2</b>, respectively). The oxadiazole <b>4</b> also displayed significantly reduced liver exposure (liver levels at 4 <i>h</i> = 0.03 and 13.4 μM for <b>4</b> and <b>2</b>, respectively).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Aminoheterocyclic Derivatives in the Isoquinoline and Quinoline Series<a class="ref internalNav" href="#tbl1-fn1" aria-label="e">e</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0003.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0002.gif" alt="" id="fx2" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Enzyme potency measured in a NS3/4A time-resolved fluorescence assay; for details, see ref <a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">32</a>; reported <i>K</i><sub>i</sub> values are the mean of ≥3 experiments, standard deviation was within ±20% of the reported value.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Cellular activity determined in the HCV bicistronic replicon assay, using HuH-7 cells stably transfected with genotype 1b HCV replicon RNA; for details, see ref <a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">33</a>; EC<sub>50</sub> are measured in the presence of 10% fetal bovine serum (FBS) and 50% normal human serum (NHS); values are the mean of ≥3 experiments, standard deviation was within ±20% of the reported value.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Area under the curve following oral administration to Sprague−Dawley rats at 5 mg/kg (solution, PEG-400), 3 animals per group.</p></div><div class="footnote" id="tbl1-fn2"><sup>d</sup><p class="last">Concentration of compound measured in rat liver at 4 h from oral dosing.</p></div><div class="footnote" id="tbl1-fn1"><sup>e</sup><p class="last">Compounds <b>5</b> and <b>47</b>−<b>52</b> are trifluoroacetate salts; sat = saturated; db = double bond.</p></div></div></div><div class="NLM_p">On the other hand, thiazole <b>5</b>, which compared less favorably than both <b>4</b> and <b>2</b> in the enzyme and in the replicon assay (<i>K</i><sub>i</sub> = 1.7 nM; EC<sub>50</sub> = 60/920 nM 10% FBS/50% NHS), showed a dramatic increase in systemic exposure following oral administration at 5 mg/kg, with an AUC = 9.9 μM·h (entry 3, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Moreover, liver levels for <b>5</b> were also significantly improved over oxadiazole <b>4</b> and only 2-fold lower than <b>2</b> (5.5 μM). An excellent oral bioavailability (<i>F</i> = 60%) and a low plasma clearance (Clp = 7 mL/min/kg) completed the favorable in vivo profile of <b>5</b> and warranted further investigations of this series.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">Indeed, these findings prompted us to embark in extensive structural modifications within the thiazole series, addressing systematically the different regions of the macrocyclic core with the primary objective to improve potency while maintaining systemic and liver exposure. As described earlier, the targeted analogues were efficiently prepared by means of modular assembly of key intermediates. The selection of the appropriate building blocks originated from extensive structure−activity investigations previously conducted by us and others on both substrate based peptide inhibitors as well as P2−P4 macrocyclic inhibitors. In particular, it has been shown that a variety of small lipophilic β-branched amino acids are well tolerated in the P3 position, including both natural residues such as valine and isoleucine and unnatural ones such as <i>tert</i>-butyl- and cyclohexyl-glycine.<a onclick="showRef(event, 'ref20 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref20 ref35 ref36">(20, 35, 36)</a> It has also been disclosed that a significant boost in potency could be obtained by introducing large aromatic substituents stemming from the P2 proline and that this region of the inhibitor tolerates substantial structural modification.<a onclick="showRef(event, 'ref23 ref37'); return false;" href="javascript:void(0);" class="ref ref23 ref37">(23, 37)</a> In the context of the P2−P4 macrocycles, these findings led to subnanomolar inhibitors bearing, among others, a 2-phenyl-quinoline, an isoquinoline, or an indoline substituent in the P2 region.<a onclick="showRef(event, 'ref18 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref20">(18, 20)</a> On the basis of the aforementioned findings, we selected these structural features as starting points in the optimization of our thiazole series and set out to combine the above P2-substituents with a variety of appropriate P3 amino acids. We also planned to investigate a limited number of structural modifications within the P2−P4 linker chain such as length, saturation, and presence of small alkyl groups, given that in related series these features had positively affected the inhibitory potency.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">With <b>5</b> as a starting point, we started our investigations by homologating the linker chain to a C5 tether. Despite comparable levels of enzyme potency, analogue <b>47</b> (entry 4, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) showed a modest reduction in replicon activity with 10% FBS and did not offer advantage over <b>5</b> when tested with 50% NHS (<i>K</i><sub>i</sub> = 1.5 nM; EC<sub>50</sub> = 120/830 nM 10% FBS/50% NHS). Unlike previous findings reported for the carbamate series,<a onclick="showRef(event, 'cit18a'); return false;" href="javascript:void(0);" class="ref cit18a">(18a)</a> the introduction of an <i>E</i>-double bond adjacent to the P2-substitutent as in analogue <b>48</b> (entry 5, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) resulted in a 3-fold loss of enzyme potency, although the conformational restraint did result in a marginal improvement in replicon potency (<i>K</i><sub>i</sub> = 5 nM; EC<sub>50</sub> = 30/730 nM 10% FBS/50% NHS). However, following oral administration in rats at 5 mg/kg, <b>48</b> showed 2-fold lower liver levels and a significant reduction in plasma exposure in comparison to the saturated analogue <b>5</b> (liver levels at 4 <i>h</i> = 2.4 μM; AUC = 0.9 μM·h). We continued our investigations by introducing in the position adjacent to the thiazole ring a <i>gem</i>-dimethyl group, a structural feature that proved to be beneficial in related series both in terms of potency as well as liver levels.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Indeed, the <i>gem</i>-dimethyl analogue <b>49</b> (entry 6, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) was only slightly less potent than <b>5</b> in the enzyme assay and showed a 9-fold boost in cellular potency in high serum conditions (<i>K</i><sub>i</sub> = 3 nM; EC<sub>50</sub> = 20/100 nM 10% FBS/50% NHS). On the other hand, following single oral dosing at 5 mg/kg, <b>49</b> showed lower liver levels and a significant reduction in plasma exposure in respect to its unsubstituted analogue <b>5</b> (liver levels at 4 <i>h</i> = 3.6 μM; AUC = 0.8 μM·h). These findings prompted us to focus our efforts toward analogues bearing a saturated and unsubstituted C4-linker, and additional opportunities to boost potency within the series came from screening of different residues in P3, a small subset of which is reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> (entries 7 and 8). The cyclohexyl-glycine analogue <b>50</b> offered a moderate increase in replicon potency over <b>5</b> (<i>K</i><sub>i</sub> = 1.3 nM; EC<sub>50</sub> = 30/350 nM 10% FBS/50% NHS), and the introduction of <i>tert</i>-butyl-glycine in P3 as in <b>51</b> resulted in a more significant gain of potency. Compound <b>51</b> showed in fact a 10-fold boost over <b>5</b> with subnanomolar inhibition of NS3/4A protease (<i>K</i><sub>i</sub> = 0.2 nM) and a 6-fold increase in replicon potency in high serum conditions (EC<sub>50</sub> = 20/130 nM 10% FBS/50% NHS). Evaluation of the pharmacokinetic profile of <b>50</b> and <b>51</b> in rat at 5 mg/kg showed an inverse correlation between their in vitro potency and plasma and liver exposure after oral administration. The most potent <i>tert</i>-butyl glycine derivative <b>51</b> was characterized by a drastic decrease in plasma exposure (AUC = 0.1 μM·h) and a 5-fold reduction in liver levels in comparison to the valine analogue <b>5</b> (1.0 and 5.5 μM, respectively). On the other hand, the cyclohexyl-glycine derivative <b>50</b> showed higher liver and plasma exposure, with liver levels = 3.4 μM and AUC = 4.7 μM·h. These findings proved that it was indeed possible to achieve satisfactory levels of systemic and liver exposure with 2-aminothiazole analogues and prompted us to further explore the series beyond the initial isoquinoline derivatives in the hope of obtaining a significant boost in potency by means of fine-tuning the structure.</div><div class="NLM_p">Progressing further in our quest for potency, we then turned our attention to the variation of the extended P2 region. On the basis of previous results in related series of macrocyclic inhibitors, we focused our efforts on the introduction of the phenylquinoline and the isoindoline P2 residues,<a onclick="showRef(event, 'ref18 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref20">(18, 20)</a> exemplified by compounds <b>52</b> (entry 9, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and <b>53</b>, respectively (entry 1, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In both cases, the structural modifications produced subnanomolar enzyme inhibitors (<b>52</b>: <i>K</i><sub>i</sub> = 0.5 nM; <b>53</b>: <i>K</i><sub>i</sub> = 0.16 nM) and, while the phenylquinoline analogue <b>52</b> showed a moderate boost in replicon potency compared to the corresponding quinoline analogue <b>5</b> (EC<sub>50</sub> = 40/390 nM 10% FBS/50% NHS), the isoindoline <b>53</b> displayed superior cellular activity, with single digit nanomolar replicon potency in 10% FBS and an almost 20-fold boost in 50% NHS compared to <b>5</b> (EC<sub>50</sub> = 5/50 nM 10% FBS/50% NHS). Evaluation of the pharmacokinetic profile of the two analogues in rat gave additional insights toward the potential for further development of the two distinct structural series. In particular, after oral administration at 5 mg/kg, compound <b>52</b> was undetectable, while the potent isoindoline derivative <b>53</b> displayed plasma exposure with AUC = 0.4 μM·h and liver concentration = 0.60 μM at 4 h, offering therefore a promising starting point for further optimization.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Aminothiazole Derivatives in the Isoindoline Series<a class="ref internalNav" href="#tbl2-fn1" aria-label="g">g</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0001.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0011.gif" alt="" id="fx4" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">See footnote details in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">See footnote details in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Area under the curve following oral administration to Sprague−Dawley rats at 4 mg/kg or 5 mg/kg* (solution, PEG-400; 3 animals per group).</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Oral bioavailability.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Plasma clearance (intravenous dosing vehicle: DMSO/PEG-400/water 20%/60%20%; 3 animals per group).</p></div><div class="footnote" id="t2fn6"><sup>f</sup><p class="last">Concentration of compound measured in rat liver at 4 h from oral dosing.</p></div><div class="footnote" id="tbl2-fn1"><sup>g</sup><p class="last">All compounds are trifluoroacetate salts; sat = saturated; db = double bond.</p></div></div></div><div class="NLM_p">Following the significant boost in enzyme and replicon potency observed for the isoindoline analogue <b>53</b>, we focused our efforts on 2-amino-thiazole analogues bearing this particular P2 residue. Within this series, we planned to capitalize on our previous SAR in the linker tether and in P3 to positively impact on the overall in vitro and in vivo profile of these inhibitors.</div><div class="NLM_p">Unlike previous results within the isoquinoline series, it was found that a C5 linker chain offered a significant advantage over the C4 tether in terms of replicon potency. In fact, although the C4-analogue <b>54</b> maintained high levels of enzyme inhibition (<i>K</i><sub>i</sub> = 0.28 nM; entry 2, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), it was affected by a more than 10-fold loss in replicon potency compared to its C5 analogue <b>53</b> (EC<sub>50</sub> = 90/635 nM 10% FBS/50% NHS).</div><div class="NLM_p">Optimization of the series progressed with the introduction of <i>tert</i>-butyl- and cyclohexyl-glycine residues in P3 to give analogues <b>55</b> and <b>57</b>, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, entries 3 and 5). In line with our previous findings within the isoquinoline series, these two structural modifications proved to be beneficial in terms of potency, with a further boost in replicon EC<sub>50</sub> in 50% NHS observed for both the analogues (EC<sub>50</sub> = 3/23 nM and EC<sub>50</sub> = 3/16 nM in 10% FBS/50% NHS, respectively). Notably, the introduction of the cyclohexyl-glycine residue in P3 as in compound <b>57</b> resulted in a <i>K</i><sub>i</sub> = 0.04 nM, a level of enzyme potency comparable with the most potent protease inhibitors. When profiled in rats (4 mg/kg iv and po), <b>57</b> proved to have a significantly higher plasma exposure in comparison with the <i>tert</i>-butyl-glycine derivative <b>55</b> (oral AUC = 0.40 μM·h and 0.06 μM·h, respectively) and 3-fold higher liver levels (<b>57</b>: 0.35 μM; <b>55</b>: 0.13 μM). Moreover, <b>57</b> showed a considerably reduced plasma clearance in comparison to <b>55</b> (Clp = 17 and = 85 mL/min/kg, respectively).</div><div class="NLM_p">Having secured high levels of potency across the series and identified analogues such <b>57</b> with improved liver levels and pharmacokinetic properties, we then turned our attention to explore additional structural variations within the macrocyclic scaffold, with the aim to identify opportunities to optimize further the in vivo profile. Removal of the <i>E</i>-double bond within the linker chain did not affect potency, as exemplified by analogue <b>56</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, entry 4; <i>K</i><sub>i</sub> = 0.16 nM; EC<sub>50</sub> = 4/19 nM 10% FBS/50% NHS). However, this structural modification resulted in a 2-fold decrease in liver levels compared to the unsaturated analogue <b>55</b> (0.06 μM). Saturation of the P1-double bond to give analogue <b>58</b> proved also to be detrimental (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, entry 6), as this compound showed a 4-fold decrease in enzyme potency and a lower activity in replicon compared to the unsaturated analogue <b>57</b> (<i>K</i><sub>i</sub> = 0.16 nM; EC<sub>50</sub> = 12/50 nM 10% FBS/50% NHS). Moreover, despite the good liver exposure (0.57 μM), <b>58</b> suffered from undetectable plasma levels, which was considered likely to hinder further development.</div><div class="NLM_p">As a consequence of these findings, the efforts focused on isoindoline derivatives bearing a double bond both within the linker chain as well as in P1. Further screening of a variety of P3 residues identified the isoleucine and cyclopentyl glycine derivatives <b>59</b> and <b>60</b> as other promising candidates within the series (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, entry 7 and 8). Both analogues displayed excellent potency against NS3/4A (<i>K</i><sub>i</sub> = 0.04 nM and <i>K</i><sub>i</sub> = 0.08 nM respectively) and maintained the high levels of replicon potency observed for <b>57</b>, with EC<sub>50</sub> = 2/18 nM and 2/16 nM (10% FBS/50% NHS) for <b>59</b> and <b>60</b>, respectively, values comparable to those of several protease inhibitors currently under clinical investigation. Remarkable also was the replicon EC<sub>90</sub> measured for <b>59</b> and <b>60</b>: 3 nM in 10% FBS, 40 nM and 34 nM, respectively, in 50% NHS.</div><div class="NLM_p">The in vitro profiling of analogues <b>57</b>, <b>59</b>, and <b>60</b> was further extended to assess their stability in liver microsomes in the presence of NADPH and in hepatocytes. In both systems, the compounds showed an encouraging profile, with stability rank order dog > rat ∼ human. Metabolite identification studies in rat, dog, and human hepatocytes showed a similar profile for the three analogues, with the formation of several species derived by oxidation in multiple parts of the macrocyclic structure with the exception of the isoindoline core.</div><div class="NLM_p">Proceeding in the characterization of these analogues, we were pleased to observe that for the isoindoline derivatives the most promising in vivo profiles were associated with the highest potency, in contrast with our previous findings in the isoquinoline series. Indeed following iv and po dosing in rat at 4 mg/kg, both <b>59</b> and <b>60</b> showed moderate plasma clearance (17 and 25 mL/min/kg, respectively). However, <b>59</b> and <b>60</b> displayed improved systemic exposure and bioavailability over <b>57</b>, with oral AUC = 0.70 μM·h and <i>F</i> = 13% and 36%, respectively. An additional attribute for the isoleucine derivative <b>59</b> was the superior liver concentration seen with this compound, which provided a 2-fold improvement in liver exposure over <b>60</b> (liver levels at 4 <i>h</i> = 0.35 and 0.18 μM, respectively). Overall, the profile of <b>59</b> prompted us to select this particular analogue for further investigation. The pharmacokinetic properties of <b>59</b> in rats were further evaluated following conversion of the acid <i>N</i>-acyl-sulphonamide moiety into the corresponding amorphous potassium salt (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). We were pleased to find that oral dosing of the potassium salt form in rats at 5 mg/kg resulted in higher plasma exposure compared to the free base, with a more than 2-fold increase in the measured AUC (1.7 μM·h). Importantly, the K<sup>+</sup> salt of <b>59</b> displayed detectable liver levels at 24 h from dosing, with liver concentration of 0.01 μM. On the basis of these encouraging data, we selected the K<sup>+</sup> salt of <b>59</b> for a dose proportionality study in rat, administering the compound orally at 10, 20, and 30 mg/kg, respectively. As reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, a more than dose proportional increase was observed for both plasma exposure and <i>C</i><sub>max</sub>, which reached the values of 21 μM·h and 8 μM, respectively, at the highest dose. In contrast, the liver levels measured at 24 h increased in a linear manner and, noticeably, the measured concentration of <b>59</b> in liver following a single oral dose of 20 mg/kg and higher was comparable or higher than the replicon EC<sub>90</sub> measured in high serum conditions (EC<sub>90</sub> = 40 nM). The pharmacokinetic profile of the K<sup>+</sup> salt of <b>59</b> in beagle dogs was also encouraging. The compound was dosed at 2 mg/kg intravenously and orally at 2, 5, and 10 mg/kg and, despite a high plasma clearance of 38 mL/min/kg, <b>59</b> displayed acceptable oral bioavailability with <i>F</i> = 17% at 2 mg/kg (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Similarly to what was previously observed in rat, also in dog a more than linear increase was found in oral exposure with increasing dose, reaching the values of AUC = 10 μM·h and <i>C</i><sub>max</sub> = 4 μM at 10 mg/kg. These data showed that it is possible for inhibitors belonging to this structural class to reach satisfactory levels of systemic exposure following oral dosing in at least two different preclinical species and, in combination with the sustained liver levels observed in rat, suggest a potential to achieve significant liver exposure also in the clinical setting.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Parameters and Liver Levels for Amorphous <b>59</b>-Potassium Salt Following Oral and Intravenous Administration in Rat and Dog (3 Animals per Group)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col width="12.5%" align="left" /></col><col width="12.5%" align="left" /></col><col width="12.5%" align="char" char="." /></col><col width="12.5%" align="char" char="." /></col><col width="12.5%" align="char" char="." /></col><col width="12.5%" align="char" char="." /></col><col width="12.5%" align="char" char="." /></col><col width="12.5%" align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">compd</th><th align="center">species</th><th align="center" char=".">dose (mg/kg)</th><th align="center" char=".">Clp<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (mL/m in/kg)</th><th align="center" char=".">AUCpo<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> (μM*h)</th><th align="center" char="."><i>C</i><sub>max</sub><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a> (μM)</th><th align="center" char="."><i>F</i> (%)<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th><th align="center" char=".">liver conc<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a> 24 h, po (μM)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>59</b></td><td align="left">rat</td><td align="char" char=".">4<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></td><td align="char" char=".">17</td><td align="char" char=".">0.7</td><td align="char" char=".">0.4</td><td align="char" char=".">13</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>59</b>-<b>K</b><sup><b>+</b></sup></td><td align="left">rat</td><td align="char" char=".">5<a class="ref internalNav" href="#t3fn7" aria-label="g">g</a></td><td align="char" char="."> </td><td align="char" char=".">1.7</td><td align="char" char=".">0.5</td><td align="char" char=".">26<a class="ref internalNav" href="#t3fn8" aria-label="h">h</a></td><td align="char" char=".">0.01</td></tr><tr valign="top"><td align="left"><b>59</b>-<b>K</b><sup><b>+</b></sup></td><td align="left">rat</td><td align="char" char=".">10<a class="ref internalNav" href="#t3fn7" aria-label="g">g</a></td><td align="char" char="."> </td><td align="char" char=".">2.5</td><td align="char" char=".">1.4</td><td align="char" char="."> </td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>59</b>-<b>K</b><sup><b>+</b></sup></td><td align="left">rat</td><td align="char" char=".">20<a class="ref internalNav" href="#t3fn7" aria-label="g">g</a></td><td align="char" char="."> </td><td align="char" char=".">13.3</td><td align="char" char=".">5.9</td><td align="char" char="."> </td><td align="char" char=".">0.04</td></tr><tr valign="top"><td align="left"><b>59</b>-<b>K</b><sup><b>+</b></sup></td><td align="left">rat</td><td align="char" char=".">30<a class="ref internalNav" href="#t3fn7" aria-label="g">g</a></td><td align="char" char="."> </td><td align="char" char=".">21.0</td><td align="char" char=".">8.0</td><td align="char" char="."> </td><td align="char" char=".">0.06</td></tr><tr valign="top"><td align="left"><b>59</b>-<b>K</b><sup><b>+</b></sup></td><td align="left">dog</td><td align="char" char=".">2<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></td><td align="char" char=".">38</td><td align="char" char=".">0.2</td><td align="char" char=".">0.06</td><td align="char" char=".">17</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>59</b>-<b>K</b><sup><b>+</b></sup></td><td align="left">dog</td><td align="char" char=".">5<a class="ref internalNav" href="#t3fn7" aria-label="g">g</a></td><td align="char" char="."> </td><td align="char" char=".">0.5</td><td align="char" char=".">1.16</td><td align="char" char="."> </td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>59</b>-<b>K</b><sup><b>+</b></sup></td><td align="left">dog</td><td align="char" char=".">10<a class="ref internalNav" href="#t3fn7" aria-label="g">g</a></td><td align="char" char="."> </td><td align="char" char=".">10</td><td align="char" char=".">4.0</td><td align="char" char="."> </td><td align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Plasma clearance.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Area under the curve following oral administration.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Maximum plasma concentration after oral dosing.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Oral bioavailability.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">Concentration of compound measured in rat liver at 24 h from oral dosing.</p></div><div class="footnote" id="t3fn6"><sup>f</sup><p class="last">Dosed intravenously; rat: DMSO/PEG-400/water 20%/60%20%; dog: DMSO/saline 30%/70%.</p></div><div class="footnote" id="t3fn7"><sup>g</sup><p class="last">Dosed orally; rat: solution, PEG-400; dog: solution, PEG-400/water 70%/30%.</p></div><div class="footnote" id="t3fn8"><sup>h</sup><p class="last">Compared to <b>59</b>-free base dosed intravenously at 4 mg/kg.</p></div></div></div><div class="NLM_p last">In view of the interesting overall profile shown by <b>59</b>, the compound was further evaluated and found to be an inhibitor of wild type NS3 protease of genotypes 2a and 3a with <i>K</i><sub>i</sub> = 0.4 nM and <i>K</i><sub>i</sub> = 45 nM, respectively. Interestingly, <b>59</b> also proved to be a low nanomolar inhibitor of the mutant enzyme carrying the R155K single point mutation, a variant associated with decreased sensitivity to protease inhibitors both in vitro and in the clinical setting (<i>K</i><sub>i</sub> = 4 nM).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Moreover, <b>59</b> did not significantly inhibit other serine proteases (>15000-fold selectivity over trypsin and chymotripsin) and showed more than 100000-fold selectivity in a broad range screen on more than 150 different enzyme and receptor assays.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84502" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84502" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Within the class of P2−P4 macrocyclic inhibitors of HCV NS3/4A we investigated the possibility of replacing the P4 carbamate with a suitably substituted heterocycle. We discovered that the introduction of a 2-amino-1,3-thiazole within the macrocyclic linker was well tolerated in terms of potency and can offer an acceptable pharmacokinetic profile. Following on from these initial findings, optimization studies within the aminothiazole series were conducted to address structural modifications in the P3, P2, and P1 region of the macrocyclic core as well as in the linker chain and resulted in the identification of a series of compounds characterized by levels of enzyme and cellular potency comparable to those of current clinical candidates. Among these analogues, the isoindoline analogue <b>59</b> was evaluated in more detail and proved to be also a potent inhibitor of genotype 2a NS3 protease as well as of the clinically relevant mutant R155K. Moreover, <b>59</b> had an acceptable preclinical pharmacokinetic profile and displayed sustained lever levels following oral administration in rat.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75513" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75513" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Molecular Modeling</h3><div class="NLM_p last">The crystal structure of a peptidomimetic inhibitor bound to the NS3 protease was used as a starting point to build the macrocyclic inhibitor.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> After minimization, a conformational analysis was performed with MacroModel<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> generating 10000 initial conformers for each compound using the Monte Carlo algorithm. The conformers were subsequently energy-minimized with the MMFF method.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> Finally, the compound was optimized in the active site of the protein.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chemistry</h3><div class="NLM_p">Reagents and solvents were obtained from commercial suppliers and were used without further purification. Flash chromatography purifications were performed on Merck silica gel (200−400 mesh) as the stationary phase or were conducted using prepacked cartridges on a Biotage system, eluting with PE 40−60 °C/EtOAc or DCM/MeOH mixtures. Analytical high performance and ultraperformance liquid chromatography−mass analysis (HPLC-MS and UPLC-MS) were performed on either a Waters Alliance 2795 apparatus or a Waters Acquity UPLC instrument, equipped with a PDA detector and a Waters ZQ mass spectrometer, using a X-Terra C<sub>18</sub> column (5 μm, 4.6 mm × 50 mm), an Acquity UPLC BEH C<sub>18</sub> column (1.7 μm, 2.1 mm × 50 mm), or an Acquity UPLC BEH Shield RP<sub>18</sub> column (1.7 μm, 2.1 mm × mm 50 mm). Mobile phase comprised a linear gradient of binary mixtures of H<sub>2</sub>O and MeCN, both containing 0.1% of HCO<sub>2</sub>H. Preparative RP-HPLC was carried out on a Waters Micromass system incorporating a 2525 pump module, a Micromass ZQ detector and a 2767 collection module under Fraction Linx software or on a Shimadzu 10AV-VP coupled with a diode array detector SPD10AV-VP, using either a Waters Symmetry C<sub>18</sub> (7 μm, 19 mm × 300 mm) or a Waters XBridge C<sub>18</sub> (5 μm, 19 mm × 100 mm) column. Eluting conditions comprised a linear gradient of binary mixtures of H<sub>2</sub>O and MeCN, both containing 0.1% of TFA, flow rate 20 mL/min. All final compounds within the aminothiazole series were isolated as TFA salts.</div><div class="NLM_p">Nuclear magnetic resonance spectra (<sup>1</sup>H NMR recorded at frequencies between 300 and 600 MHz) were obtained on Bruker Avance spectrometers and are referenced in ppm relative to TMS. Unless otherwise indicated, spectra were acquired at 300 K.</div><div class="NLM_p">Low resolution mass spectra (MS) were obtained on a Perkin-Elmer API 100 or on a Waters MicroMass ZQ, operating in negative (ES<sup>−</sup>) or positive (ES<sup>+</sup>) electrospray ionization mode, and results are reported as the ratio of mass over charge (<i>m</i>/<i>z</i>). High resolving power accurate mass measurement electrospray mass spectral data (HRMS) were acquired by use of a Bruker Daltonics apex-Qe Fourier transform ion cyclotron resonance mass spetrometer (FT-ICR MS). External calibration was accomplished with oligomers of polypropylene glycol.</div><div class="NLM_p">The purity of final compounds was assessed by two different analytical UPLC methods and found to be ≥95% in all cases. The UPLC analysis was perfomed on a Waters Acquity UPLC instrument, equipped with a PDA detector, using one of the following two methods: (1) Method A: column Acquity UPLC BEH C<sub>18</sub> (1.7 μm, 2.1 mm × 50 mm); gradient: 10% to 100% MeCN/H<sub>2</sub>O (0.1% HCO<sub>2</sub>H) in 2.5 min, flow rate 0.5 mL/min. 2). Method B: column Acquity UPLC BEH Shield RP <sub>18</sub> (1.7 μm, 2.1 mm × 50 mm); gradient: 30% to 100% MeCN/H<sub>2</sub>O (0.1% HCO<sub>2</sub>H) in 2.6 min, flow rate 0.5 mL/min.</div><div class="NLM_p last">Compounds <b>7</b>,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><b>10A</b>,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a><b>10B</b>,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a><b>10C</b>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a><b>13A</b>,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and <b>13B</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> were prepared according to reported literature procedures.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Synthesis of 2-Amino-1,3,4-oxadiazole Analogue <b>4</b>. Pent-4-enohydrazide (<b>6</b>)</h3><div class="NLM_p last">To a solution of pent-4-enoic acid (3.96 g, 39.6 mmol) in DCM (400 mL) was added <i>tert</i>-butyl carbazate (10.46 g, 79.0 mmol), followed by 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (7.74 g, 40.4 mmol), and the mixture was stirred at RT for 16 h. The reaction mixture was then diluted with DCM, washed sequentially with sat. aq NaHCO<sub>3</sub> and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure to give <i>tert</i>-butyl 2-pent-4-enoylhydrazinecarboxylate as a colorless oil (8.48 g). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.33 (bs, 1H), 6.51 (bs, 1H), 5.82 (m, 1H), 5.10−4.99 (m, 2H), 2.43−2.38 (m, 2H), 2.32 (t, <i>J</i> = 6.8 Hz, 2H), 2.03 (s, 9H). The obtained hydrazide was then dissolved in DCM (70 mL), and trifluoroacetic acid (75 mL, 973 mmol) was added dropwise at 0 °C. The resulting mixture was allowed to warm to RT over 1 h and brought to pH = 7 by addition of sat. aq NaHCO<sub>3</sub>. The phases were separated and the organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure to give <b>6</b> as a pale-yellow oil (2.1 g, 44% yield from pent-4-enoic acid). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.95 (bs, 1H), 5.79 (m, 1H), 5.04 (dd, <i>J</i> = 17.0, 1.6 Hz, 1H), 4.97 (d, <i>J</i> = 10.0 Hz, 1H), 4.26 (bs, 2H), 2.45−2.23 (m, 2H), 2.12−2.08 (m, 2H).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Methyl <i>N</i>-[(2-Pent-4-enoylhydrazino)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valinate (<b>8</b>)</h3><div class="NLM_p last">Isocyanate <b>7</b><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (3.92 g, 24.9 mmol) was added to a solution of <b>6</b> (1.9 g, 16.6 mmol) in dioxane (10 mL), and the resulting mixture was stirred 3 h at RT. The volatiles were then removed under reduced pressure, and the residue was purified by SiO<sub>2</sub> gel chromatography (PE/EtOAc = 1/1) to obtain <b>8</b> as a pale-yellow oil (3.0 g, 66% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.55 (d, <i>J</i> = 2.1 Hz, 1H), 7.86 (d, <i>J</i> = 2.2 Hz, 1H), 6.48 (d, <i>J</i> = 8.7 Hz, 1H), 5.81 (m, 1H), 5.04 (dd, <i>J</i> = 17.2, 1.5 Hz, 1H), 4.96 (dd, <i>J</i> = 10.3, 1.5 Hz, 1H), 4.09 (dd, <i>J</i> = 8.7, 5.7 Hz, 1H), 3.64 (s, 3H), 2.32−2.24 (m, 2H), 2.22−2.15 (m, 2H), 1.94 (m, 1H), 0.86 (d, <i>J</i> = 6.9 Hz, 3H), 0.83 (d, <i>J</i> = 6.9 Hz, 3H). MS (ES<sup>+</sup>) C<sub>12</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub> requires 271; found 272 (M + H<sup>+</sup>).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>N</i>-(5-But-3-en-1-yl-1,3,4-oxadiazol-2-yl)-<span class="smallcaps smallerCapital">l</span>-valine (<b>9</b>)</h3><div class="NLM_p last">A mixture of compound <b>8</b> (1.0 g, 3.69 mmol) and POCl<sub>3</sub> (4 mL, 42.9 mmol) was heated at 80 °C for 2 h. After cooling to 0 °C, water (5 mL) was carefully added and the mixture was brought to pH = 7 by addition of solid NaHCO<sub>3</sub>. The mixture was then extracted with EtOAc and the organic layer dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure to give methyl <i>N</i>-(5-but-3-en-1-yl-1,3,4-oxadiazol-2-yl)-<span class="smallcaps smallerCapital">l</span>-valinate as a pale-yellow oil (0.93 g). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.89 (d, <i>J</i> = 8.8 Hz, 1H), 5.83 (m, 1H), 5.08 (d, <i>J</i> = 17.2 Hz, 1H), 5.01 (d, <i>J</i> = 10.3 Hz, 1H), 3.93 (dd, <i>J</i> = 8.8, 6.1 Hz, 1H), 3.64 (s, 3H), 2.75 (t, <i>J</i> = 7.3 Hz, 2H), 2.43−2.39 (m, 2H), 2.10 (m, 1H), 0.94 (d, <i>J</i> = 6.8 Hz, 3 H), 0.92 (d, <i>J</i> = 6.8 Hz, 3 H). MS (ES<sup>+</sup>) C<sub>12</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub> requires 253; found 254 (M + H<sup>+</sup>). A solution of the obtained methyl ester (0.45 g, 1.78 mmol) and LiOH (85 mg, 3.55 mmol) in H<sub>2</sub>O/THF (1/1 v/v, 10 mL) was stirred for 1 h at RT. HCl (1N aq) was then added dropwise until pH = 2 was reached and the mixture was extracted with EtOAc. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure to obtain <b>9</b> as a pale-yellow solid (0.42 g, 98% yield over two steps). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.98 (bs, 1H), 7.63 (d, <i>J</i> = 8.8 Hz, 1H), 5.82 (m, 1H), 5.08 (d, <i>J =</i> 17.1 Hz, 1H), 5.01 (d, <i>J</i> = 10.3 Hz, 1H), 3.86 (dd, <i>J</i> = 9.1, 5.8 Hz, 1H), 2.75 (t, <i>J</i> = 7.5 Hz, 2H), 2.42−2.37 (m, 2H), 2.12 (m, 1H), 0.98−0.92 (m, 6H). MS (ES<sup>+</sup>) C<sub>11</sub>H<sub>17</sub>N<sub>3</sub>O<sub>3</sub> requires 239; found 240 (M + H<sup>+</sup>).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Methyl <i>N</i>-(5-But-3-en-1-yl-1,3,4-oxadiazol-2-yl)-<span class="smallcaps smallerCapital">l</span>-valyl-4-[(7-vinylisoquinolin-1-yl)oxy]-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>11</b>)</h3><div class="NLM_p last">To a solution of <b>10A</b> (0.67 g, 1.81 mmol) in DCM (15 mL) was added <b>9</b> (0.42 g, 1.78 mmol), followed by <sup><i>i</i></sup>Pr<sub>2</sub>NEt (0.93 mL, 5.33 mmol) and TBTU (0.63 g, 1.95 mmol). The resulting reaction mixture was stirred for 12 h at RT and partitioned between EtOAc and brine. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated under reduced pressure, and the residue was purified by SiO<sub>2</sub> gel chromatography (PE/EtOAc = 1/1) to give <b>11</b> as a colorless oil (0.3 g, 33% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.01 (bs, 1H), 7.95 (d, <i>J</i> = 5.7 Hz, 1H), 7.83 (dd, <i>J</i> = 8.8, 1.3 Hz, 1H), 7.68 (d, <i>J</i> = 8.9 Hz, 1H), 7.22 (d, <i>J</i> = 5.7 Hz, 1H), 6.90 (dd, <i>J</i> = 17.6, 10.9 Hz, 1H), 5.91(m, 1H), 5.87 (d, <i>J</i> = 17.5 Hz, 1H), 5.81 (m, 1H), 5.35 (d, <i>J</i> = 10.9 Hz, 1H), 5.29 (d, <i>J</i> = 8.8 Hz, 1H), 5.06 (d, <i>J</i> = 17.5 Hz, 1H), 5.02 (d, <i>J</i> = 10.0 Hz, 1H), 4.78 (t, <i>J</i> = 8.3 Hz, 1H), 4.39 (dd, <i>J</i> = 8.9, 5.5 Hz, 1H), 4.27 (d, <i>J</i> = 11.5 Hz, 1H), 4.13 (dd, <i>J</i> = 11.5, 4.5 Hz, 1H), 3.78 (s, 3H), 2.76 (m, 1H), 2.67 (t, <i>J</i> = 7.7 Hz, 2H), 2.42−2.34 (m, 3H), 2.19 (m, 1H), 1.11 (d, <i>J</i> = 6.8 Hz, 3H), 1.01 (d, <i>J</i> = 6.8 Hz, 3H). MS (ES<sup>+</sup>) C<sub>28</sub>H<sub>33</sub>N<sub>5</sub>O<sub>5</sub> requires 519; found 520 (M + H<sup>+</sup>).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Methyl (3<i>R</i>,5<i>S</i>,8<i>S</i>,16-<i>E</i>)-8-Isopropyl-7-oxo-2,27-dioxa-6,9,11,12,24-pentaazapentacyclo[16.6.2.1<sup>3,6</sup>.1<sup>10,13</sup>.0<sup>21,25</sup>]octacosa-1(24),10,12,16,18,20,22,25-octaene-5-carboxylate (<b>12</b>)</h3><div class="NLM_p last">To a solution of <b>11</b> (0.1 g, 0.19 mmol) in DCE (20 mL) at 80 °C was added the Zhan 1<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> catalyst (25 mg, 0.038 mmol), and the resulting reaction mixture was stirred at 80 °C for 2 h (only <i>E</i>-isomer detected by UPLC-MS analysis). After cooling to RT, the volatiles were removed under reduced pressure and the residue was purified by SiO<sub>2</sub> gel chromatography (PE/EtOAc = 3/7) to obtain <b>12</b> as a pale-yellow oil (55 mg, 55% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.86 (d, <i>J</i> = 5.9 Hz, 1H), 7.78 (bs, 1H), 7.60 (d, <i>J</i> = 8.3 Hz, 1H), 7.46 (dd, <i>J</i> = 8.3, 1.7 Hz, 1H), 7.16 (d, <i>J</i> = 5.9 Hz, 1H), 6.47 (d, <i>J</i> = 16.0 Hz, 1H), 5.85 (ddd, <i>J</i> = 16.0, 8.8, 6.6 Hz, 1H), 5.74 (t, <i>J</i> = 3.3 Hz, 1H), 5.38 (d, <i>J</i> = 9.9 Hz, 1H), 4.68 (dd, <i>J</i> = 9.9, 8.1 Hz, 1H), 4.61−4.53 (m, 2H), 3.92 (dd, <i>J</i> = 11.4, 3.3 Hz, 1H), 3.75 (s, 3H), 2.96−2.86 (m, 2H), 2.67−2.60 (m, 2H), 2.26 (m, 1H), 2.14 (m, 1H), 1.16 (d, <i>J</i> = 6.7 Hz, 3H), 1.14 (d, <i>J</i> = 6.7 Hz, 3H). MS (ES<sup>+</sup>) C<sub>26</sub>H<sub>29</sub>N<sub>5</sub>O<sub>5</sub> requires 491; found 492 (M + H<sup>+</sup>).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 3<i>R</i>,5<i>S</i>,8<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(Cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-8-isopropyl-7-oxo-2,27-dioxa-6,9,11,12,24-pentazapentacyclo[16.6.2.1<sup>3,6</sup>.1<sup>10,13</sup>.0<sup>21,25</sup>]octacosa-1(24),10,12,18,20,22,25-heptaene-5-carboxamide (<b>4</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (55 mg, 0.047 mmol) in EtOH (10 mL) was added 10% Pd/C (0.005 mg, 10% w/w), and the resulting reaction mixture was stirred at RT under an atmosphere of H<sub>2</sub> for 2 h. The catalyst was filtered off, and the volatiles were removed under reduced pressure to give methyl (3<i>R</i>,5<i>S</i>,8<i>S</i>)-8-isopropyl-7-oxo-2,27-dioxa-11-thia-6,9,11,12,24-pentaazapentacyclo[16.6.2.1<sup>3,6</sup>.1<sup>10,13</sup>.0<sup>21,25</sup>]octacosa-1(24),10,12,18,20,22,25-heptaene-5-carboxylate as a colorless oil (49 mg, 89% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.85 (d, <i>J</i> = 5.7 Hz, 1H), 7.64 (s, 1H), 7.60 (d, <i>J</i> = 8.3 Hz, 1H), 7.43 (d, <i>J</i> = 8.3 Hz, 1H), 7.18 (d, <i>J</i> = 6.1 Hz, 1H), 5.83 (m, 1H), 5.19 (m, 1H), 4.78 (d, <i>J</i> = 11.4 Hz, 1H), 4.64 (dd, <i>J</i> = 10.2, 8.0 Hz, 1H), 4.43 (d, <i>J</i> = 9.7 Hz, 1H), 3.99 (dd, <i>J</i> = 11.7, 3.2 Hz, 1H), 3.77 (s, 3H), 3.75−3.73 (m, 2H), 3.49 (t, <i>J</i> = 3.5 Hz, 1H), 2.97−2.90 (m, 2H), 2.60 (m, 1H), 2.27 (m, 1H), 2.17 (m, 1H), 1.18−1.77 (m, 2H), 0.93−0.88 (m, 6H). MS (ES<sup>+</sup>) C<sub>26</sub>H<sub>31</sub>N<sub>5</sub>O<sub>5</sub> requires 493; found 494 (M + H<sup>+</sup>). A solution of the obtained methyl ester (49 mg, 0.099 mmol) and LiOH (9.5 mg, 0.40 mmol) in H<sub>2</sub>O/THF (1/1 v/v, 2 mL) was stirred for 1 h at RT. HCl (1N aq) was then added dropwise until pH = 2 was reached and the mixture was extracted with EtOAc. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure to obtain (3<i>R</i>,5<i>S</i>,8<i>S</i>)-8-isopropyl-7-oxo-2,27-dioxa-6,9,11,12,24-pentaazapentacyclo[16.6.2.1<sup>3,6</sup>.1<sup>10,13</sup>.0<sup>21,25</sup>]octacosa-1(24),10,12,18,20,22,25-heptaene-5-carboxylic acid as a white solid (47 mg, 99% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.91 (d, <i>J</i> = 6.1 Hz, 1H), 7.71 (s, 1H), 7.65 (d, <i>J</i> = 8.3 Hz, 1H), 7.49 (d, <i>J</i> = 8.3 Hz, 1H), 7.24 (d, <i>J</i> = 6.1 Hz, 1H), 5.96 (m, 1H), 4.75 (t, <i>J</i> = 9.0 Hz, 1H), 4.61 (d, <i>J</i> = 11.8 Hz, 1H), 4.40 (d, <i>J</i> = 6.8 Hz, 1H), 3.99 (dd, <i>J</i> = 11.9, 3.2 Hz, 1H), 2.98−2.82 (m, 4H), 2.67−2.53 (m, 2H), 2.25−2.17 (m, 2H), 1.83−1.70 (m, 2H), 1.60 (m, 1H), 1.11−1.06 (m, 6H). MS (ES<sup>+</sup>) C<sub>25</sub>H<sub>29</sub>N<sub>5</sub>O<sub>5</sub> requires 479; found 480 (M + H<sup>+</sup>). To a solution the obtained carboxylic acid in DMF (1 mL) was added <b>13A</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (29 mg, 0.108 mmol), followed by <sup><i>i</i></sup>Pr<sub>2</sub>NEt (0.019 mL, 0.108 mmol) and TBTU (32 mg, 0.099 mmol). The resulting reaction mixture was stirred for 12 h at RT and purified by reverse phase HPLC to give the title compound as an off-white solid (25 mg, 37% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.34 (s, 1H), 8.93 (s, 1H), 7.95 (d, <i>J</i> = 9.2 Hz, 1H), 7.92 (d, <i>J</i> = 5.9 Hz, 1H), 7.78 (d, <i>J</i> = 8.3 Hz, 1H), 7.68 (s, 1H), 7.60 (d, <i>J</i> = 8.3 Hz, 1H), 7.36 (d, <i>J</i> = 5.9 Hz, 1H), 5.76 (m, 1H), 5.60 (m, 1H), 5.21 (d, <i>J</i> = 17.1 Hz, 1H), 5.08 (d, <i>J</i> = 10.7 Hz, 1H), 4.90 (d, <i>J</i> = 11.3 Hz, 1H), 4.25−4.16 (m, 2H), 3.97 (dd, <i>J</i> = 11.3, 3.3 Hz, 1H), 2.96−2.89 (m, 4H), 2.86−2.58 (m, 2H), 2.19−2.07 (m, 3H), 1.75−1.62 (m, 5H), 1.41 (m, 1H), 1.29 (m, 1H), 1.10−1.05 (m, 3H), 1.01 (d, <i>J</i> = 6.6 Hz, 3H), 0.96 (d, <i>J</i> = 6.6 Hz, 3 H). HRMS (ES<sup>+</sup>) expected for C<sub>34</sub>H<sub>42</sub>N<sub>7</sub>O<sub>7</sub>S (M + H<sup>+</sup>) 692.2861; found 692.2886.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Synthesis of 2-Amino-1,3-thiazole Analogue <b>5</b>. 1-Bromohex-5-en-2-one (<b>14a</b>)</h3><div class="NLM_p last">A solution of 4-pentenoyl chloride (0.78 g, 6.6 mmol) in Et<sub>2</sub>O (5 mL) was added portionwise to a freshly prepared solution of diazomethane (ca. 16.6 mmol, 2.5 equiv) in Et<sub>2</sub>O (50 mL) at 0 °C. The resulting reaction mixture was stirred for 30 min at 0 °C and for further 12 h at RT in an open flask. After cooling at 0 °C, HBr (48% aq, 1.3 mL, 8.6 mmol) was added dropwise, and the resulting reaction mixture was stirred at RT for 15 min, after which time the gas evolution had ceased. The ethereal solution was then washed with sat. aq NaHCO<sub>3</sub> (2 × 50 mL), brine (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure to give the title compound as a pale-yellow oil (1.09 g, 94% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.80 (m, 1H), 5.06 (dd, <i>J</i> = 17.5, 1.3 Hz, 1H), 5.01 (dd, <i>J</i> = 10.5, 1.2 Hz, 1H), 3.88 (s, 2H), 2.76 (t, <i>J</i> = 7.3 Hz, 2H), 2.37 (m, 2H).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Methyl <span class="smallcaps smallerCapital">l</span>-Valyl-(4<i>R</i>)-4-[(7-vinylisoquinolin-1-yl)oxy]-<span class="smallcaps smallerCapital">l</span>-prolinate Hydrochloride (<b>18</b>)</h3><div class="NLM_p last">To a solution of <b>10A</b> hydrochloride (1.0 g, 2.72 mmol) in DMF (10 mL) was added Boc-(<span class="smallcaps smallerCapital">l</span>)-Val (0.61 g, 2.83 mmol), followed by <sup><i>i</i></sup>Pr<sub>2</sub>NEt (1.65 mL, 9.45 mmol) and TBTU (9.09 g, 2.83 mmol). The resulting reaction mixture was stirred 12 h at RT and partitioned between EtOAc and 1N aq HCl. The organic layer was further washed with sat. aq NaHCO<sub>3</sub>, brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The residue was purified by SiO<sub>2</sub> gel chromatography (PE/EtOAc = 7/3) to give methyl <i>N</i>-(<i>tert</i>-butoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-[(7-vinylisoquinolin-1-yl)oxy]-<span class="smallcaps smallerCapital">l</span>-prolinate as a colorless oil (0.65 g, <i>Y</i> = 54%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.01 (s, 1H), 7.92 (d, <i>J</i> = 5.8 Hz, 1H), 7.80 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.68 (d, <i>J</i> = 8.4 Hz, 1H), 7.21 (d, <i>J</i> = 5.4 Hz, 1H), 6.87 (dd, <i>J</i> = 17.5, 11.0 Hz, 1H), 5.89−5.83 (m, 2H), 5.34 (d, <i>J</i> = 11.0 Hz, 1H), 5.19 (bd, <i>J</i> = 8.8 Hz, 1H), 4.79 (bt, <i>J</i> = 8.3 Hz, 1H), 4.28−4.21 (m, 2H), 4.08 (dd, <i>J</i> = 11.5, 4.4 Hz, 1H), 3.77 (s, 3H), 2.72 (m, 1H), 2.36 (m, 1H), 2.05 (m, 1H), 1.03 (d, <i>J</i> = 6.7 Hz, 3H), 0.93 (d, <i>J</i> = 6.7 Hz, 3H). MS (ES<sup>+</sup>) C<sub>27</sub>H<sub>35</sub>N<sub>3</sub>O<sub>6</sub> requires 497; found: 498 (M + H<sup>+</sup>). A solution of the above compound (0.65 g, 1.31 mmol) in HCl/dioxane (4N, 10 mL) was stirred at RT for 2 h. The volatiles were then removed under reduced pressure to give <b>18</b> as an off-white solid (0.56 g). MS (ES<sup>+</sup>) C<sub>22</sub>H<sub>27</sub>N<sub>3</sub>O<sub>4</sub> requires 397; found 398 (M + H<sup>+</sup>).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Methyl <i>N</i>-(Aminocarbonothioyl)-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-[(7-vinylisoquinolin-1-yl)oxy]-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>19</b>)</h3><div class="NLM_p last"><sup><i>i</i></sup>Pr<sub>2</sub>NEt (0.44 mL, 2.5 mmol) was added to a suspension of <b>18</b> (0.54 g, 1.25 mmol) in DCM (5 mL) at 0 °C, and the resulting solution was immediately added to a solution of FMOC isothiocyanate (0.39 g, 1.37 mmol) in DCM (5 mL) at 0 °C. The resulting mixture was stirred at RT for 30 min and then treated with a 20% solution of piperidine in MeOH (5 mL). After 3 h, the volatiles were removed under reduced pressure and the residue was purified by SiO<sub>2</sub> gel chromatography (gradient elution, PE/EtOAc = 8/2 to DCM/MeOH = 95/5) to give the title compound as a pale-yellow foam (0.53 g, 93% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.12 (s,1H), 7.90 (d, <i>J</i> = 5.8 Hz, 1H), 7.78 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 7.65 (d, <i>J</i> = 8.5 Hz, 1H), 7.19 (d, <i>J</i> = 5.7 Hz, 1H), 6.91 (dd, <i>J</i> = 17.7, 10.9 Hz, 1H), 6.26 (bs, 2H), 5.91−5.86 (m, 2H), 5.34 (d, <i>J</i> = 11.1 Hz, 1H), 4.94 (m, 1H), 4.85 (bd, <i>J</i> = 11.1 Hz, 1H), 4.64 (bt, <i>J</i> = 8.6 Hz, 1H), 4.14−4.07 (m, 2H), 3.72 (s, 3H), 2.77 (m, 1H), 2.36 (m, 1H), 2.07 (m, 1H), 1.11 (d, <i>J</i> = 6.8 Hz, 3H), 1.06 (d, <i>J</i> = 6.7 Hz, 3H). MS (ES<sup>+</sup>) C<sub>23</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub>S requires 456; found 457 (M + H<sup>+</sup>).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Methyl <i>N</i>-(4-But-3-en-1-yl-1,3-thiazol-2-yl)-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-[(7-vinylisoquinolin-1-yl)oxy]-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>20a</b>)</h3><div class="NLM_p last">A solution of thiourea <b>19</b> (0.19 g, 0.42 mmol) and <b>14a</b> (0.11 g, 0.63 mmol) in dioxane (3 mL) was stirred at 65 °C for 1 h. The volatiles were then removed under reduced pressure and the residue was purified by SiO<sub>2</sub> gel chromatography (DCM/MeOH = 98/2) to give the title compound as a pale-brown oil (0.21 g, 93% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.92 (d, <i>J</i> = 5.7 Hz, 1H), 7.87 (bs, 1H), 7.79 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 7.67 (d, <i>J</i> = 8.5 Hz, 1H), 7.20 (d, <i>J</i> = 6.0 Hz, 1H), 6.77 (dd, <i>J</i> = 17.1, 11.0 Hz, 1H), 5.92 (m, 1H), 5.81 (d, <i>J</i> = 17.6 Hz, 1H), 5.68 (s, 1H), 5.59 (m, 1H), 5.39 (bd, <i>J</i> = 10.5 Hz, 1H), 5.33 (d, <i>J</i> = 10.9 Hz, 1H), 4.85−4.76 (m, 2H), 4.44 (d, <i>J</i> = 11.7 Hz, 1H), 4.25 (bt, <i>J</i> = 8.2 Hz, 1H), 4.11 (dd, <i>J</i> = 11.4, 4.4 Hz, 1H), 3.76 (s, 3H), 2.67 (m, 1H), 2.40−2.23 (m, 3H), 2.13−2.05 (m, 3H), 1.10 (d, <i>J</i> = 6.7 Hz, 3H), 1.04 (d, <i>J</i> = 6.7 Hz, 3H). MS (ES<sup>+</sup>) C<sub>29</sub>H<sub>34</sub>N<sub>4</sub>O<sub>4</sub>S requires 534; found 535 (M + H<sup>+</sup>).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Methyl (3<i>R</i>, 5<i>S</i>, 8<i>S</i>)-8-Isopropyl-7-oxo-2oxa-11-thia-6,9,24,27-tetraazapentacyclo[16.6.2.1<sup>3,5</sup>.1<sup>10,13</sup>.0<sup>21,25</sup>]octacosa-1(24),10(27),12,18,20,22,25-heptaene-5-carboxylate (<b>21a</b>)</h3><div class="NLM_p last">To a solution of <b>20a</b> (0.2 g, 0.37 mmol) in DCE (7 mL) was added Zhan 1<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> catalyst (36 mg, 0.055 mmol), and the resulting reaction mixture was stirred at 85 °C for 2 h. The volatiles were then removed under reduced pressure, and the residue was purified by SiO<sub>2</sub> gel chromatography (PE/EtOAc = 1/1) to give methyl (3<i>R</i>,5<i>S</i>,8<i>S</i>,16<i>E</i> or <i>Z</i>)-8-isopropyl-7-oxo-2oxa-11-thia-6,9,24,27-tetraazapentacyclo[16.6.2.1<sup>3,5</sup>.1<sup>10,13</sup>.0<sup>21,25</sup>]octacosa-1(24),10(27),12,18,20,22,25-heptaene-5-carboxylate as a ca. 4:1 mixture of <i>E</i>- and <i>Z</i>-olefins as determined by UPLC-MS analysis (pale-brown glass; 0.10 g, 55% yield). MS (ES<sup>+</sup>) C<sub>27</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub>S requires 506; found 507 (M + H<sup>+</sup>). To a solution of the above compound (100 mg, 0.19 mmol) in MeOH/EtOAc (1/1 v/v, 4 mL) was added 10% Pd/C (10 mg, 10% w/w), and the resulting reaction mixture was stirred at RT under an atmosphere of H<sub>2</sub> for 2 h. The catalyst was filtered off, replaced with a fresh aliquot (10 mg), and the reaction mixture was stirred in the above conditions for a further period of time. The process was repeated as previously described until complete conversion to product was observed (typically 36 h, 3 fresh aliquots of catalyst). After filtering off the catalyst, the volatiles were removed under reduced pressure to give <b>21a</b> as a pale-yellow oil (64 mg, 62% yield over two steps). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.88 (d, <i>J</i> = 5.8 Hz, 1H), 7.86 (bs, 1H), 7.63 (d, <i>J</i> = 8.4 Hz, 1H), 7.45 (d, <i>J</i> = 8.6 Hz, 1H), 7.21 (d, <i>J</i> = 5.5 Hz, 1H), 6.01 (s, 1H), 5.97 (m, 1H), 4.76 (bt, <i>J</i> = 8.8 Hz, 1H), 4.67 (m, 1H), 4.23 (d, <i>J</i> = 11.9 Hz, 1H), 3.96 (dd, <i>J</i> = 11.5, 3.7 Hz, 1H), 3.76 (s, 3H), 2.89−2.74 (m, 3H), 2.55−2.50 (m, 2H), 2.37−2.17 (m, 3H), 1.75−1.67 (m, 4H), 1.13 (d, <i>J</i> = 6.7 Hz, 3H), 1.01 (d, <i>J</i> = 6.8 Hz, 3H). MS (ES<sup>+</sup>) C<sub>27</sub>H<sub>32</sub>N<sub>4</sub>O<sub>4</sub>S requires 508; found 509 (M + H<sup>+</sup>).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (3<i>R</i>,5<i>S</i>,8<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(Cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-8-isopropyl-7-oxo-2oxa-11-thia-6,9,24,27-tetraazapentacyclo[16.6.2.1<sup>3,5</sup>.1<sup>10,13</sup>.0<sup>21,25</sup>]octacosa-1(24),10(27),12,18,20,22,25-heptaene-5-carboxylate (<b>5</b>)</h3><div class="NLM_p last">To a solution of methyl ester <b>21a</b> (64 mg, 0.126 mmol) in THF/H<sub>2</sub>O (1/1 v/v, 1 mL) was added LiOH (30 mg, 1.26 mmol). The resulting reaction mixture was stirred at RT for 2 h and then treated with 1N aq HCl until pH = 2 was reached. The volatiles were removed under reduced pressure, and the residue was taken up in toluene (3 mL) and concentrated under reduced pressure three times to give the corresponding carboxylic acid. MS(ES<sup>+</sup>) C<sub>26</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub>S requires 494; found 495 (M + H<sup>+</sup>). To a solution of the latter in DMF (1 mL was added hydrochloride <b>13A</b> (37 mg, 0.138 mmol) followed by <sup><i>i</i></sup>Pr<sub>2</sub>NEt (0.80 mL, 0.44 mmol) and TBTU (44 mg, 0.138 mmol). The resulting reaction mixture was stirred 12 h at RT and purified by preparative RP HPLC to give <b>5</b> as a trifluoroacetate salt (off-white solid, 47 mg, 62% yield). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub> + TFA) δ 10.70 (s, 1H), 9.60 (d, <i>J</i> = 8.9 Hz, 1H), 8.74 (s, 1H), 7.97 (d, <i>J</i> = 5.8 Hz, 1H), 7.91 (bs, 1H), 7.83 (d, <i>J</i> = 8.4 Hz, 1H), 7.61 (dd, <i>J</i> = 8.4, 1.5 Hz, 1H), 7.39 (d, <i>J</i> = 5.8 Hz, 1H), 6.67 (s, 1H), 5.95 (bt, <i>J</i> = 3.5 Hz, 1H), 5.56 (ddd, <i>J</i> = 17.2, 10.4, 9.1 Hz, 1H), 5.21 (dd, <i>J</i> = 17.2, 1.3 Hz, 1H), 5.09 (dd, <i>J</i> = 10.4, 1.3 Hz, 1H), 5.02 (bs, 1H), 4.44 (dd, <i>J</i> = 9.9, 7.6 Hz, 1H), 4.35 (d, <i>J</i> = 11.4 Hz, 1H), 3.93 (dd, <i>J</i> = 11.4, 3.3 Hz, 1H), 2.94−2.86 (m, 2H), 2.72−2.64 (m, 3H), 2.52 (m, 1H), 2.40 (m, 1H), 2.20 (ddd, <i>J</i> = 14.0, 10.4, 4.5 Hz, 1H), 2.13 (app q, <i>J</i> = 8.6 Hz, 1H), 1.78−1.63 (m, 3H), 1.62−1.50 (m, 2H), 1.28 (dd, <i>J</i> = 9.4, 5.3 Hz, 1H), 1.13−0.98 (m, 4H), 1.06 (d, <i>J</i> = 6.8 Hz, 3H), 0.96 (d, <i>J</i> = 6.8 Hz, 3H). HRMS (ES<sup>+</sup>) expected for C<sub>35</sub>H<sub>43</sub>N<sub>6</sub>O<sub>6</sub>S<sub>2</sub> (M + H<sup>+</sup>) 707.2680; found 707.2679.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Procedure for the Synthesis of the α-Bromo-methylketones <b>14b</b> and <b>14c</b></h3><div class="NLM_p last">To a solution of the appropriate carboxylic acid (15 mmol) in DCM (10 mL) at 0 °C was added dropwise oxalylchloride (2 M in DCM, 22.5 mmol) and a catalytic amount of DMF (0.2 mL). The resulting mixture was stirred at RT for 2 h and then concentrated under reduced pressure. The residue was dissolved in Et<sub>2</sub>O (10 mL) and added portionwise to a freshly prepared solution of diazomethane (ca. 33 mmol, 2.2 equiv) in Et<sub>2</sub>O (110 mL) at 0 °C. The resulting mixture was stirred for 30 min at 0 °C and a further 12 h at RT in an open flask. After cooling to 0 °C, HBr (48% aq, 3 mL) was added dropwise and the solution stirred at RT for 30 min until the gas evolution had ceased. The ethereal solution was washed with aq sat. NaHCO<sub>3</sub>, brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The residue was typically used as such in the following step. Alternatively, it could be purified by SiO<sub>2</sub> gel chromatography, eluting with PE/Et<sub>2</sub>O = 98/2.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedure for the Synthesis of the Thioureas <b>23</b>−<b>30</b></h3><div id="sec5_17_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Step 1</h4><div class="NLM_p last">To a 0.3 M solution of one of the P2-building blocks <b>10A</b>−<b>C</b> in DCM was added the appropriate <i>N</i>-Boc-protected amino acid <b>22a</b>−<b>e</b> (1.1 equiv), followed by <sup><i>i</i></sup>Pr<sub>2</sub>NEt (2.0 equiv) and TBTU (1.5 equiv), and the reaction mixture was stirred for 1 h at RT. The volatiles were removed under reduced pressure, and the residue was dissolved in EtOAc. The organic layer was washed with 1N aq HCl, sat. aq NaHCO<sub>3</sub>, brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The residue was purified by SiO<sub>2</sub> gel chromatography (typically with gradient elution: PE/EtOAc = 8/2 to 7/3) to give the <i>N</i>-Boc-protected P2−P3 coupling product.</div></div><div id="sec5_17_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Step 2</h4><div class="NLM_p last">The product from step 1 was dissolved in 4N HCl in dioxane, and the resulting solution (0.4 M) was stirred at RT for 2 h. The volatiles were removed under reduced pressure to give the P2−P3 coupling product as hydrochloride salt.</div></div><div id="sec5_17_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Step 3</h4><div class="NLM_p last">To a 0.25 M solution of the compound from step 2 in DCM at 0 °C was added <sup><i>i</i></sup>Pr<sub>2</sub>NEt (2.0 equiv), and the resulting mixture was added immediately to a 0.25 M solution of Fmoc-isothiocyanate (1.1 equiv) in DCM at 0 °C. The resulting mixture was stirred at RT for 30 min and then treated with a 20% solution of piperidine in MeOH (2.5−5.0 mL) and stirred for further 3 h at RT. The volatiles were removed under reduced pressure, and the residue was purified by SiO<sub>2</sub> gel chromatography (typically with gradient elution PE/EtOAc = 8/2 to DCM/MeOH = 95/5).</div></div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> General Procedure for the Synthesis of the Aminothiazoles <b>20b</b>−<b>c</b> and <b>31a</b>−<b>c</b> to <b>38a</b>−<b>c</b></h3><div class="NLM_p last">A 0.14 M solution of the selected thiourea <b>19</b> or <b>23</b>−<b>30</b> and the chosen α-bromomethylketone <b>14a</b>−<b>c</b> (1.2 equiv) in dioxane was stirred at 65 °C for 1 h. The solution was then cooled to RT, the volatiles were removed under reduced pressure, and the residue was usually employed in the following step without further purification; when required, the compound was purified by SiO<sub>2</sub> gel chromatography (typically with gradient elution PE/EtOAc = 8/2 to DCM/MeOH = 98/2).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> General Procedure for the Synthesis of the Methyl Esters <b>21b</b>−<b>c</b> and <b>39a</b>−<b>c</b> to <b>46a</b>−<b>c</b></h3><div id="sec5_19_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Step 1</h4><div class="NLM_p last">To a 0.015 M solution of the selected aminothiazole <b>20b</b>−<b>c</b> or <b>31a</b>−<b>c</b> to <b>38a</b>−<b>c</b> in DCE at 85 °C was added the Zhan 1<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> catalyst (0.15 equiv), and the resulting reaction mixture was stirred at 85 °C for 2 h. After cooling to RT, the volatiles were removed under reduced pressure and the residue was either used as such in the following step or purified by SiO<sub>2</sub> gel chromatography (typically with gradient elution PE/EtOAc = 8/2 to DCM/MeOH = 98/2).</div></div><div id="sec5_19_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Step 2</h4><div class="NLM_p last">(Performed only en route to analogues bearing a saturated linker chain). To a 0.05 M solution of the methyl ester from step 1 in MeOH/EtOAc (1/1 v/v) was added 10% Pd/C (10% w/w), and the resulting reaction mixture was stirred under an atmosphere of H<sub>2</sub> at RT for 2 h. The catalyst was filtered off, replaced with a fresh aliquot, and the reaction mixture was stirred in the above conditions for a further period of time. The process was repeated as previously described until complete conversion to product was observed (typically 36 h, 3 fresh aliquots of catalyst). After filtering off the catalyst, the volatiles were removed under reduced pressure to give the saturated macrocyclic methyl esters, which were used directly in the following step.</div></div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> General Procedure for the Synthesis of Aminothiazole Macrocyclic Analogues <b>47</b>−<b>60</b></h3><div id="sec5_20_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Step 1</h4><div class="NLM_p last">To a 0.13 M solution of the selected methyl ester <b>21</b> or <b>39</b>−<b>46</b> in THF/H<sub>2</sub>O (1/1 v/v, 1 mL) was added LiOH (10 equiv). The resulting reaction mixture was stirred at RT for 2 h and then treated with 1N aq HCl until pH = 2 was reached. The volatiles were removed under reduced pressure, the residue was taken up in toluene, and concentrated three times to give the corresponding carboxylic acid.</div></div><div id="sec5_20_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Step 2</h4><div class="NLM_p last">To a 0.13 M solution of the carboxylic acid from step 1 in DMF was added hydrochloride <b>13A</b> or <b>13B</b> (1.1 equiv), followed by <sup><i>i</i></sup>Pr<sub>2</sub>NEt (3.5 equiv) and TBTU (1.1 equiv). The resulting reaction mixture was stirred 12 h at RT and purified by preparative RP HPLC to give compounds <b>47</b>−<b>60</b> as a trifluoroacetate salts. The reported yields for the final compounds are all given after preparative RP HPLC purification and calculated over two steps from the macrocyclic methyl ester unless otherwise specified.</div></div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (3<i>R</i>,5<i>S</i>,8<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(Cyclopropylsulfonyl)amino]carbonyl}-2-ethenylcyclopropyl)-8-(1-methylethyl)-7-oxo-2-oxa-11-thia-6,9,25,28-tetraazapentacyclo[17.6.2.1<sup>3,6</sup>.1<sup>10,13</sup>.0<sup>22,26</sup>]nonacosa-1(25),10(28),12,19,21,23,26-heptaene-5-carboxamide (<b>47</b>)</h3><div class="NLM_p last">The title compound was prepared using ester <b>21b</b>(sat) and <b>13A</b>; off-white solid (7 mg, 10% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.57 (s, 1H), 8.98 (s, 1H), 8.01 (d, <i>J</i> = 5.8 Hz, 1H), 7.90−7−77 (m, 2H), 7.67 (d, <i>J</i> = 8.4 Hz, 1H), 7.43 (d, <i>J</i> = 5.8 Hz, 1H), 6.20 (bs, 1H), 6.08 (m, 1H), 5.64 (m, 1H), 5.24 (d, <i>J</i> = 17.0 Hz, 1H), 5.12 (d, <i>J</i> = 10.2 Hz, 1H), 4.48−4.38 (m, 2H), 4.19−3.95 (m, 2H), 2.97 (m, 1H), 2.88−2.74 (m, 2H), 2.48−2.41 (m, 3H), 2.31−2.13 (m, 3H), 1.80−1.69 (m, 3H), 1.54 (m, 1H), 1.36−1.26 (m, 4H), 1.13−0.98 (m, 10H). MS (ES<sup>+</sup>) C<sub>36</sub>H<sub>44</sub>N<sub>6</sub>O<sub>6</sub>S<sub>2</sub> requires 720; found 721 (M + H<sup>+</sup>).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (3<i>R</i>,5<i>S</i>,8<i>S</i>,16<i>E</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(Cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-8-isopropyl-7-oxo-2-oxa-11-thia-6,9,24,27-tetraazapentacyclo[16.6.2.13,5.110,13.021,25]octacosa-1(24),10(27),12,16,18,20,21,23,25-nonaene-5-carboxamide (<b>48</b>)</h3><div class="NLM_p last">The title compound was prepared using ester <b>21b</b>(<i><b>E</b></i>-<b>db</b>) and <b>13A</b>; off-white solid (24 mg, 36% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.83 (s, 1H), 8.69 (s, 1H), 8.33 (s, 1H), 7.98 (d, <i>J</i> = 5.7 Hz, 1H), 7.86 (d, <i>J</i> = 8.4 Hz, 1H), 7.64 (d, <i>J</i> = 8.4 Hz, 1H), 7.40 (d, <i>J</i> = 5.7 Hz, 1H), 6.68−6.53 (m, 2H), 6.36 (m, 1H), 5.78−5.54 (m, 2H), 5.24 (d, <i>J</i> = 17.0 Hz, 1H), 5.15−5.04 (m, 2H), 4.46−4.41 (m, 2H), 3.95 (d, <i>J</i> = 11.4 Hz, 1H), 3.00−2.65 (m, 5H), 2.32−2.11 (m, 4H), 1.73 (m, 1H), 1.28 (m, 1H), 1.17−0.96 (m, 10H). HRMS (ES<sup>+</sup>) expected for C<sub>35</sub>H<sub>41</sub>N<sub>6</sub>O<sub>6</sub>S<sub>2</sub> (M + H<sup>+</sup>) 705.2524; found 705.2557.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (3<i>R</i>,5<i>S</i>,8<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(Cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-8-isopropyl-14,14-dimethyl-7-oxo-2-oxa-11-thia-6,9,24,27-tetraazapentacyclo[16.6.2.1<sup>3,6</sup>.1<sup>10,13</sup>.0<sup>21,25</sup>]octacosa-1(24),10(27),12,18,20,22,25-heptaene-5-carboxamide (<b>49</b>)</h3><div class="NLM_p last">The title compound was prepared using ester <b>21c</b>(sat) and <b>13A</b>; off-white solid (33 mg, 28% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.83 (s, 1H), 8.88 (s, 1H), 7.96 (d, <i>J</i> = 5.8 Hz, 1H), 7.80 (d, <i>J</i> = 8.4 Hz, 1H), 7.75 (s, 1H), 7.58 (bd, <i>J</i> = 8.4 Hz, 1H), 7.38 (d, <i>J</i> = 5.8 Hz, 1H), 6.21 (bs, 1H), 5.89 (bs, 1H), 5.59 (dt, <i>J</i><sub>1</sub> = 17.1 Hz, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 10.1 Hz, 1H), 5.22 (d, <i>J</i> = 17.1 Hz, 1H), 5.10 (d, <i>J</i> = 10.1 Hz, 1H), 4.40 (m, 1H), 4.17 (d, <i>J</i> = 11.4 Hz, 1H), 3.98 (bd, <i>J</i> = 11.4 Hz, 1H), 2.94 (m, 1H), 2.75−2.69 (m, 2H), 2.59 (dd, <i>J</i> = 13.8, 7.6 Hz, 1H), 2.27−2.07 (m, 4H), 1.79−1.66 (m, 2H), 1.51 (m, 1H), 1.42−1.28 (m, 3H), 1.23 (s, 3H), 1.14−1.02 (m, 12H), 0.97 (d, <i>J</i> = 6.6 Hz, 3H). HRMS (ES<sup>+</sup>) expected for C<sub>37</sub>H<sub>47</sub>N<sub>6</sub>O<sub>6</sub>S<sub>2</sub> (M + H<sup>+</sup>) 735.2993; found 735.3029.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (3<i>R</i>,5<i>S</i>,8<i>S</i>)-8-Cyclohexyl-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl)amino] carbonyl}-2-ethenylcyclopropyl)-7-oxo-2-oxa-11-thia-6,9,24,27-tetraazapentacyclo[16.6.2.1<sup>3,6</sup>.1<sup>10,13</sup>.0<sup>21,25</sup>]octacosa-1(24),10(27),12,18,20,22,25-heptaene-5-carboxamide (<b>50</b>)</h3><div class="NLM_p last">The title compound was prepared using ester <b>40a</b>(sat) and <b>13A</b>; off-white solid (33 mg, 13% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.67 (s, 1H), 8.81 (s, 1H), 7.98 (d, <i>J</i> = 5.8 Hz, 1H), 7.91 (s, 1H), 7.83 (d, <i>J</i> = 8.3 Hz, 1H), 7.61 (d, <i>J</i> = 8.3 Hz, 1H), 7.40 (d, <i>J</i> = 5.8 Hz, 1H) 6.47 (bs, 1H), 5.98 (m, 1H), 5.56 (m, 1H), 5.22 (d, <i>J</i> = 17.2 Hz, 1H), 5.10 (d, <i>J</i> = 10.1 Hz, 1H), 4.79 (m, 1H), 4.41 (t, <i>J</i> = 8.3 Hz, 1H), 4.28 (m, 1H), 3.98 (bd, <i>J</i> = 12.1 Hz, 1H), 2.98−1.85 (m, 9H), 1.83−1.46 (m, 9H), 1.45−0.84 (m, 11H). HRMS (ES<sup>+</sup>) expected for C<sub>38</sub>H<sub>47</sub>N<sub>6</sub>O<sub>6</sub>S<sub>2</sub> (M + H<sup>+</sup>) 746.2993; found 747.2947.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (3<i>R</i>,5<i>S</i>,8<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(Cyclopropylsulfonyl)amino]carbonyl}-2-ethenylcyclopropyl)-8-(1,1-dimethylethyl)-7-oxo-2-oxa-11-thia-6,9,24,27-tetraazapentacyclo[16.6.2.1<sup>3,6</sup>.1<sup>10,13</sup>.0<sup>21,25</sup>]octacosa-1(24),10(27),12,16,18,20,22,25-octaene-5-carboxamide (<b>51</b>)</h3><div class="NLM_p last">The title compound was prepared using ester <b>39a</b>(sat) and <b>13A</b>; off-white solid (30 mg, 22% yield). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub> + TFA) δ 10.74 (s, 1H), 10.08 (bs, 1H), 8.61 (s, 1H), 7.96 (d, <i>J</i> = 5.7 Hz, 1H), 7.81 (d, <i>J</i> = 7.8 Hz, 1H), 7.78 (bs, 1H), 7.58 (d, <i>J</i> = 7.8 Hz, 1H), 7.38 (d, <i>J</i> = 5.7 Hz, 1H), 6.70 (s, 1H), 5.64 (bt, <i>J</i> = 3.6 Hz, 1H), 5.57 (ddd, <i>J</i> = 17.2, 10.1, 9.0 Hz, 1H), 5.22 (d, <i>J</i> = 17.2 Hz, 1H), 5.10 (d, <i>J</i> = 10.1 Hz, 1H), 4.98 (d, <i>J</i> = 9.1 Hz, 1H), 4.77 (d, <i>J</i> = 12.3 Hz, 1H), 4.51 (t, <i>J</i> = 8.4 Hz, 1H), 3.86 (dd, <i>J</i> = 12.3 Hz, 3.8 Hz, 1H), 2.93 (m, 1H), 2.87−2.79 (m, 2H), 2.80−2.63 (m, 3H), 2.30 (m, 1H), 2.19 (app q, <i>J</i> = 9.0 Hz, 1H), 1.84 (m, 1H), 1.73 (dd, <i>J</i> = 7.8, 5.6 Hz, 1H), 1.72−1.61 (m, 2H), 1.52 (m, 1H), 1.32 (dd, <i>J</i> = 9.4, 5.6 Hz, 1H), 1.08 (s, 9H), 1.10−1.02 (m, 4H). HRMS (ES<sup>+</sup>) expected for C<sub>36</sub>H<sub>45</sub>N<sub>6</sub>O<sub>6</sub>S<sub>2</sub> (M + H<sup>+</sup>) 721.2837; found 721.2799.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (3<i>R</i>,5<i>S</i>,8<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(Cyclopropylsulfonyl)amino]carbonyl}-2-ethenylcyclopropyl)-8-(1-methylethyl)-7-oxo-23-phenyl-2-oxa-11-thia-6,9,22,27-tetraazapentacyclo[16.6.2.1<sup>3,6</sup>.1<sup>10,13</sup>.0<sup>21,25</sup>]octacosa-1(24),10(27),12,18,20,22,25-heptaene-5-carboxamide (<b>52</b>)</h3><div class="NLM_p last">The title compound was prepared using ester <b>41a</b> (sat) and <b>13A</b>; off-white solid (30 mg, 26% yield). <sup>1</sup>H NMR (600 MHz, C<sub>5</sub>D<sub>5</sub>N) δ 10.58 (s, 1H), 8.46 (d, <i>J</i> = 7.3 Hz, 2H), 8.29 (d, <i>J</i> = 8.5 Hz, 1H), 8.11 (s, 1H), 7.97 (d, <i>J</i> = 9.5 Hz, 1H), 7.55−7.49 (m, 4H), 7.30 (s, 1H), 6.33 (s, 1H), 6.10 (dt, <i>J</i><sub>1</sub> = 16.9, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 10.0 Hz, 1H), 5.27−5.18 (m, 2H), 5.07 (d, <i>J</i> = 10.0 Hz, 1H), 4.89 (t, <i>J</i> = 8.1 Hz, 1H), 4.59 (d, <i>J</i> = 12.1 Hz, 1H), 4.35 (bd, <i>J</i> = 12.1 Hz, 1H), 3.30 (m, 1H), 2.80−2.47 (m, 11H), 2.24 (t, <i>J</i> = 6.9 Hz, 1H), 1.87−1.79 (m, 2H), 1.77−1.70 (m, 3H), 1.44 (m, 1H), 1.35 (m, 1H), 1.25 (d, <i>J</i> = 6.7 Hz, 3H), 1.21 (d, <i>J</i> = 6.7 Hz, 3H), 0.97−0.84 (m, 2H). MS (ES<sup>+</sup>) C<sub>41</sub>H<sub>46</sub>N<sub>6</sub>O<sub>6</sub>S<sub>2</sub> requires 782; found 783 (M + H<sup>+</sup>).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (1<i>R</i>,12<i>E</i>,22<i>S</i>,25<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(Cyclopropylsulfonyl)amino]carbonyl}-2-ethenylcyclopropyl)-22-(1-methylethyl)-3,23-dioxo-2-oxa-19-thia-4,21,24,28-tetraazapentacyclo [22.2.1.1<sup>4,7</sup>.1<sup>17,20</sup>.0<sup>6,11</sup>]octacosa-6,8,10,12,17,20(28)-hexaene-25-carboxamide (<b>53</b>)</h3><div class="NLM_p last">The title compound was prepared using ester <b>42b</b>(<b><i><b>E</b></i></b>-<b>db</b>) and <b>13A</b>; off-white solid (36 mg, 24% yield from thiazole <b>34b</b>). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.62 (s, 1H), 8.84 (s, 1H), 7.31−7.21 (m, 3H), 6.38 (d, <i>J</i> = 16.2 Hz, 1H), 6.36 (bs, 1H), 6.05 (dt, <i>J</i><sub>1</sub> = 16.2 Hz, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 6.9 Hz, 1H), 5.60 (ddd, <i>J</i> = 17.2, 10.3, 9.8 Hz, 1H), 5.29 (bt, 1H), 5.23 (d, <i>J</i> = 17.2 Hz, 1H), 5.10 (d, <i>J</i> = 10.3 Hz, 1H), 4.71−4.59 (m, 6H), 4.30 (bt, <i>J</i> = 8.4 Hz, 1H), 4.16 (d, <i>J</i> = 11.8 Hz, 1H), 3.97 (m, 1H), 2.93 (m, 1H), 2.59 (m, 2H), 2.34−2.13 (m, 6H), 1.89−1.76 (m, 2H), 1.71 (dd, <i>J</i> = 7.7, 5.2 Hz, 1H), 1.32 (dd, <i>J</i> = 9.2, 5.2 Hz, 1H), 1.10−1.03 (m, 6H), 0.93 (d, <i>J</i> = 6.7 Hz, 3H). HRMS (ES<sup>+</sup>) expected for C<sub>36</sub>H<sub>45</sub>N<sub>6</sub>O<sub>6</sub>S<sub>2</sub> (M + H<sup>+</sup>) 737.2786; found 737.2788.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (1<i>R</i>,12<i>E</i>,21<i>S</i>,24<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(Cyclopropylsulfonyl)amino]carbonyl}-2-ethenylcyclopropyl)-21-(1-methylethyl)-3,22-dioxo-2-oxa-18-thia-4,20,23,27-tetraazapentacyclo[21.2.1.1<sup>4,7</sup>.1<sup>16,19</sup>.0<sup>6,11</sup>]octacosa-6,8,10,12,16,19(27)-hexaene-24-carboxamide (<b>54</b>)</h3><div class="NLM_p last">The title compound was prepared using ester <b>42a</b>(<i><b>E</b></i>-<b>db</b>) and <b>13A</b>; off-white solid (19 mg, 24% yield from thiazole <b>34a</b>). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 11.55 (bs, 1H), 9.95 (bs, 1H), 7.30−7.20 (m, 2H), 7.15 (s, 1H), 6.00−5.88 (m, 3H), 5.72 (m, 1H), 5.52 (m, 1H), 5.29 (d, <i>J</i> = 12.0 Hz, 1H), 5.16 (d, <i>J</i> = 6.5 Hz, 1H), 4.76−4.69 (m, 2H), 4.48−4.40 (m, 2H), 4.24 (m, 1H), 4.08 (m, 1H), 3.94 (m, 1H), 3.64 (m, 1H), 3.05 (m, 1H), 2.95 (m, 1H), 2.59 (m, 2H), 2.68−2.49 (m, 7H), 2.14 (m, 1H), 2.03 (m, 1H), 1.48−1.33 (m, 3H), 1.15 (d, <i>J</i> = 6.0 Hz, 3H), 1.05 (d, <i>J</i> = 6.0 Hz, 3H). HRMS (ES<sup>+</sup>) expected for C<sub>35</sub>H<sub>43</sub>N<sub>6</sub>O<sub>6</sub>S<sub>2</sub> (M + H<sup>+</sup>) 723.2629; found 723.2639.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (1<i>R</i>,12<i>E</i>,22<i>S</i>,25<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(Cyclopropylsulfonyl)amino]carbonyl}-2-ethenylcyclopropyl)-22-(1,1-dimethylethyl)-3,23-dioxo-2-oxa-19-thia-4,21,24,28-tetraazapentacyclo[22.2.1.1<sup>4,7</sup>.1<sup>17,20</sup>.0<sup>6,11</sup>]nonaacosa-6,8,10,12,17,20(28)-hexaene-25-carboxamide (<b>55</b>)</h3><div class="NLM_p last">The title compound was prepared using ester <b>43b</b>(<i><b>E</b></i>-<b>db</b>) and <b>13A</b>; off-white solid (50 mg, 45% yield from thiazole <b>35b</b>). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.48 (s, 1H), 9.73 (s, 1H), 8.72 (bs, 1H), 7.28 (t, <i>J</i> = 7.5 Hz, 1H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.19 (d, <i>J</i> = 7.5 Hz, 1H), 6.39 (d, <i>J</i> = 16.1 Hz, 1H), 6.29 (s, 1H), 6.00 (dt, <i>J</i><sub>1</sub> = 16.1 Hz, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 6.9 Hz, 1H), 5.62 (dt, <i>J</i><sub>1</sub> = 17.2, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 10.0 Hz, 1H), 5.25 (bs, 1H), 5.21 (d, <i>J</i> = 17.2 Hz, 1H), 5.09 (d, <i>J</i> = 10.0 Hz, 1H), 4.77 (d, <i>J</i> = 14.8 Hz, 1H), 4.72−4.64 (m, 3H), 4.61−4.52 (m, 2H), 4.34 (t, <i>J</i> = 8.2 Hz, 1H), 4.24 (d, <i>J</i> = 11.9 Hz, 1H), 4.07 (dd, <i>J</i> = 11.9, 5.2 Hz, 1H), 2.93 (m, 1H), 2.67 (m, 1H), 2.54 (m, 1H), 2.42 (dd, <i>J</i> = 13.4, 7.2 Hz, 1H), 2.34−2.28 (m, 2H), 2.24−2.14 (m, 2H), 1.88−1.76 (m, 2H), 1.69 (dd, <i>J</i> = 7.9, 5.5 Hz, 1H), 1.35 (dd, <i>J</i> = 9.4, 5.5 Hz, 1H), 1.11−1.02 (m, 4H), 1.06 (s, 9H). HRMS (ES<sup>+</sup>) expected for C<sub>37</sub>H<sub>47</sub>N<sub>6</sub>O<sub>7</sub>S<sub>2</sub> (M + H<sup>+</sup>) 751.2942; found 751.2956.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (1<i>R</i>,22<i>S</i>,25<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(Cyclopropylsulfonyl)amino]carbonyl}-2-ethenylcyclopropyl)-22-(1,1-dimethylethyl)-3,23-dioxo-2-oxa-19-thia-4,21,24,28-tetraazapentacyclo[22.2.1.1<sup>4,7</sup>.1<sup>17,20</sup>.0<sup>6,11</sup>]nonaacosa-6,8,10,17,20(28)-pentaene-25-carboxamide (<b>56</b>)</h3><div class="NLM_p last">The title compound was prepared using ester <b>43b</b>(sat) and <b>13A</b>; off-white solid (50 mg, 33% yield from thiazole <b>35b</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.54 (s, 1H), 8.78 (s, 1H), 7.23 (t, <i>J</i> = 7.4 Hz, 1H), 7.15 (d, <i>J</i> = 7.4 Hz, 1H), 7.09 (d, <i>J</i> = 7.4 Hz, 1H), 6.27 (bs, 1H), 5.64 (m, 1H), 5.26 (m, 1H), 5.22 (d, <i>J</i> = 17.2 Hz, 1H), 5.09 (d, <i>J</i> = 11.1 Hz, 1H), 4.77−4.46 (m, 5H), 4.28 (t, <i>J</i> = 8.1 Hz, 1H), 4.22 (d, <i>J</i> = 11.4 Hz, 1H), 4.04 (m, 1H), 2.93 (m, 1H), 2.68−2.29 (m, 6H), 2.24 (app q, <i>J</i> = 8.6 Hz, 1H), 2.13 (m, 1H), 1.78−1.62 (m, 3H), 1.58−1.41 (m, 3H), 1.37 (dd, <i>J</i> = 9.6, 5.5 Hz, 1H), 1.15−0.93 (m, 13H). HRMS (ES<sup>+</sup>) expected for C<sub>37</sub>H<sub>49</sub>N<sub>6</sub>O<sub>7</sub>S<sub>2</sub> (M + H<sup>+</sup>) 753.3099; found 753.3110.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (1<i>R</i>,12<i>E</i>,22<i>S</i>,25<i>S</i>)-22-Cyclohexyl-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-3,23-dioxo-2-oxa-19-thia-4,21,24,28-tetraazapentacyclo[22.2.1.1<sup>4,7</sup>.1<sup>17,20</sup>.0<sup>6,11</sup>]nonacosa-6,8,10,12,17,20(28)-hexaene-25-carboxamide (<b>57</b>)</h3><div class="NLM_p last">The title compound was prepared using ester <b>44b</b>(<i><b>E</b></i>-<b>db</b>) and <b>13A</b>; off-white solid (58 mg, 24% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.64 (s, 1H), 8.80 (s, 1H), 7.32−7.20 (m, 3H), 6.40 (bs, 1H), 6.36 (d, <i>J</i> = 16.2 Hz, 1H), 6.05 (dt, <i>J</i><sub>1</sub> = 16.2 Hz, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 6.7 Hz, 1H), 5.58 (m, 1H), 5.27 (m, 1H), 5.23 (d, <i>J</i> = 17.1 Hz, 1H), 5.11 (d, <i>J</i> = 11.1 Hz, 1H), 4.79 (d, <i>J</i> = 14.6 Hz, 1H), 4.72−4.56 (m, 4H), 4.29 (t, <i>J</i> = 8.3 Hz, 1H), 4.15 (d, <i>J</i> = 11.9 Hz, 1H), 3.97 (m, 1H), 2.93 (m, 1H), 2.66−2.36 (m, 4H), 2.35−2.09 (m, 9H), 1.90−1.59 (m, 7H) 1.34−0.99 (m, 7H). HRMS (ES<sup>+</sup>) expected for C<sub>39</sub>H<sub>49</sub>N<sub>6</sub>O<sub>7</sub>S<sub>2</sub> (M + H<sup>+</sup>) 777.3099; found 777.3068.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (1<i>R</i>,12<i>E</i>,22<i>S</i>,25<i>S</i>)-22-Cyclohexyl-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl) Amino]carbonyl}-2-ethylcyclopropyl)-3,23-dioxo-2-oxa-19-thia-4,21,24,28-tetraazapentacyclo[22.2.1.1<sup>4,7</sup>.1<sup>17,20</sup>.0<sup>6,11</sup>] nonacosa-6,8,10,12,17,20(28)-hexaene-25-carboxamide (<b>58</b>)</h3><div class="NLM_p last">The title compound was prepared using ester <b>44b</b>(<i><b>E</b></i>-<b>db</b>) and <b>13B</b>; off-white solid (58 mg, 29% yield). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub> + TFA) δ 10.62 (s, 1H), 8.59 (s, 1H), 7.29 (d, <i>J</i> = 7.6 Hz, 1H), 7.27 (t, <i>J</i> = 7.6 Hz, 1H), 7.21 (d, <i>J</i> = 7.6 Hz, 1H), 6.63 (s, 1H), 6.28 (d, <i>J</i> = 16.2 Hz, 1H), 6.09 (dt, <i>J</i><sub>1</sub> = 16.2 Hz, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 7.0 Hz, 1H), 5.32 (bt, <i>J</i> = 3.8 Hz, 1H), 4.87 (bs, 1H), 4.77 (d, <i>J</i> = 14.8 Hz, 1H), 4.70 (d, <i>J</i> = 14.8 Hz, 1H), 4.64−4.57 (m, 2H), 4.33 (t, <i>J</i> = 8.8 Hz, 1H). 4.22 (d, <i>J</i> = 11.9 Hz, 1H), 3.87 (dd, <i>J</i> = 11.9, 3.8 Hz, 1H), 2.94 (m, 1H), 2.63−2.57 (m, 2H), 2.40 (dd, <i>J</i> = 14.0, 7.6 Hz, 1H), 2.29 (m, 1H), 2.16−2.09 (m, 2H), 2.00−1.90 (m, 2H), 1.80−1.70 (m, 4H), 1.65 (bd, <i>J</i> = 12.0 Hz, 1H), 1.58 (bd, <i>J</i> = 11.7 Hz, 1H) 1.52−1.36 (m, 4H), 1.35−0.96 (m, 10H), 0.90 (t, <i>J</i> = 7.2 Hz, 3H). MS (ES<sup>+</sup>) C<sub>39</sub>H<sub>50</sub>N<sub>6</sub>O<sub>7</sub>S<sub>2</sub> requires 778; found 779 (M + H<sup>+</sup>).</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (1<i>R</i>,12<i>E</i>,22<i>S</i>,25<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(Cyclopropylsulfonyl)amino]carbonyl}-2-ethenylcyclopropyl)-22-[(1<i>S</i>)-1-methylpropyl]-3,23-dioxo-2-oxa-19-thia-4,21,24,28-tetraazapentacyclo[22.2.1.1<sup>4,7</sup>.1<sup>17,20</sup>.0<sup>6,11</sup>]nonaacosa-6,8,10,12,17,20(28)-hexaene-25-carboxamide (<b>59</b>)</h3><div class="NLM_p last">The title compound was prepared using ester <b>45b</b>(<i><b>E</b></i>-<b>db</b>) and <b>13A</b>; off-white solid (52 mg, 27% yield). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.70 (s, 1H), 9.72 (bs, 1H), 8.69 (s, 1H), 7.31 (d, <i>J</i> = 7.5 Hz, 1H), 7.27 (t, <i>J</i> = 7.5 Hz, 1H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 6.64 (s, 1H), 6.28 (d, <i>J</i> = 16.2 Hz, 1H), 6.10 (dt, <i>J</i><sub>1</sub> = 16.2 Hz, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 6.8 Hz, 1H), 5.56 (dt, <i>J</i><sub>1</sub> = 17.3 Hz, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 10.1 Hz, 1H), 5.32 (bt, 1H), 5.23 (d, <i>J</i> = 17.3 Hz, 1H), 5.10 (d, <i>J</i> = 10.1 Hz, 1H), 4.91 (bs, 1H), 4.78 (d, <i>J</i> = 14.7 Hz, 1H), 4.70−4.58 (m, 3H), 4.34 (dd, <i>J</i> = 9.7, 7.4 Hz, 1H), 4.23 (d, <i>J</i> = 11.7 Hz, 1H), 3.85 (dd, <i>J</i> = 11.7, 3.8 Hz, 1H), 2.93 (m, 1H), 2.62−2.58 (m, 2H), 2.42 (dd, <i>J</i> = 14.2, 7.4 Hz, 1H), 2.29 (m, 1H), 2.17−2.09 (m, 3H), 2.05 (m, 1H), 1.94 (m, 1H), 1.77−1.69 (m, 2H), 1.45 (m, 1H), 1.25 (dd, <i>J</i> = 9.3, 5.3 Hz, 1H), 1.18 (m, 1H), 1.13−1.03 (m, 4H), 1.01 (d, <i>J</i> = 6.7 Hz, 3H), 0.90 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (ES<sup>+</sup>) expected for C<sub>37</sub>H<sub>47</sub>N<sub>6</sub>O<sub>7</sub>S<sub>2</sub> (M + H<sup>+</sup>) 751.2942; found 751.2921.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (1<i>R</i>,12<i>E</i>,22<i>S</i>,25<i>S</i>)-22-Cyclopentyl-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-3,23-dioxo-2-oxa-19-thia-4,21,24,28-tetraazapentacyclo[22.2.1.1<sup>4,7</sup>.1<sup>17,20</sup>.0<sup>6,11</sup>]nonacosa-6,8,10,12,17,20(28)-hexaene-25-carboxamide (<b>60</b>)</h3><div class="NLM_p last">The title compound was prepared using ester <b>46b</b>(<i><b>E</b></i>-<b>db</b>) and <b>13A</b>; off-white solid (60 mg, 30% yield). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, <i>T</i> = 330 K) δ 10.43 (s, 1H), 8.79 (s, 1H), 7.70 (bs, 1H), 7.28 (t, <i>J</i> = 7.6 Hz, 1H), 7.21 (d, <i>J</i> = 7.6 Hz, 1H), 7.20 (d, <i>J</i> = 7.6 Hz, 1H), 6.40 (d, <i>J</i> = 16.2 Hz, 1H), 6.28 (bs, 1H), 6.02 (dt, <i>J</i><sub>1</sub> = 16.2 Hz, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 7.0 Hz, 1H), 5.62 (ddd, <i>J</i> = 17.2, 10.4, 10.0 Hz, 1H), 5.29 (bt, <i>J</i> = 3.9 Hz, 1H), 5.23 (dd, <i>J</i> = 17.2, 1.4 Hz, 1H), 5.10 (dd, <i>J</i> = 10.4, 1.4 Hz, 1H), 4.80 (d, <i>J</i> = 14.4 Hz, 1H), 4.71−4.59 (m, 4H), 4.31 (dd, <i>J</i> = 9.0, 7.7 Hz, 1H), 4.17 (d, <i>J</i> = 11.7 Hz, 1H), 4.04 (dd, <i>J</i> = 11.7, 5.1 Hz, 1H), 2.93 (m, 1H), 2.62 (m, 1H), 2.57 (m, 1H), 2.39 (dd, <i>J</i> = 12.1, 7.8 Hz, 1H), 2.34−2.24 (m, 3H), 2.21−2.14 (m, 2H), 1.87−1.76 (m, 3H), 1.74−1.68 (m, 2H), 1.65−1.60 (m, 2H), 1.55−1.46 (m, 2H), 1.43−1.35 (m, 2H), 1.33 (dd, <i>J</i> = 9.4, 5.2 Hz, 1H), 1.13−1.10 (m, 2H), 1.07−1.03 (m, 2H). HRMS (ES<sup>+</sup>) expected for C<sub>38</sub>H<sub>47</sub>N<sub>6</sub>O<sub>6</sub>S<sub>2</sub> (M + H<sup>+</sup>) 763.2942; found 763.2939.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53"><a href="/doi/suppl/10.1021/jm900524b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15473" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15473" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Characterization data for intermediates <b>14</b>, <b>20</b>, <b>21</b>, <b>23</b>−<b>30</b>, <b>32</b>−<b>38</b>, and <b>39</b>−<b>46</b>; additional characterization data for compounds <b>4</b>, <b>5</b>, <b>51</b>, <b>55</b>, <b>57</b>, <b>59</b>, and <b>60</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900524b/suppl_file/jm900524b_si_001.pdf">jm900524b_si_001.pdf (630.26 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm900524b" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41588" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41588" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">M. Emilia Di Francesco</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A., Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Pomezia, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b7dad6c5ded6d2dadedbded6e8d3ded1c5d6d9d4d2c4d4d8f7dad2c5d4dc99d4d8da"><span class="__cf_email__" data-cfemail="94f9f5e6fdf5f1f9fdf8fdf5cbf0fdf2e6f5faf7f1e7f7fbd4f9f1e6f7ffbaf7fbf9">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gabriella Dessole</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A., Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emanuela Nizi</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A., Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paola Pace</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A., Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Uwe Koch</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A., Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrizio Fiore</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A., Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Pesci</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A., Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jillian Di Muzio</span> - <span class="hlFld-Affiliation affiliation">Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edith Monteagudo</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A., Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Rowley</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A., Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincenzo Summa</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A., Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Claudio De Nardi and Francesca Naimo for bioanalytical data and Sergio Altamura and Nadia Gennari for cellular assays.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57205" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57205" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">World Health Organization (WHO)</span><span class="NLM_x">. </span>Initiative for Vaccine Research. Hepatitis C.<a href="http://www.who.int/vaccine_research/diseases/viral_cancers/en/index2.html" class="extLink">http://www.who.int/vaccine_research/diseases/viral_cancers/en/index2.html</a></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health+Organization+%28WHO%29.+Initiative+for+Vaccine+Research.+Hepatitis+C.http%3A%2F%2Fwww.who.int%2Fvaccine_research%2Fdiseases%2Fviral_cancers%2Fen%2Findex2.html"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DInitiative%2520for%2520Vaccine%2520Research.%2520Hepatitis%2520C." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hoofnagle, J. H.</span><span> </span><span class="NLM_article-title">Course and outcome of hepatitis C</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">S21</span><span class="NLM_x">–</span> <span class="NLM_lpage">S29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1002%2Fhep.1840360704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=12407573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A280%3ADC%252BD38nkslWntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=S21-S29&author=J.+H.+Hoofnagle&title=Course+and+outcome+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Course and outcome of hepatitis C</span></div><div class="casAuthors">Hoofnagle Jay H</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Baltimore, Md.)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5 Suppl 1</span>),
    <span class="NLM_cas:pages">S21-9</span>
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    </div><div class="casAbstract">The hepatitis C virus (HCV) is a small enveloped RNA virus belonging to the family flaviviridae and genus hepacivirus.  The HCV RNA genome is 9,600 nucleotides in length and encodes a single polyprotein that is post-translationally cleaved into 10 polypeptides including t3 structural (C, E1, and E2) and multiple nonstructural proteins ([NS] NS2 to NS5).  The NS proteins include enzymes necessary for protein processing (proteases) and viral replication (RNA polymerase).  The virus replicates at a high rate in the liver and has marked sequence heterogeneity.  There are 6 genotypes and more than 90 subtypes of HCV, the most common in the United States being 1a and 1b (approximately 75%), 2a and 2b (approximately 15%), and 3 (approximately 7%).  Acute hepatitis C is marked by appearance of HCV RNA in serum within 1 to 2 weeks of exposure followed by serum alanine aminotransferase (ALT) elevations, and then symptoms and jaundice.  Antibody to HCV (anti-HCV) tends to arise late.  In acute resolving hepatitis, HCV RNA is cleared and serum ALT levels fall to normal.  However, 55% to 85% of patients do not clear virus, but develop chronic hepatitis C.  Chronic hepatitis C is often asymptomatic, but is usually associated with persistent or fluctuating elevations in ALT levels.  The chronic sequelae of hepatitis C include progressive hepatic fibrosis, cirrhosis, and hepatocellular carcinoma.  Extra-hepatic manifestations include sicca syndrome, cryoglobulinemia, glomerulonephritis, and porphyria cutanea tarda.  Knowledge of the course and outcome of hepatitis C is important in developing approaches to management and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUup51yhOB770AGQpJZWpJfW6udTcc2eYBesYEEe6j0Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38nkslWntw%253D%253D&md5=dd5c88eaad10bd81cc98ab2e344aab71</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1002%2Fhep.1840360704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.1840360704%26sid%3Dliteratum%253Aachs%26aulast%3DHoofnagle%26aufirst%3DJ.%2BH.%26atitle%3DCourse%2520and%2520outcome%2520of%2520hepatitis%2520C%26jtitle%3DHepatology%26date%3D2002%26volume%3D36%26spage%3DS21%26epage%3DS29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liang, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, T.</span><span> </span><span class="NLM_article-title">Pathogenesis of hepatitis C—associated hepatocellular carcinoma</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">S62</span><span class="NLM_x">–</span> <span class="NLM_lpage">S71</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=S62-S71&author=T.+J.+Liangauthor=T.+Heller&title=Pathogenesis+of+hepatitis+C%E2%80%94associated+hepatocellular+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DT.%2BJ.%26aulast%3DHeller%26aufirst%3DT.%26atitle%3DPathogenesis%2520of%2520hepatitis%2520C%25E2%2580%2594associated%2520hepatocellular%2520carcinoma%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D127%26spage%3DS62%26epage%3DS71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Rustgi, V. K.</span><span> </span><span class="NLM_article-title">The epidemiology of hepatitis C infection in the United States</span> <span class="citation_source-journal">J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1007%2Fs00535-007-2064-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=17653645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A280%3ADC%252BD2svjt1altg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=513-21&issue=7&author=V.+K.+Rustgi&title=The+epidemiology+of+hepatitis+C+infection+in+the+United+States"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The epidemiology of hepatitis C infection in the United States</span></div><div class="casAuthors">Rustgi Vinod K</div><div class="citationInfo"><span class="NLM_cas:title">Journal of gastroenterology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">513-21</span>
        ISSN:<span class="NLM_cas:issn">0944-1174</span>.
    </div><div class="casAbstract">BACKGROUND:  The prevalence of hepatitis C virus (HCV) infection in the United States has remained constant from 1988 through 2002, although the peak age of infection has increased.  While the number of new HCV cases is declining, the rates of HCV-associated morbidity and mortality are increasing.  We reviewed the risk factors for HCV infection, the laboratory methods used to diagnose it, the dynamics of disease progression, and the natural history of HCV infection.  METHODS:  Medline searches were performed using the key word HCV, together with incidence, risk factors, demographics, diagnostic methods, disease progression, natural history, normal alanine aminotransferase (ALT), fibrosis, and hepatocellular carcinoma (HCC).  RESULTS:  Three characteristics-abnormal serum ALT, history of injection drug use, and blood transfusion before 1992-identified 85% of HCV-positive individuals 20-59 years old.  About 75%-85% of acutely infected individuals progress to chronic infection, with up to 20% developing liver cirrhosis over 20-25 years, putting them at increased risk for end-stage liver disease and/or HCC.  HCV-associated cirrhosis is the leading cause of liver transplantation in the United States.  Rates of infection are higher in non-Hispanic blacks than in non-Hispanic whites and Mexican Americans and higher in men than in women.  In the United States, over 70% of HCV-infected individuals are infected with genotype 1.  CONCLUSIONS:  HCV infection is more prevalent than human immunodeficiency virus or hepatitis B virus infection and is particularly common among certain demographic groups.  Individual rates of fibrosis progression vary, but identification of host and viral characteristics associated with disease progression may reveal the mechanisms of HCV-associated hepatic fibrosis/cirrhosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSbTKo3W8ZBP6xYuD7tu2XfW6udTcc2eZVZaIDjv1Ttrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svjt1altg%253D%253D&md5=d8def6b8a9631953e8c5210b7800f53c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs00535-007-2064-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00535-007-2064-6%26sid%3Dliteratum%253Aachs%26aulast%3DRustgi%26aufirst%3DV.%2BK.%26atitle%3DThe%2520epidemiology%2520of%2520hepatitis%2520C%2520infection%2520in%2520the%2520United%2520States%26jtitle%3DJ.%2520Gastroenterol.%26date%3D2007%26volume%3D42%26issue%3D7%26spage%3D513%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Di Bisceglie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoofnagle, J. H.</span><span> </span><span class="NLM_article-title">Optimal therapy of hepatitis C</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">S121</span><span class="NLM_x">–</span> <span class="NLM_lpage">S127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=S121-S127&author=A.+M.+Di+Bisceglieauthor=J.+H.+Hoofnagle&title=Optimal+therapy+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BBisceglie%26aufirst%3DA.%2BM.%26aulast%3DHoofnagle%26aufirst%3DJ.%2BH.%26atitle%3DOptimal%2520therapy%2520of%2520hepatitis%2520C%26jtitle%3DHepatology%26date%3D2002%26volume%3D36%26spage%3DS121%26epage%3DS127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fried, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goncales, F. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haussinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diago, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carosi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhumeaux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craxi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span> </span><span class="NLM_article-title">Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1056%2FNEJMoa020047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=12324553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=975-982&issue=13&author=M.+W.+Friedauthor=M.+L.+Shiffmanauthor=K.+R.+Reddyauthor=C.+Smithauthor=G.+Marinosauthor=F.+L.+Goncalesauthor=D.+Haussingerauthor=M.+Diagoauthor=G.+Carosiauthor=D.+Dhumeauxauthor=A.+Craxiauthor=A.+Linauthor=J.+Hoffmanauthor=J.+Yu&title=Peginterferon+alfa-2a+plus+ribavirin+for+chronic+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</span></div><div class="casAuthors">Fried, Michael W.; Shiffman, Mitchell L.; Reddy, K. Rajender; Smith, Coleman; Marinos, George; Goncales, Fernando L., Jr.; Haussinger, Dieter; Diago, Moises; Carosi, Giampiero; Dhumeaux, Daniel; Craxi, Antonio; Lin, Amy; Hoffman, Joseph; Yu, Jian</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">975-982</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Treatment with peginterferon alfa-2a alone produces significantly higher sustained virol. responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) infection.  We compared the efficacy and safety of peginterferon alfa-2a plus ribavirin, interferon alfa-2b plus ribavirin, and peginterferon alfa-2a alone in the initial treatment of chronic hepatitis C.  Methods: A total of 1121 patients were randomly assigned to treatment and received at least one dose of study medication, consisting of 180 μg of peginterferon alfa-2a once weekly plus daily ribavirin (1000 or 1200 mg, depending on body wt.), weekly peginterferon alfa-2a plus daily placebo, or 3 million units of interferon alfa-2b thrice weekly plus daily ribavirin for 48 wk.  Results: A significantly higher proportion of patients who received peginterferon alfa-2a plus ribavirin had a sustained virol. response (defined as the absence of detectable HCV RNA 24 wk after cessation of therapy) than of patients who received interferon alfa-2b plus ribavirin (56 % vs. 44 %, P<0.001) or peginterferon alfa-2a alone (56 % vs. 29 %, P<0.001).  The proportions of patients with HCV genotype 1 who had sustained virol. responses were 46 %, 36 %, and 21 %, resp., for the three regimens.  Among patients with HCV genotype 1 and high base-line levels of HCV RNA, the proportions of those with sustained virol. responses were 41 %, 33 %, and 13 %, resp.  The overall safety profiles of the three treatment regimens were similar; the incidence of influenza-like symptoms and depression was lower in the groups receiving peginterferon alfa-2a than in the group receiving interferon alfa-2b plus ribavirin.  Conclusions: In patients with chronic hepatitis C, once-weekly peginterferon alfa-2a plus ribavirin was tolerated as well as interferon alfa-2b plus ribavirin and produced significant improvements in the rate of sustained virol. response, as compared with interferon alfa-2b plus ribavirin or peginterferon alfa-2a alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqblwkeNXWJzbVg90H21EOLACvtfcHk0ljNwOEqFpZ-uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D&md5=2fd959d790b9505384fbd26ef44b2963</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa020047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa020047%26sid%3Dliteratum%253Aachs%26aulast%3DFried%26aufirst%3DM.%2BW.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DMarinos%26aufirst%3DG.%26aulast%3DGoncales%26aufirst%3DF.%2BL.%26aulast%3DHaussinger%26aufirst%3DD.%26aulast%3DDiago%26aufirst%3DM.%26aulast%3DCarosi%26aufirst%3DG.%26aulast%3DDhumeaux%26aufirst%3DD.%26aulast%3DCraxi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26atitle%3DPeginterferon%2520alfa-2a%2520plus%2520ribavirin%2520for%2520chronic%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26issue%3D13%26spage%3D975%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Feld, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoofnagle, J. H.</span><span> </span><span class="NLM_article-title">Mechanism of action of interferon and ribavirin in treatment of hepatitis C</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x"> (</span><span class="NLM_issue">7053</span><span class="NLM_x">) </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">972</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=967-972&issue=7053&author=J.+J.+Feldauthor=J.+H.+Hoofnagle&title=Mechanism+of+action+of+interferon+and+ribavirin+in+treatment+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeld%26aufirst%3DJ.%2BJ.%26aulast%3DHoofnagle%26aufirst%3DJ.%2BH.%26atitle%3DMechanism%2520of%2520action%2520of%2520interferon%2520and%2520ribavirin%2520in%2520treatment%2520of%2520hepatitis%2520C%26jtitle%3DNature%26date%3D2005%26volume%3D436%26issue%3D7053%26spage%3D967%26epage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Strader, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeffm, L. B.</span><span> </span><span class="NLM_article-title">Diagnosis, management, and treatment of hepatitis C</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1147</span><span class="NLM_x">–</span> <span class="NLM_lpage">1171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2004&pages=1147-1171&issue=4&author=D.+B.+Straderauthor=T.+Wrightauthor=D.+L.+Thomasauthor=L.+B.+Seeffm&title=Diagnosis%2C+management%2C+and+treatment+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrader%26aufirst%3DD.%2BB.%26aulast%3DWright%26aufirst%3DT.%26aulast%3DThomas%26aufirst%3DD.%2BL.%26aulast%3DSeeffm%26aufirst%3DL.%2BB.%26atitle%3DDiagnosis%252C%2520management%252C%2520and%2520treatment%2520of%2520hepatitis%2520C%26jtitle%3DHepatology%26date%3D2004%26volume%3D39%26issue%3D4%26spage%3D1147%26epage%3D1171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornberg, M.</span><span> </span><span class="NLM_article-title">Treating viral hepatitis C: efficacy, side effects, and complications</span> <span class="citation_source-journal">Gut</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1350</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2006&pages=1350-1359&issue=9&author=M.+P.+Mannsauthor=H.+Wedemeyerauthor=M.+Cornberg&title=Treating+viral+hepatitis+C%3A+efficacy%2C+side+effects%2C+and+complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DCornberg%26aufirst%3DM.%26atitle%3DTreating%2520viral%2520hepatitis%2520C%253A%2520efficacy%252C%2520side%2520effects%252C%2520and%2520complications%26jtitle%3DGut%26date%3D2006%26volume%3D55%26issue%3D9%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><div class="note"><p class="first last">Reviewed in </p></div><span class="NLM_contrib-group">Moradpour, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, M. C.</span><span> </span><span class="NLM_article-title">Replication of hepatitis C virus</span> <span class="citation_source-journal">Nat. Rev. Microb.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1038%2Fnrmicro1645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=17487147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlSqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=453-463&issue=6&author=D.+Moradpourauthor=F.+Peninauthor=M.+C.+Rice&title=Replication+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of hepatitis C virus</span></div><div class="casAuthors">Moradpour, Darius; Penin, Francois; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">453-463</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Exciting progress has recently been made in understanding the replication of hepatitis C virus, a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma worldwide.  The development of complete cell-culture systems should now enable the systematic dissection of the entire viral life-cycle, providing insights into the hitherto difficult-to-study early and late steps.  These efforts have already translated into the identification of novel antiviral targets and the development of new therapeutic strategies, some of which are currently undergoing clin. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreB87JperiIrVg90H21EOLACvtfcHk0lgjlap9YTBAVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlSqtb8%253D&md5=be020cc05a67e7256779b1c0ce797089</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1645%26sid%3Dliteratum%253Aachs%26aulast%3DMoradpour%26aufirst%3DD.%26aulast%3DPenin%26aufirst%3DF.%26aulast%3DRice%26aufirst%3DM.%2BC.%26atitle%3DReplication%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DNat.%2520Rev.%2520Microb.%26date%3D2007%26volume%3D5%26issue%3D6%26spage%3D453%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="note"><p class="first last">Reviewed in: </p></div><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span> </span><span class="NLM_article-title">Peptidomimetic Therapeutic Agents Targeting the Protease Enzyme of the Human Immunodeficiency Virus and Hepatitis C Virus</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1252</span><span class="NLM_x">–</span> <span class="NLM_lpage">1263</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar8000519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=1252-1263&issue=10&author=Y.+S.+Tsantrizos&title=Peptidomimetic+Therapeutic+Agents+Targeting+the+Protease+Enzyme+of+the+Human+Immunodeficiency+Virus+and+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1021%2Far8000519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far8000519%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DPeptidomimetic%2520Therapeutic%2520Agents%2520Targeting%2520the%2520Protease%2520Enzyme%2520of%2520the%2520Human%2520Immunodeficiency%2520Virus%2520and%2520Hepatitis%2520C%2520Virus%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26issue%3D10%26spage%3D1252%26epage%3D1263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carfi, A.</span><span> </span><span class="NLM_article-title">Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1242</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2007&pages=1242-1262&issue=12&author=R.+De+Francescoauthor=A.+Carfi&title=Advances+in+the+development+of+new+therapeutic+agents+targeting+the+NS3-4A+serine+protease+or+the+NS5B+RNA-dependent+RNA+polymerase+of+the+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DCarfi%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520the%2520development%2520of%2520new%2520therapeutic%2520agents%2520targeting%2520the%2520NS3-4A%2520serine%2520protease%2520or%2520the%2520NS5B%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520the%2520hepatitis%2520C%2520virus%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2007%26volume%3D59%26issue%3D12%26spage%3D1242%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><div class="note"><p class="first last">Reviewed in </p></div><span class="NLM_contrib-group">Gale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foy, E. M.</span><span> </span><span class="NLM_article-title">Evasion of intracellular host defence by hepatitis C virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x"> (</span><span class="NLM_issue">7053</span><span class="NLM_x">) </span> <span class="NLM_fpage">939</span><span class="NLM_x">–</span> <span class="NLM_lpage">945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=939-945&issue=7053&author=M.+Galeauthor=E.+M.+Foy&title=Evasion+of+intracellular+host+defence+by+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGale%26aufirst%3DM.%26aulast%3DFoy%26aufirst%3DE.%2BM.%26atitle%3DEvasion%2520of%2520intracellular%2520host%2520defence%2520by%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2005%26volume%3D436%26issue%3D7053%26spage%3D939%26epage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinkuhler, C.</span><span> </span><span class="NLM_article-title">Structure and function of the hepatitis C virus NS3-NS4A serine proteinase</span> <span class="citation_source-journal">Curr. Top. Microbiol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">242</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=242&publication_year=2000&pages=149-169&author=R.+De+Francescoauthor=C.+Steinkuhler&title=Structure+and+function+of+the+hepatitis+C+virus+NS3-NS4A+serine+proteinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DSteinkuhler%26aufirst%3DC.%26atitle%3DStructure%2520and%2520function%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3-NS4A%2520serine%2520proteinase%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2000%26volume%3D242%26spage%3D149%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deziel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2724</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=2719-2724&issue=19&author=M.+Llinas-Brunetauthor=M.+Baileyauthor=R.+Dezielauthor=G.+Fazalauthor=V.+Gorysauthor=S.+Gouletauthor=T.+Halmosauthor=R.+Mauriceauthor=M.+Poirierauthor=M.+A.+Poupartauthor=J.+Rancourtauthor=D.+Thibeaultauthor=D.+Wernicauthor=D.+Lamarre&title=Studies+on+the+C-terminal+of+hexapeptide+inhibitors+of+the+hepatitis+C+virus+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DDeziel%26aufirst%3DR.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DMaurice%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DPoupart%26aufirst%3DM.%2BA.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DWernic%26aufirst%3DD.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DStudies%2520on%2520the%2520C-terminal%2520of%2520hexapeptide%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26issue%3D19%26spage%3D2719%26epage%3D2724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Steinkuhler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biasiol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span> </span><span class="NLM_article-title">Product inhibition of the hepatitis C virus NS3 protease</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">8899</span><span class="NLM_x">–</span> <span class="NLM_lpage">8905</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi980313v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=8899-8905&issue=25&author=C.+Steinkuhlerauthor=G.+Biasiolauthor=M.+Brunettiauthor=A.+Urbaniauthor=U.+Kochauthor=R.+Corteseauthor=A.+Pessiauthor=R.+De+Francesco&title=Product+inhibition+of+the+hepatitis+C+virus+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fbi980313v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi980313v%26sid%3Dliteratum%253Aachs%26aulast%3DSteinkuhler%26aufirst%3DC.%26aulast%3DBiasiol%26aufirst%3DG.%26aulast%3DBrunetti%26aufirst%3DM.%26aulast%3DUrbani%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DPessi%26aufirst%3DA.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26atitle%3DProduct%2520inhibition%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26issue%3D25%26spage%3D8899%26epage%3D8905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bös, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. George, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span> </span><span class="NLM_article-title">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1038%2Fnature02099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=14578911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=186-189&author=D.+Lamarreauthor=P.+C.+Andersonauthor=M.+Baileyauthor=P.+Beaulieuauthor=G.+Bolgerauthor=P.+Bonneauauthor=M.+B%C3%B6sauthor=D.+R.+Cameronauthor=M.+Cartierauthor=M.+G.+Cordingleyauthor=A.-M.+Faucherauthor=N.+Goudreauauthor=S.+H.+Kawaiauthor=G.+Kukoljauthor=L.+Lagac%C3%A9author=S.+R.+LaPlanteauthor=H.+Narjesauthor=M.-A.+Poupartauthor=J.+Rancourtauthor=R.+E.+Sentjensauthor=R.+St.+Georgeauthor=B.+Simoneauauthor=G.+Steinmannauthor=D.+Thibeaultauthor=Y.+S.+Tsantrizosauthor=S.+M.+Weldonauthor=C.-L.+Yongauthor=M.+Llin%C3%A0s-Brunet&title=An+NS3+protease+inhibitor+with+antiviral+effects+in+humans+infected+with+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span></div><div class="casAuthors">Lamarre, Daniel; Anderson, Paul C.; Bailey, Murray; Beaulieu, Pierre; Bolger, Gordon; Bonneau, Pierre; Boes, Michael; Cameron, Dale R.; Cartier, Mireille; Cordingley, Michael G.; Faucher, Anne-Marie; Goudreau, Nathalie; Kawai, Stephen H.; Kukolj, George; Lagace, Lisette; LaPlante, Steven R.; Narjes, Hans; Poupart, Marc-Andre; Rancourt, Jean; Sentjens, Roel E.; St. George, Roger; Simoneau, Bruno; Steinmann, Gerhard; Thibeault, Diane; Tsantrizos, Youla S.; Weldon, Steven M.; Yong, Chan-Loi; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6963</span>),
    <span class="NLM_cas:pages">186-189</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide with more than 170 million infected individuals at risk of developing significant morbidity and mortality.  Current interferon-based therapies are suboptimal esp. in patients infected with HCV genotype 1, and they are poorly tolerated, highlighting the unmet medical need for new therapeutics.  The HCV-encoded NS3 protease is essential for viral replication and has long been considered an attractive target for therapeutic intervention in HCV-infected patients.  Here we identify a class of specific and potent NS3 protease inhibitors and report the evaluation of BILN 2061, a small mol. inhibitor biol. available through oral ingestion and the first of its class in human trials.  Administration of BILN 2061 to patients infected with HCV genotype 1 for 2 days resulted in an impressive redn. of HCV RNA plasma levels, and established proof-of-concept in humans for an HCV NS3 protease inhibitor.  Our results further illustrate the potential of the viral-enzyme-targeted drug discovery approach for the development of new HCV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnVapDO21RLVg90H21EOLACvtfcHk0lgDplSv1gZigA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D&md5=36db818d5af257d3ebeef1a061ca68cb</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1038%2Fnature02099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02099%26sid%3Dliteratum%253Aachs%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DB%25C3%25B6s%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DSt.%2BGeorge%26aufirst%3DR.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DWeldon%26aufirst%3DS.%2BM.%26aulast%3DYong%26aufirst%3DC.-L.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DAn%2520NS3%2520protease%2520inhibitor%2520with%2520antiviral%2520effects%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2003%26volume%3D426%26spage%3D186%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grand-Maître, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapeyre-Paquette, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhéaume, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1608</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0342414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1605-1608&author=M.+Llin%C3%A0s-Brunetauthor=M.+D.+Baileyauthor=G.+Bolgerauthor=C.+Brochuauthor=A.-M.+Faucherauthor=J.+M.+Ferlandauthor=M.+Garneauauthor=E.+Ghiroauthor=V.+Gorysauthor=C.+Grand-Ma%C3%AEtreauthor=T.+Halmosauthor=N.+Lapeyre-Paquetteauthor=F.+Liardauthor=M.+Poirierauthor=M.+Rh%C3%A9aumeauthor=Y.+S.+Tsantrizosauthor=D.+Lamarre&title=Structure%E2%88%92Activity+Study+on+a+Novel+Series+of+Macrocyclic+Inhibitors+of+the+Hepatitis+C+Virus+NS3+Protease+Leading+to+the+Discovery+of+BILN+2061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fjm0342414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0342414%26sid%3Dliteratum%253Aachs%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DFerland%26aufirst%3DJ.%2BM.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGrand-Ma%25C3%25AEtre%26aufirst%3DC.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLapeyre-Paquette%26aufirst%3DN.%26aulast%3DLiard%26aufirst%3DF.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRh%25C3%25A9aume%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DStructure%25E2%2588%2592Activity%2520Study%2520on%2520a%2520Novel%2520Series%2520of%2520Macrocyclic%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%2520Leading%2520to%2520the%2520Discovery%2520of%2520BILN%25202061%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1605%26epage%3D1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3−4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.-P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+hepatitis+C+virus+NS3%E2%88%924A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%25E2%2588%25924A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span> </span><span class="NLM_article-title">Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Infect. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.2174%2F187152606776056706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=16787300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=3-16&author=C.+Linauthor=A.+D.+Kwongauthor=R.+B.+Perni&title=Discovery+and+development+of+VX-950%2C+a+novel%2C+covalent%2C+and+reversible+inhibitor+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3•4A serine protease</span></div><div class="casAuthors">Lin, C.; Kwong, A. D.; Perni, R. B.</div><div class="citationInfo"><span class="NLM_cas:title">Infectious Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-16</span>CODEN:
                <span class="NLM_cas:coden">IDDTAD</span>;
        ISSN:<span class="NLM_cas:issn">1871-5265</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The hepatitis C virus (HCV) NS3•4A protease, which is essential for viral replication, is considered one of the most attractive targets for developing novel anti-HCV therapies.  However, discovery of potent and selective small-mol. inhibitors of HCV NS3•4A protease as oral drug candidates has been hampered by the shallow substrate-binding groove of the protease.  Serine trap warheads have been used to covalently anchor inhibitor scaffolds and to increase their affinity to the protease.  This review will examine the evolution of covalent inhibitors of the HCV NS3•4A protease from early aldehyde mols. to α-ketoamide inhibitors.  Kinetic and structural studies of α-ketoacid and α-ketoamide inhibitors revealed an unusual mechanism of binding in the catalytic site.  Optimization of α-ketoamide scaffolds by scientists at Vertex and Eli Lilly led to the discovery of VX-950, a novel, potent, selective inhibitor of HCV NS3•4A protease.  VX-950 possesses excellent antiviral activity in both HCV replicon cells and human fetal hepatocytes infected with HCV-pos. patient sera.  In addn., VX-950 exhibits a favorable pharmacokinetic profile in several animal species and demonstrates potent inhibition of the HCV NS3•4A protease activity in a mouse model.  In a recent phase 1b clin. trial, VX-950 was able to rapidly reduce the plasma viral load of patients chronically infected with genotype 1 HCV by a mean ∼3 log10 in 2 days.  The median viral load redn. was 4.4 log10 for the best dose group after 14 days of dosing.  The preclin. profile and early clin. data of VX-950 will be discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOA6Gspx5Jv7Vg90H21EOLACvtfcHk0liXOsHbX41QBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7k%253D&md5=dbf5706a5d351aabf722d88216d88b78</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.2174%2F187152606776056706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152606776056706%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26atitle%3DDiscovery%2520and%2520development%2520of%2520VX-950%252C%2520a%2520novel%252C%2520covalent%252C%2520and%2520reversible%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DInfect.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2006%26volume%3D6%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broske, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisson, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prelusky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korfmacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdanowich-Knipp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery of (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6074</span><span class="NLM_x">–</span> <span class="NLM_lpage">6086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agrawalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=V.+Madisonauthor=L.+Broskeauthor=X.+Cuiauthor=K.-C.+Chengauthor=Y.+Hsiehauthor=J.-M.+Brissonauthor=D.+Preluskyauthor=W.+Korfmacherauthor=R.+Whiteauthor=S.+Bogdanowich-Knippauthor=A.+Pavlovskyauthor=P.+Bradleyauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-Amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+Selective%2C+Potent%2C+Orally+Bioavailable+Hepatitis+C+Virus+NS3+Protease+Inhibitor%3A+A+Potential+Therapeutic+Agent+for+the+Treatment+of+Hepatitis+C+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DBroske%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DBrisson%26aufirst%3DJ.-M.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogdanowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DBradley%26aufirst%3DP.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-Amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520Selective%252C%2520Potent%252C%2520Orally%2520Bioavailable%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%2520Inhibitor%253A%2520A%2520Potential%2520Therapeutic%2520Agent%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6074%26epage%3D6086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Prongay, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosise, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taremi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarosh-Tomaine, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senior, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span> </span><span class="NLM_article-title">Discovery of the HCV NS3/4A Protease Inhibitor (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (SCH 503034). Key Steps in Structure-Based Optimization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2310</span><span class="NLM_x">–</span> <span class="NLM_lpage">2318</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060173k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2310-2318&author=A.+J.+Prongayauthor=Z.+Guoauthor=N.+Yaoauthor=J.+Pichardoauthor=T.+Fischmannauthor=C.+Stricklandauthor=J.+Myersauthor=P.+C.+Weberauthor=B.+M.+Beyerauthor=R.+Ingramauthor=Z.+Hongauthor=W.+W.+Prosiseauthor=L.+Ramanathanauthor=S.+S.+Taremiauthor=T.+Yarosh-Tomaineauthor=R.+Zhangauthor=M.+Seniorauthor=R.-S.+Yangauthor=B.+Malcolmauthor=A.+Arasappanauthor=F.+Bennettauthor=S.+L.+Bogenauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+G.+Loveyauthor=A.+K.+Saksenaauthor=S.+Venkatramanauthor=V.+Girijavallabhanauthor=F.+G.+Njorogeauthor=V.+Madison&title=Discovery+of+the+HCV+NS3%2F4A+Protease+Inhibitor+%281R%2C5S%29-N-%5B3-Amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29.+Key+Steps+in+Structure-Based+Optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fjm060173k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060173k%26sid%3Dliteratum%253Aachs%26aulast%3DProngay%26aufirst%3DA.%2BJ.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DFischmann%26aufirst%3DT.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMyers%26aufirst%3DJ.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26aulast%3DIngram%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DProsise%26aufirst%3DW.%2BW.%26aulast%3DRamanathan%26aufirst%3DL.%26aulast%3DTaremi%26aufirst%3DS.%2BS.%26aulast%3DYarosh-Tomaine%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DSenior%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DR.-S.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%2BG.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DMadison%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520the%2520HCV%2520NS3%252F4A%2520Protease%2520Inhibitor%2520%25281R%252C5S%2529-N-%255B3-Amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529.%2520Key%2520Steps%2520in%2520Structure-Based%2520Optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2310%26epage%3D2318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, Å.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvador-Oden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wähling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickström, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pille, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Structure−activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">–</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4853-4858&author=P.+Raboissonauthor=H.+De+Kockauthor=%C3%85.+Rosenquistauthor=M.+Nilssonauthor=L.+Salvador-Odenauthor=T.+Linauthor=N.+Roueauthor=V.+Ivanovauthor=H.+W%C3%A4hlingauthor=K.+Wickstr%C3%B6mauthor=E.+Hamelinkauthor=M.+Edlungauthor=L.+Vrangauthor=S.+Vendevilleauthor=W.+V.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=C.+Bouttonauthor=O.+Lenzauthor=F.+Delouvroyauthor=G.+Pilleauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=B.+Samuelssonauthor=K.+Simmen&title=Structure%E2%88%92activity+relationship+study+on+a+novel+series+of+cyclopentane-containing+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease+leading+to+the+discovery+of+TMC435350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DDe%2BKock%26aufirst%3DH.%26aulast%3DRosenquist%26aufirst%3D%25C3%2585.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DSalvador-Oden%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DRoue%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DW%25C3%25A4hling%26aufirst%3DH.%26aulast%3DWickstr%25C3%25B6m%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DEdlung%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%2BV.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DBoutton%26aufirst%3DC.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DPille%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DStructure%25E2%2588%2592activity%2520relationship%2520study%2520on%2520a%2520novel%2520series%2520of%2520cyclopentane-containing%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520TMC435350%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4853%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lin, T.-I.; Lenz, O.; Fanning, G.; Verbinnen, T.; Delouvroy, F.; Scholliers, A.; Vermeiren, K.; Rosenquist, Å.; Edlund, M.; Samuelsson, B.; Vrang, L.; de Kock, H.; Wigerinck, P.; Raboisson, P.; Simmen, K.</span><span> </span><span class="NLM_article-title">In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor</span>.  <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span>− <span class="NLM_lpage">1385</span>; New Data on Tibotec Investigational Hepatitic C Compounds being Presented at EASL. Press releases at the Tibotec homepage: <a href="http://www.tibotec.com/news/detail.jhtml?action=view&amp;itemname=news_60" class="extLink">http://www.tibotec.com/news/detail.jhtml?action=view&itemname=news_60</a> (accessed Jul 2009).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=1377-1385&author=T.-I.+Lin&author=O.+Lenz&author=G.+Fanning&author=T.+Verbinnen&author=F.+Delouvroy&author=A.+Scholliers&author=K.+Vermeiren&author=%C3%85.+Rosenquist&author=M.+Edlund&author=B.+Samuelsson&author=L.+Vrang&author=H.+de+Kock&author=P.+Wigerinck&author=P.+Raboisson&author=K.+Simmen&title=In+Vitro+Activity+and+Preclinical+Profile+of+TMC435350%2C+a+Potent+Hepatitis+C+Virus+Protease+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DT.-I.%26atitle%3DIn%2520Vitro%2520Activity%2520and%2520Preclinical%2520Profile%2520of%2520TMC435350%252C%2520a%2520Potent%2520Hepatitis%2520C%2520Virus%2520Protease%2520Inhibitor%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D1377%26epage%3D1385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Manns, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reesink, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamous, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horsmans, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusheiko, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flisiak, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyvisch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van’t Klooster, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verloes, R.</span><span> </span><span class="NLM_article-title">Opera-1 Trial: Interim Analysis Of Safety and Antiviral Activity of TMC435 in Treatment-Naïve Genotype 1 HCV Patients</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">S7</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=S7&author=M.+Mannsauthor=H.+Reesinkauthor=C.+Morenoauthor=T.+Bergauthor=Y.+Benhamousauthor=Y.+Horsmansauthor=G.+Dusheikoauthor=R.+Flisiakauthor=P.+Meyvischauthor=O.+Lenzauthor=V.+Sekarauthor=G.+Van%E2%80%99t+Kloosterauthor=K.+Simmenauthor=R.+Verloes&title=Opera-1+Trial%3A+Interim+Analysis+Of+Safety+and+Antiviral+Activity+of+TMC435+in+Treatment-Na%C3%AFve+Genotype+1+HCV+Patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%26aulast%3DReesink%26aufirst%3DH.%26aulast%3DMoreno%26aufirst%3DC.%26aulast%3DBerg%26aufirst%3DT.%26aulast%3DBenhamous%26aufirst%3DY.%26aulast%3DHorsmans%26aufirst%3DY.%26aulast%3DDusheiko%26aufirst%3DG.%26aulast%3DFlisiak%26aufirst%3DR.%26aulast%3DMeyvisch%26aufirst%3DP.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DSekar%26aufirst%3DV.%26aulast%3DVan%25E2%2580%2599t%2BKlooster%26aufirst%3DG.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DVerloes%26aufirst%3DR.%26atitle%3DOpera-1%2520Trial%253A%2520Interim%2520Analysis%2520Of%2520Safety%2520and%2520Antiviral%2520Activity%2520of%2520TMC435%2520in%2520Treatment-Na%25C3%25AFve%2520Genotype%25201%2520HCV%2520Patients%26jtitle%3DJ.%2520Hepatol.%26date%3D2009%26volume%3D50%26spage%3DS7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, P. T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoycheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L. M.</span><span> </span><span class="NLM_article-title">Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4432-4441&issue=12&author=S.+D.+Seiwertauthor=S.+W.+Andrewsauthor=Y.+Jiangauthor=V.+Serebryanyauthor=H.+Tanauthor=K.+Kossenauthor=P.+T.+R.+Rajagopalanauthor=S.+Misialekauthor=S.+K.+Stevensauthor=A.+Stoychevaauthor=J.+Hongauthor=S.+R.+Limauthor=X.+Qinauthor=R.+Riegerauthor=K.+R.+Condroskiauthor=H.+Zhangauthor=M.+G.+Doauthor=C.+Lemieuxauthor=G.+P.+Hingoraniauthor=D.+P.+Hartleyauthor=J.+A.+Joseyauthor=L.+Panauthor=L.+Beigelmanauthor=L.+M.+Blatt&title=Preclinical+characteristics+of+the+hepatitis+C+virus+NS3%2F4A+protease+inhibitor+ITMN-191+%28R7227%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DKossen%26aufirst%3DK.%26aulast%3DRajagopalan%26aufirst%3DP.%2BT.%2BR.%26aulast%3DMisialek%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DStoycheva%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%2BR.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DRieger%26aufirst%3DR.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDo%26aufirst%3DM.%2BG.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DHingorani%26aufirst%3DG.%2BP.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DPreclinical%2520characteristics%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520inhibitor%2520ITMN-191%2520%2528R7227%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26issue%3D12%26spage%3D4432%26epage%3D4441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Blatt, L. M.; Wenglowsky, S. M.; Andrews, S. W.; Jiang, Y.; Kennedy, A. L.; Condroski, K. R.; Josey, J. A.; Stengel, P. J.; Madduru, M. R.; Doherty, G. A.; Woodard, B. T.</span><span> </span><span class="NLM_article-title">Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication</span>. PCT Int. Appl. WO 2005/037214, <b>2005</b>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Blatt%2C+L.+M.%3B+Wenglowsky%2C+S.+M.%3B+Andrews%2C+S.+W.%3B+Jiang%2C+Y.%3B+Kennedy%2C+A.+L.%3B+Condroski%2C+K.+R.%3B+Josey%2C+J.+A.%3B+Stengel%2C+P.+J.%3B+Madduru%2C+M.+R.%3B+Doherty%2C+G.+A.%3B+Woodard%2C+B.+T.+Macrocyclic+carboxylic+acids+and+acylsulfonamides+as+inhibitors+of+HCV+replication.+PCT+Int.+Appl.+WO+2005%2F037214%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DMacrocyclic%2520carboxylic%2520acids%2520and%2520acylsulfonamides%2520as%2520inhibitors%2520of%2520HCV%2520replication" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Marchetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ontoria, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span> </span><span class="NLM_article-title">Synthesis of Two Novel Cyclic Biphenyl Ether Analogs of an Inhibitor of HCV NS3 Protease</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">S1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1000</span><span class="NLM_x">–</span> <span class="NLM_lpage">1002</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=S1&publication_year=1999&pages=1000-1002&author=A.+Marchettiauthor=J.+M.+Ontoriaauthor=V.+G.+Matassa&title=Synthesis+of+Two+Novel+Cyclic+Biphenyl+Ether+Analogs+of+an+Inhibitor+of+HCV+NS3+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetti%26aufirst%3DA.%26aulast%3DOntoria%26aufirst%3DJ.%2BM.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26atitle%3DSynthesis%2520of%2520Two%2520Novel%2520Cyclic%2520Biphenyl%2520Ether%2520Analogs%2520of%2520an%2520Inhibitor%2520of%2520HCV%2520NS3%2520Protease%26jtitle%3DSynlett%26date%3D1999%26volume%3DS1%26spage%3D1000%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Activity of <i>m</i>-Tyrosine-Based 16- and 17-Membered Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">6229</span><span class="NLM_x">–</span> <span class="NLM_lpage">6235</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050323b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6229-6235&issue=20&author=K.+X.+Chenauthor=F.+G.+Njorogeauthor=J.+Pichardoauthor=A.+Prongayauthor=N.+Butkiewiczauthor=N.+Yaoauthor=V.+Madisonauthor=V.+Girijavallabhan&title=Design%2C+Synthesis%2C+and+Biological+Activity+of+m-Tyrosine-Based+16-+and+17-Membered+Macrocyclic+Inhibitors+of+Hepatitis+C+Virus+NS3+Serine+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fjm050323b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050323b%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Activity%2520of%2520m-Tyrosine-Based%252016-%2520and%252017-Membered%2520Macrocyclic%2520Inhibitors%2520of%2520Hepatitis%2520C%2520Virus%2520NS3%2520Serine%2520Protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D20%26spage%3D6229%26epage%3D6235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span> </span><span class="NLM_article-title">Potent 7-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid-Based Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050520a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=567-574&issue=2&author=K.+X.+Chenauthor=F.+G.+Njorogeauthor=J.+Pichardoauthor=A.+Prongayauthor=N.+Butkiewiczauthor=N.+Yaoauthor=V.+Madisonauthor=V.+Girijavallabhan&title=Potent+7-Hydroxy-1%2C2%2C3%2C4-tetrahydroisoquinoline-3-carboxylic+Acid-Based+Macrocyclic+Inhibitors+of+Hepatitis+C+Virus+NS3+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjm050520a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050520a%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26atitle%3DPotent%25207-Hydroxy-1%252C2%252C3%252C4-tetrahydroisoquinoline-3-carboxylic%2520Acid-Based%2520Macrocyclic%2520Inhibitors%2520of%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D2%26spage%3D567%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span> </span><span class="NLM_article-title">P2−P4 Macrocyclic inhibitors of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">3960</span><span class="NLM_x">–</span> <span class="NLM_lpage">3965</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3960-3965&issue=15&author=A.+Arasappanauthor=F.+G.+Njorogeauthor=K.+X.+Chenauthor=S.+Venkatramanauthor=T.+N.+Parekhauthor=H.+Guauthor=J.+Pichardoauthor=N.+Butkiewiczauthor=A.+Prongayauthor=V.+Madisonauthor=V.+Girijavallabhan&title=P2%E2%88%92P4+Macrocyclic+inhibitors+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DParekh%26aufirst%3DT.%2BN.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26atitle%3DP2%25E2%2588%2592P4%2520Macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D15%26spage%3D3960%26epage%3D3965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Molecular modeling based approach to potent P2−P4 macrocyclic inhibitors of hepatitis C NS3/4a protease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4607</span><span class="NLM_x">–</span> <span class="NLM_lpage">4609</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFygur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=J.+W.+Butcherauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.-S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=B.-L.+Wanauthor=D.+B.+Olsenauthor=J.+P.+Vacca&title=Molecular+modeling+based+approach+to+potent+P2%E2%88%92P4+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4a+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Modeling Based Approach to Potent P2-P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease</span></div><div class="casAuthors">Liverton, Nigel J.; Holloway, M. Katharine; McCauley, John A.; Rudd, Michael T.; Butcher, John W.; Carroll, Steven S.; DiMuzio, Jillian; Fandozzi, Christine; Gilbert, Kevin F.; Mao, Shi-Shan; McIntyre, Charles J.; Nguyen, Kevin T.; Romano, Joseph J.; Stahlhut, Mark; Wan, Bang-Lin; Olsen, David B.; Vacca, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4607-4609</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. modeling of inhibitor bound full length HCV NS3/4A protease structures proved to be a valuable tool in the design of a new series of potent NS3 protease inhibitors.  Optimization of initial compds. provided 25a.  The in vitro activity and selectivity as well as the rat pharmacokinetic profile of 25a compare favorably with the data for other NS3/4A protease inhibitors currently in clin. development for the treatment of HCV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppYenMBNqdeLVg90H21EOLACvtfcHk0lhwd4Qy3jzMcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFygur8%253D&md5=5e7bb98bdb19c30bebb30f03a702838d</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520modeling%2520based%2520approach%2520to%2520potent%2520P2%25E2%2588%2592P4%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4a%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4607%26epage%3D4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. W.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Bismacrocyclic inhibitors of hepatitis C NS3/4a protease</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">47</span><span class="NLM_x">) </span> <span class="NLM_fpage">9104</span><span class="NLM_x">–</span> <span class="NLM_lpage">9107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=9104-9107&issue=47&author=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=K.+T.+Nguyenauthor=C.+J.+McIntyreauthor=J.+J.+Romanoauthor=K.+J.+Bushauthor=S.+L.+Vargaauthor=C.+W.+Rossauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=T.+A.+Lyleauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Bismacrocyclic+inhibitors+of+hepatitis+C+NS3%2F4a+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DVarga%26aufirst%3DS.%2BL.%26aulast%3DRoss%26aufirst%3DC.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DBismacrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4a%2520protease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26issue%3D47%26spage%3D9104%26epage%3D9107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Scola, P. M.; Campbell, J. A.; Sin, N.; Sun, L.; Wang, X. A.</span>Preparation of peptides as hepatitis C virus inhibitors. PCT Int. Appl. WO 2005/051410,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=P.+M.+Scola&author=J.+A.+Campbell&author=N.+Sin&author=L.+Sun&author=X.+A.+Wang&title=Preparation+of+peptides+as+hepatitis+C+virus+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DScola%26aufirst%3DP.%2BM.%26jtitle%3DPreparation%2520of%2520peptides%2520as%2520hepatitis%2520C%2520virus%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">McCauley, J. A.; Rudd, M. T.; McIntyre, C. J.; Nguyen, K. T.; Romano, J. J.; Butcher, J. W.; Holloway, M. K.; Wan, B.; Carroll, S. S.; DiMuzio, J. M.; Graham, D. J.; Ludmerer, S. W.; Mao, S.; Stahlhut, M.; Fandozzi, C.; Trainor, N.; Olsen, D. B.; Vacca, J. P.; Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-7009:a novel macrocyclic HCV NS3/4A protease inhibitor</span>.  <span class="citation_source-book">Abstracts of Papers, 235th ACS National Meeting</span>, <span class="NLM_conf-loc">New Orleans, LA</span>, <span class="NLM_conf-date">April 6−10</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+A.+McCauley&author=M.+T.+Rudd&author=C.+J.+McIntyre&author=K.+T.+Nguyen&author=J.+J.+Romano&author=J.+W.+Butcher&author=M.+K.+Holloway&author=B.+Wan&author=S.+S.+Carroll&author=J.+M.+DiMuzio&author=D.+J.+Graham&author=S.+W.+Ludmerer&author=S.+Mao&author=M.+Stahlhut&author=C.+Fandozzi&author=N.+Trainor&author=D.+B.+Olsen&author=J.+P.+Vacca&author=N.+J.+Liverton&title=Abstracts+of+Papers%2C+235th+ACS+National+Meeting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520MK-7009%253Aa%2520novel%2520macrocyclic%2520HCV%2520NS3%252F4A%2520protease%2520inhibitor%26btitle%3DAbstracts%2520of%2520Papers%252C%2520235th%2520ACS%2520National%2520Meeting%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span>Reviewed in <span class="NLM_contrib-group">Patani, G. A.; LaVoie, E. J.</span><span> </span><span class="NLM_article-title">Bioisosterism: A rational approach in drug design</span>.  <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">3147</span>− <span class="NLM_lpage">3176</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/cr950066q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADyaK28XntFSitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1996&pages=3147-3176&author=G.+A.+Patani&author=E.+J.+LaVoie&title=Bioisosterism%3A+A+rational+approach+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Bioisosterism: A rational approach in drug design</span></div><div class="casAuthors">Patani, George A.; LaVoie, Edmond J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3147-3176</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with 191 refs., on bioisosteres that incorporates sufficient detail to enable the reader to understand the concepts being delineated.  Classical bioisosteres, such as monovalent atoms and groups, divalent isosteres, trivalent atoms and groups, tetra substituted atoms, and ring equiv., and non-classical bioisosteres, such as cyclic vs. non-cyclic non-classical bioisosteric replacements and non-classical bioisosteric replacements of functional groups, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrADeNoRGbU9LVg90H21EOLACvtfcHk0ljZAtAjUqu4YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntFSitLg%253D&md5=4b3ec55087feabc53e0490ebd5a3ddcd</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fcr950066q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr950066q%26sid%3Dliteratum%253Aachs%26aulast%3DPatani%26aufirst%3DG.%2BA.%26atitle%3DBioisosterism%253A%2520A%2520rational%2520approach%2520in%2520drug%2520design%26jtitle%3DChem.%2520Rev.%26date%3D1996%26volume%3D96%26spage%3D3147%26epage%3D3176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Thompson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eppley, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darcy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszek, T. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanoff, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternberg, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petteway, S. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, J. G.</span><span> </span><span class="NLM_article-title">Synthesis and antiviral activity of a novel class of HIV-1 protease inhibitors containing a heterocyclic P<sub>1</sub>′−P<sub>2</sub>′ amide bond isostere</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2441</span><span class="NLM_x">–</span> <span class="NLM_lpage">2446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=2441-2446&author=S.+K.+Thompsonauthor=A.+M.+Eppleyauthor=J.+S.+Frazeeauthor=M.+G.+Darcyauthor=R.+T.+Lumauthor=T.+A.+Tomaszekauthor=L.+A.+Ivanoffauthor=J.+F.+Morrisauthor=E.+J.+Sternbergauthor=D.+M.+Lambertauthor=A.+V.+Fernandezauthor=S.+R.+Pettewayauthor=T.+D.+Meekauthor=B.+W.+Metcalfauthor=J.+G.+Gleason&title=Synthesis+and+antiviral+activity+of+a+novel+class+of+HIV-1+protease+inhibitors+containing+a+heterocyclic+P1%E2%80%B2%E2%88%92P2%E2%80%B2+amide+bond+isostere"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DS.%2BK.%26aulast%3DEppley%26aufirst%3DA.%2BM.%26aulast%3DFrazee%26aufirst%3DJ.%2BS.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DLum%26aufirst%3DR.%2BT.%26aulast%3DTomaszek%26aufirst%3DT.%2BA.%26aulast%3DIvanoff%26aufirst%3DL.%2BA.%26aulast%3DMorris%26aufirst%3DJ.%2BF.%26aulast%3DSternberg%26aufirst%3DE.%2BJ.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DFernandez%26aufirst%3DA.%2BV.%26aulast%3DPetteway%26aufirst%3DS.%2BR.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DMetcalf%26aufirst%3DB.%2BW.%26aulast%3DGleason%26aufirst%3DJ.%2BG.%26atitle%3DSynthesis%2520and%2520antiviral%2520activity%2520of%2520a%2520novel%2520class%2520of%2520HIV-1%2520protease%2520inhibitors%2520containing%2520a%2520heterocyclic%2520P1%25E2%2580%25B2%25E2%2588%2592P2%25E2%2580%25B2%2520amide%2520bond%2520isostere%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26spage%3D2441%26epage%3D2446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Di Marco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colarusso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollazzo, M.</span><span> </span><span class="NLM_article-title">Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">7152</span><span class="NLM_x">–</span> <span class="NLM_lpage">7157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=7152-7157&issue=10&author=S.+Di+Marcoauthor=M.+Rizziauthor=C.+Volpariauthor=M.+A.+Walshauthor=F.+Narjesauthor=S.+Colarussoauthor=R.+De+Francescoauthor=V.+G.+Matassaauthor=M.+Sollazzo&title=Inhibition+of+the+hepatitis+C+virus+NS3%2F4A+protease.+The+crystal+structures+of+two+protease-inhibitor+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMarco%26aufirst%3DS.%26aulast%3DRizzi%26aufirst%3DM.%26aulast%3DVolpari%26aufirst%3DC.%26aulast%3DWalsh%26aufirst%3DM.%2BA.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DColarusso%26aufirst%3DS.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DSollazzo%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease.%2520The%2520crystal%2520structures%2520of%2520two%2520protease-inhibitor%2520complexes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26issue%3D10%26spage%3D7152%26epage%3D7157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cicero, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbato, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingallinella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardi, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinkuhler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazzo, R..</span><span> </span><span class="NLM_article-title">Structural Characterization of the Interactions of Optimized Product Inhibitors with the N-terminal Proteinase Domain of the Hepatitis C Virus (HCV) NS3 Protein by NMR and Modelling Studies</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=385-396&issue=2&author=D.+O.+Ciceroauthor=G.+Barbatoauthor=U.+Kochauthor=P.+Ingallinellaauthor=E.+Bianchiauthor=M.+C.+Nardiauthor=C.+Steinkuhlerauthor=R.+Corteseauthor=V.+Matassaauthor=R.+De+Francescoauthor=A.+Pessiauthor=R..+Bazzo&title=Structural+Characterization+of+the+Interactions+of+Optimized+Product+Inhibitors+with+the+N-terminal+Proteinase+Domain+of+the+Hepatitis+C+Virus+%28HCV%29+NS3+Protein+by+NMR+and+Modelling+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCicero%26aufirst%3DD.%2BO.%26aulast%3DBarbato%26aufirst%3DG.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DIngallinella%26aufirst%3DP.%26aulast%3DBianchi%26aufirst%3DE.%26aulast%3DNardi%26aufirst%3DM.%2BC.%26aulast%3DSteinkuhler%26aufirst%3DC.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DMatassa%26aufirst%3DV.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DPessi%26aufirst%3DA.%26aulast%3DBazzo%26aufirst%3DR..%26atitle%3DStructural%2520Characterization%2520of%2520the%2520Interactions%2520of%2520Optimized%2520Product%2520Inhibitors%2520with%2520the%2520N-terminal%2520Proteinase%2520Domain%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520%2528HCV%2529%2520NS3%2520Protein%2520by%2520NMR%2520and%2520Modelling%2520Studies%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1999%26volume%3D289%26issue%3D2%26spage%3D385%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plouffe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">NMR Structural Characterization of Peptide Inhibitors Bound to the Hepatitis C Virus NS3 Protease: Design of a New P2 Substituent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0303002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=123-132&issue=1&author=N.+Goudreauauthor=D.+R.+Cameronauthor=P.+Bonneauauthor=V.+Gorysauthor=C.+Plouffeauthor=M.+Poirierauthor=D.+Lamarreauthor=M.+Llinas-Brunet&title=NMR+Structural+Characterization+of+Peptide+Inhibitors+Bound+to+the+Hepatitis+C+Virus+NS3+Protease%3A+Design+of+a+New+P2+Substituent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1021%2Fjm0303002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0303002%26sid%3Dliteratum%253Aachs%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DPlouffe%26aufirst%3DC.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DNMR%2520Structural%2520Characterization%2520of%2520Peptide%2520Inhibitors%2520Bound%2520to%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%253A%2520Design%2520of%2520a%2520New%2520P2%2520Substituent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D1%26spage%3D123%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Grubbs, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, G. C.</span><span> </span><span class="NLM_article-title">Ring-closing metathesis and related processes in organic synthesis</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">446</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar00059a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADyaK2MXosl2ns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1995&pages=446-452&issue=11&author=R.+H.+Grubbsauthor=S.+J.+Millerauthor=G.+C.+Fu&title=Ring-closing+metathesis+and+related+processes+in+organic+synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Ring-Closing Metathesis and Related Processes in Organic Synthesis</span></div><div class="casAuthors">Grubbs, Robert H.; Miller, Scott J.; Fu, Gregory C.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">446-52</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 45 refs. including, e.g. molybdenum-based alkylidenes, ruthenium-based alkylidenes and new catalysts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkuIuELXHEALVg90H21EOLACvtfcHk0lizebOZ-vnmRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXosl2ns70%253D&md5=c65649fd9d2582338f816a0b23ecc142</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Far00059a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far00059a002%26sid%3Dliteratum%253Aachs%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26aulast%3DMiller%26aufirst%3DS.%2BJ.%26aulast%3DFu%26aufirst%3DG.%2BC.%26atitle%3DRing-closing%2520metathesis%2520and%2520related%2520processes%2520in%2520organic%2520synthesis%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D1995%26volume%3D28%26issue%3D11%26spage%3D446%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grubbs, R. H.</span><span> </span><span class="NLM_article-title">Olefin metathesis catalysts for the preparation of molecules and materials (Nobel Lecture)</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3760</span><span class="NLM_x">–</span> <span class="NLM_lpage">3765</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=3760-3765&author=R.+H.+Grubbs&title=Olefin+metathesis+catalysts+for+the+preparation+of+molecules+and+materials+%28Nobel+Lecture%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26atitle%3DOlefin%2520metathesis%2520catalysts%2520for%2520the%2520preparation%2520of%2520molecules%2520and%2520materials%2520%2528Nobel%2520Lecture%2529%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D3760%26epage%3D3765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Saegusa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span> </span><span class="NLM_article-title">Reaction of 1,3,4-oxadiazolones with free <span class="smallcaps smallerCapital">l</span>-α-amino acids: a facile synthesis of novel 3,5-disubstituted hydantoins</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">742</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1990&pages=739-742&issue=3&author=Y.+Saegusaauthor=S.+Haradaauthor=S.+Nakamura&title=Reaction+of+1%2C3%2C4-oxadiazolones+with+free+l-%CE%B1-amino+acids%3A+a+facile+synthesis+of+novel+3%2C5-disubstituted+hydantoins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaegusa%26aufirst%3DY.%26aulast%3DHarada%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DS.%26atitle%3DReaction%2520of%25201%252C3%252C4-oxadiazolones%2520with%2520free%2520l-%25CE%25B1-amino%2520acids%253A%2520a%2520facile%2520synthesis%2520of%2520novel%25203%252C5-disubstituted%2520hydantoins%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1990%26volume%3D27%26issue%3D3%26spage%3D739%26epage%3D742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Di Francesco, M. E.; Nizi, E.; Pace, P.; Summa, V.</span><span> </span><span class="NLM_article-title">Preparation of peptidyl macrocyclic compounds as antiviral agents</span>. PCT Int. Appl. WO 2007/131966,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+E.+Di+Francesco&author=E.+Nizi&author=P.+Pace&author=V.+Summa&title=Preparation+of+peptidyl+macrocyclic+compounds+as+antiviral+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFrancesco%26aufirst%3DM.%2BE.%26atitle%3DPreparation%2520of%2520peptidyl%2520macrocyclic%2520compounds%2520as%2520antiviral%2520agents%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="note"><p class="first last">The Zhan ruthenium metathesis catalyst RC-301, Zhan catalyst 1, dichloro(5-chloro-2-isopropoxybenzylidene)(1,3-dimethylimidazolidin-2-ylidene)ruthenium), is available from Strem, catalogue no. 44-0082.<span class="NLM_inline-graphic"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0009.tif.gif" alt="" /></img></span></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Wang, X. A.; Sun, L.-Q.; Sit, S.-Y.; Sin, N.; Scola, P. M.; Hewawasam, P.; Good, A. C.; Chen, Y.; Campbell, J. A.</span><span> </span><span class="NLM_article-title">Hepatitis C Virus Inhibitors</span>. U.S. Patent 6,995,174,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=X.+A.+Wang&author=L.-Q.+Sun&author=S.-Y.+Sit&author=N.+Sin&author=P.+M.+Scola&author=P.+Hewawasam&author=A.+C.+Good&author=Y.+Chen&author=J.+A.+Campbell&title=Hepatitis+C+Virus+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BA.%26atitle%3DHepatitis%2520C%2520Virus%2520Inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Holloway, M. K.; Liverton, N. J.; Ludmerer, S. W.; McCauley, J. A.; Olsen, D. B.; Rudd, M. T.; Vacca, J. P.</span><span> </span><span class="NLM_article-title">Preparation of macrocyclic compounds as HCV NS3 protease inhibitors</span>. PCT Int. Appl. WO 2006/119061,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+K.+Holloway&author=N.+J.+Liverton&author=S.+W.+Ludmerer&author=J.+A.+McCauley&author=D.+B.+Olsen&author=M.+T.+Rudd&author=J.+P.+Vacca&title=Preparation+of+macrocyclic+compounds+as+HCV+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26atitle%3DPreparation%2520of%2520macrocyclic%2520compounds%2520as%2520HCV%2520NS3%2520protease%2520inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Holloway, M. K.; Liverton, N. J.; Ludmerer, S. W.; Mccauley, J. A.; Olsen, D. B.; Rudd, M. T.; Vacca, J. P.; Mcintyre, C. J.</span><span> </span><span class="NLM_article-title">Preparation of macrocyclic compounds as HCV NS3 protease inhibitors</span>. <span class="NLM_patent"></span>US 2007/027071,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+K.+Holloway&author=N.+J.+Liverton&author=S.+W.+Ludmerer&author=J.+A.+Mccauley&author=D.+B.+Olsen&author=M.+T.+Rudd&author=J.+P.+Vacca&author=C.+J.+Mcintyre&title=Preparation+of+macrocyclic+compounds+as+HCV+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26atitle%3DPreparation%2520of%2520macrocyclic%2520compounds%2520as%2520HCV%2520NS3%2520protease%2520inhibitors%26jtitle%3DUS%25202007%252F027071%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Butcher, J.; Di Filippo, M.; Ferrara, M.; Di Francesco, M. E.; Harper, S.; Rudd, M.; Summa, V.; Romano, J.; Liverton, N.; Mccauley, J.</span><span> </span><span class="NLM_article-title">Macrocyclic compounds as antiviral agents</span>. PCT Int. Appl. WO 2009/010804,<span class="NLM_x"> </span><span class="NLM_year">2009.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009.&author=J.+Butcher&author=M.+Di+Filippo&author=M.+Ferrara&author=M.+E.+Di+Francesco&author=S.+Harper&author=M.+Rudd&author=V.+Summa&author=J.+Romano&author=N.+Liverton&author=J.+Mccauley&title=Macrocyclic+compounds+as+antiviral+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DButcher%26aufirst%3DJ.%26atitle%3DMacrocyclic%2520compounds%2520as%2520antiviral%2520agents%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span> </span><span class="NLM_article-title">A time-resolved, internally quenched fluorescence assay to characterize inhibition of hepatitis C virus nonstructural protein 3−4A protease at low enzyme concentrations</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2008&pages=1-8&author=S.-S.+Maoauthor=J.+DiMuzioauthor=C.+McHaleauthor=C.+Burleinauthor=D.+Olsenauthor=S.+S.+Carroll&title=A+time-resolved%2C+internally+quenched+fluorescence+assay+to+characterize+inhibition+of+hepatitis+C+virus+nonstructural+protein+3%E2%88%924A+protease+at+low+enzyme+concentrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DMcHale%26aufirst%3DC.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DOlsen%26aufirst%3DD.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26atitle%3DA%2520time-resolved%252C%2520internally%2520quenched%2520fluorescence%2520assay%2520to%2520characterize%2520inhibition%2520of%2520hepatitis%2520C%2520virus%2520nonstructural%2520protein%25203%25E2%2588%25924A%2520protease%2520at%2520low%2520enzyme%2520concentrations%26jtitle%3DAnal.%2520Biochem.%26date%3D2008%26volume%3D373%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, J.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theilmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1126%2Fscience.285.5424.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=10390360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=110-113&author=V.+Lohmannauthor=F.+Kornerauthor=J.-O.+Kochauthor=U.+Herianauthor=L.+Theilmannauthor=R.+Bartenschlager&title=Replication+of+subgenomic+hepatitis+C+virus+RNAs+in+a+hepatoma+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span></div><div class="casAuthors">Lohmann, V.; Korner, F.; Koch, J.-O.; Herian, U.; Theilmann, L.; Bartenschlager, R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">5424</span>),
    <span class="NLM_cas:pages">110-113</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">An estd. 170 million persons worldwide are infected with hepatitis C virus (HCV), a major cause of chronic liver disease.  Despite increasing knowledge of genome structure and individual viral proteins, studies on virus replication and pathogenesis have been hampered by the lack of reliable and efficient cell culture systems.  A full-length consensus genome was cloned from viral RNA isolated from an infected human liver and used to construct subgenomic selectable replicons.  Upon transfection into a human hepatoma cell line, these RNAs replicated to high levels, permitting metabolic radiolabeling of viral RNA and proteins.  This work defines the structure of HCV replicons functional in cell culture and provides the basis for a long-sought cellular system that should allow detailed mol. studies of HCV and the development of antiviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7X754RT8y1LVg90H21EOLACvtfcHk0ljYF5OsY0R69w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D&md5=b075621b316209ecf4498c9b5b33e4b5</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1126%2Fscience.285.5424.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.285.5424.110%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DKorner%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DJ.-O.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DTheilmann%26aufirst%3DL.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DReplication%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNAs%2520in%2520a%2520hepatoma%2520cell%2520line%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span>More than 10 analogues featuring the oxadiazole moiety in P4 were prepared bearing combinations of the various P2 cores and P3 residues. Overall they proved to be inferior to the corresponding aminothiazoles, in analogy with the findings described for analogue <b>4</b>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=More+than+10+analogues+featuring+the+oxadiazole+moiety+in+P4+were+prepared+bearing+combinations+of+the+various+P2+cores+and+P3+residues.+Overall+they+proved+to+be+inferior+to+the+corresponding+aminothiazoles%2C+in+analogy+with+the+findings+described+for+analogue+4."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ingallinella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingenito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinkuehler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessi, A.</span><span> </span><span class="NLM_article-title">Potent Peptide Inhibitors of Human Hepatitis C Virus NS3 Protease Are Obtained by Optimizing the Cleavage Products</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">8906</span><span class="NLM_x">–</span> <span class="NLM_lpage">8914</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi980314n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=8906-8914&issue=25&author=P.+Ingallinellaauthor=S.+Altamuraauthor=E.+Bianchiauthor=M.+Talianiauthor=R.+Ingenitoauthor=R.+Corteseauthor=R.+De+Francescoauthor=C.+Steinkuehlerauthor=A.+Pessi&title=Potent+Peptide+Inhibitors+of+Human+Hepatitis+C+Virus+NS3+Protease+Are+Obtained+by+Optimizing+the+Cleavage+Products"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.1021%2Fbi980314n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi980314n%26sid%3Dliteratum%253Aachs%26aulast%3DIngallinella%26aufirst%3DP.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DBianchi%26aufirst%3DE.%26aulast%3DTaliani%26aufirst%3DM.%26aulast%3DIngenito%26aufirst%3DR.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DSteinkuehler%26aufirst%3DC.%26aulast%3DPessi%26aufirst%3DA.%26atitle%3DPotent%2520Peptide%2520Inhibitors%2520of%2520Human%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%2520Are%2520Obtained%2520by%2520Optimizing%2520the%2520Cleavage%2520Products%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26issue%3D25%26spage%3D8906%26epage%3D8914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laplante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Peptide-based inhibitors of the hepatitis C virus serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">1713</span><span class="NLM_x">–</span> <span class="NLM_lpage">1718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=1713-1718&issue=13&author=M.+Llinas-Brunetauthor=M.+Baileyauthor=G.+Fazalauthor=S.+Gouletauthor=T.+Halmosauthor=S.+Laplanteauthor=R.+Mauriceauthor=M.+Poirierauthor=M.+Poupartauthor=D.+Thibeaultauthor=D.+Wernicauthor=D.+Lamarre&title=Peptide-based+inhibitors+of+the+hepatitis+C+virus+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLaplante%26aufirst%3DS.%26aulast%3DMaurice%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DPoupart%26aufirst%3DM.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DWernic%26aufirst%3DD.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DPeptide-based%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26issue%3D13%26spage%3D1713%26epage%3D1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span> </span><span class="NLM_article-title">A Systematic Approach to the Optimization of Substrate-Based Inhibitors of the Hepatitis C Virus NS3 Protease: Discovery of Potent and Specific Tripeptide Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">6584</span><span class="NLM_x">–</span> <span class="NLM_lpage">6594</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0494523" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6584-6594&issue=26&author=M.+Llinas-Brunetauthor=M.+D.+Baileyauthor=E.+Ghiroauthor=V.+Gorysauthor=T.+Halmosauthor=M.+Poirierauthor=J.+Rancourtauthor=N.+Goudreau&title=A+Systematic+Approach+to+the+Optimization+of+Substrate-Based+Inhibitors+of+the+Hepatitis+C+Virus+NS3+Protease%3A+Discovery+of+Potent+and+Specific+Tripeptide+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm0494523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0494523%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DGoudreau%26aufirst%3DN.%26atitle%3DA%2520Systematic%2520Approach%2520to%2520the%2520Optimization%2520of%2520Substrate-Based%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%253A%2520Discovery%2520of%2520Potent%2520and%2520Specific%2520Tripeptide%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D26%26spage%3D6584%26epage%3D6594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">2267</span><span class="NLM_x">–</span> <span class="NLM_lpage">2270</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2267-2270&issue=20&author=M.+Llinas-Brunetauthor=M.+Baileyauthor=G.+Fazalauthor=E.+Ghiroauthor=V.+Gorysauthor=S.+Gouletauthor=T.+Halmosauthor=R.+Mauriceauthor=M.+Poirierauthor=M.-A.+Poupartauthor=J.+Rancourtauthor=D.+Thibeaultauthor=D.+Wernicauthor=D.+Lamarre&title=Highly+potent+and+selective+peptide-based+inhibitors+of+the+hepatitis+C+virus+serine+protease%3A+towards+smaller+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DMaurice%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DWernic%26aufirst%3DD.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DHighly%2520potent%2520and%2520selective%2520peptide-based%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520serine%2520protease%253A%2520towards%2520smaller%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26issue%3D20%26spage%3D2267%26epage%3D2270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit37b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Poupart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span> </span><span class="NLM_article-title">Solid-Phase Synthesis of Peptidomimetic Inhibitors for the Hepatitis C Virus NS3 Protease</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">4743</span><span class="NLM_x">–</span> <span class="NLM_lpage">4751</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo010164d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=4743-4751&issue=14&author=M.+Poupartauthor=D.+R.+Cameronauthor=C.+Chabotauthor=E.+Ghiroauthor=N.+Goudreauauthor=S.+Gouletauthor=M.+Poirierauthor=Y.+S.+Tsantrizos&title=Solid-Phase+Synthesis+of+Peptidomimetic+Inhibitors+for+the+Hepatitis+C+Virus+NS3+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=10.1021%2Fjo010164d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo010164d%26sid%3Dliteratum%253Aachs%26aulast%3DPoupart%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DSolid-Phase%2520Synthesis%2520of%2520Peptidomimetic%2520Inhibitors%2520for%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26issue%3D14%26spage%3D4743%26epage%3D4751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Bartels, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcial, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigges, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adiwijaya, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieffer, T. L.</span><span> </span><span class="NLM_article-title">Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3−4A protease inhibitors in treatment-naive subjects</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">198</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">800</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1086%2F591141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=18637752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFygs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2008&pages=800-807&issue=6&author=D.+J.+Bartelsauthor=Y.+Zhouauthor=E.+Z.+Zhangauthor=M.+Marcialauthor=R.+A.+Byrnauthor=T.+Pfeifferauthor=A.+M.+Tiggesauthor=B.+S.+Adiwijayaauthor=C.+Linauthor=A.+D.+Kwongauthor=T.+L.+Kieffer&title=Natural+prevalence+of+hepatitis+C+virus+variants+with+decreased+sensitivity+to+NS3%E2%88%924A+protease+inhibitors+in+treatment-naive+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3·4A protease inhibitors in treatment-naive subjects</span></div><div class="casAuthors">Bartels, Doug J.; Zhou, Yi; Zhang, Eileen Z.; Marcial, Michelle; Byrn, Randal A.; Pfeiffer, Thomas; Tigges, Ann M.; Adiwijaya, Bambang S.; Lin, Chao; Kwong, Ann D.; Kieffer, Tara L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">800-807</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Background: The prevalence and clin. implications of naturally occurring variants that are resistant to hepatitis C virus (HCV) protease inhibitors in treatment-naive patients has not been reported.  We report here the prevalence of such variants and their effect on clin. response.  Methods: Population sequence anal. of the NS3.4A protease was conducted in 570 treatment-naive subjects.  Results: Most subjects (98%) had wild-type virus.  The remaining subjects had the following variants present in significant proportions (∼100%): V36M, 0.9%; R155K, 0.7%; V170A, 0.2%; and R109K, 0.2%.  The V36M, R109K, and V170A substitutions confer low-level resistance (<7-fold) to protease inhibitors in replicon cells.  The R155K substitution confers low-level resistance to telaprevir (TVR) and boceprevir and confers high-level resistance (>70-fold) to BILN 2061 and ITMN-191.  Five subjects with the V36M or R109K variant were treated with 8-24 wk of TVR and peginterferon-α2a (P) with or without ribavirin (R).  Four achieved a sustained viral response, and 1 was lost to follow-up.  In subjects with the R155K variant, TVR/PR provided greater antiviral activity than PR alone; however, the antiviral response was lower than that obsd. in subjects with wild-type virus.  Conclusion: High levels of naturally occurring protease inhibitor-resistant variants were uncommon (<1% each) in HCV treatment-naive patients.  TVR/PR efficiently inhibited V36M and R109K variants and contributed partial antiviral activity against the R155K variant.  As new HCV agents are evaluated in clin. trials, it will be important to monitor the effect of baseline variants on sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU_M2kPrlZHrVg90H21EOLACvtfcHk0liLxkGF1cc7Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFygs7rE&md5=531ae93d91433667dc8c46c3a08cbc28</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1086%2F591141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F591141%26sid%3Dliteratum%253Aachs%26aulast%3DBartels%26aufirst%3DD.%2BJ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DE.%2BZ.%26aulast%3DMarcial%26aufirst%3DM.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DPfeiffer%26aufirst%3DT.%26aulast%3DTigges%26aufirst%3DA.%2BM.%26aulast%3DAdiwijaya%26aufirst%3DB.%2BS.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DKieffer%26aufirst%3DT.%2BL.%26atitle%3DNatural%2520prevalence%2520of%2520hepatitis%2520C%2520virus%2520variants%2520with%2520decreased%2520sensitivity%2520to%2520NS3%25E2%2588%25924A%2520protease%2520inhibitors%2520in%2520treatment-naive%2520subjects%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2008%26volume%3D198%26issue%3D6%26spage%3D800%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span> <span class="citation_source-book">MacroModel Version 7.0</span>; <span class="NLM_publisher-name">Schroedinger Inc.</span>: <span class="NLM_publisher-loc">Portland, OR</span>; <a href="http://www.schrodinger.com/Products/macromodel.html" class="extLink">http://www.schrodinger.com/Products/macromodel.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MacroModel+Version+7.0%3B+Schroedinger+Inc.%3A+Portland%2C+OR%3B+http%3A%2F%2Fwww.schrodinger.com%2FProducts%2Fmacromodel.html."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMacroModel%2520Version%25207.0%26pub%3DSchroedinger%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Halgren, T. A.</span><span> </span><span class="NLM_article-title">Potential energy functions</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1016%2F0959-440X%2895%2980077-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=7648322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADyaK2MXlvVOrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=205-210&author=T.+A.+Halgren&title=Potential+energy+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Potential energy functions</span></div><div class="casAuthors">Halgren, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-10</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review, with 52 refs.  When energy is a crit. quantity, accurate biomol. simulations rest in substantial part on accurate potential energy functions (force fields).  Improvements in methodol. for detg. parameters - particularly, in the systematic use of computational data obtained from quantum chem. calcns. - and enhancements in functional form are leading to better potential energy functions.  New calcns. have been developed for water (including calcns. that incorporate electronic polarizability to take account of the degree to which a mol. can be polarized), proteins, nucleic acids, carbohydrates, lipids, and general org. mols.  Most notably, two new biomol. force fields have recently been derived and significant redetns. of the parameters of two existing biomol. force fields have been carried out.  Some progress has also been made in incorporating polarizability into potential energy functions for mols. in general and in improving the treatment of metal-ligand interactions in systems of biomol. interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTetENh3B15LVg90H21EOLACvtfcHk0liLxkGF1cc7Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlvVOrtr4%253D&md5=2bae4682983c94bdf12b4d8801c9a546</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2F0959-440X%2895%2980077-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0959-440X%252895%252980077-8%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26atitle%3DPotential%2520energy%2520functions%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D1995%26volume%3D5%26spage%3D205%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Halgren, T. A.</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">586</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADyaK28XhvVGmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Halgren%2C+T.+A.J.+Comput.+Chem.+1996%2C+17%2C+490%E2%80%93586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94</span></div><div class="casAuthors">Halgren, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5 & 6</span>),
    <span class="NLM_cas:pages">490-519</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">This article introduces MMFF94, the initial published version of the Merck mol. force field (MMFF).  It describes the objectives set for MMFF, the form it takes, and the range of systems to which it applies.  This study also outlines the methodol. employed in parameterizing MMFF94 and summarizes its performance in reproducing computational and exptl. data.  Though similar to MM3 in some respects, MMFF94 differs in ways intended to facilitate application to condensed-phase processes in mol.-dynamics simulations.  Indeed, MMFF94 seeks to achieve MM3-like accuracy for small mols. in a combined "org./protein" force field that is equally applicable to proteins and other systems of biol. significance.  A second distinguishing feature is that the core protion of MMFF94 has primarily been derived from high-quality computational data-ca. 500 mol. structures optimized at the HF/6-31G* level, 475 structures optimized at the MP2/6-31G* level, 380 MP2/6-31* structures evaluated at a defined approxn. to the MP4SDQ/TZP level, and 1450 structures partly derived from MP2/6-31G* geometries and evaluated at the MP2/TZP level.  A third distinguishing feature is that MMFF94 has been parameterized for a wide variety of chem. systems of interest to org. and combinations of functional groups for which little, if any, useful exptl. data are available.  The methodol. used in parameterizing MMFF94 represents a fourth distinguishing feature.  Rather than using the common "functional group" approach, nearly all MMFF parameters have been detd. in a mutually consistent fashion from the full set of available computational data.  MMFF94 reproduces the computational data used in its parameterization very well.  In addn., MMFF94 reproduces exptl. bond lengths (0.014 Å root mean square [rms]), bond angles (1.2° rms), vibrational frequencies (61 cm-1 rms), conformational energies (0.38 kcal/mol rms), and rotational barriers (0.39 kcal/mol rms) very nearly as well as does MM3 for comparable systems.  MMFF94 also describes intermol. interactions in hydrogen-bonded systems in a way that closely parallels that given by the highly regarded OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAzCYfKnN83rVg90H21EOLACvtfcHk0liLxkGF1cc7Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvVGmsbk%253D&md5=56fb073477b4f49d1dfbd786fc56a480</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%2528199604%252917%253A5%252F6%253C490%253A%253AAID-JCC1%253E3.0.CO%253B2-P%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1996%26volume%3D17%26spage%3D490%26epage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b'],'ref11':['cit11a','cit11b'],'ref12':['cit12a','cit12b'],'ref13':['cit13a','cit13b'],'ref14':['cit14a','cit14b','cit14c'],'ref15':['cit15a','cit15b'],'ref16':['cit16'],'ref17':['cit17a','cit17b','cit17c'],'ref18':['cit18a','cit18b'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b'],'ref22':['cit22'],'ref23':['cit23a','cit23b'],'ref24':['cit24a','cit24b'],'ref25':['cit25'],'ref26':['cit26'],'ref27':[],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35a','cit35b'],'ref36':['cit36'],'ref37':['cit37a','cit37b'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Liping Zhang, Emily C. Cherney, Xiao Zhu, Tai-an Lin, Johnni Gullo-Brown, Derrick Maley, Kathy Johnston-Allegretto, Lisa Kopcho, Mark Fereshteh, Christine Huang, Xin Li, Sarah C. Traeger, Gopal Dhar, Aravind Anandam, Sandeep Mahankali, Shweta Padmanabhan, Prabhakar Rajanna, Venkata Murali, Thanga Mariappan, Robert Borzilleri, Gregory Vite, John T. Hunt, <span class="NLM_string-name hlFld-ContribAuthor">Aaron Balog</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Imidazopyridines as Potent Inhibitors of Indoleamine 2,3-Dioxygenase 1 for Cancer Immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 494-501. <a href="https://doi.org/10.1021/acsmedchemlett.1c00014" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.1c00014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.1c00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.1c00014%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BImidazopyridines%252Bas%252BPotent%252BInhibitors%252Bof%252BIndoleamine%252B2%25252C3-Dioxygenase%252B1%252Bfor%252BCancer%252BImmunotherapy%26aulast%3DZhang%26aufirst%3DLiping%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12012021%26date%3D26022021%26date%3D02032021%26volume%3D12%26issue%3D3%26spage%3D494%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maxwell D. Cummings, <span class="NLM_string-name hlFld-ContribAuthor">Sivakumar Sekharan</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (15)
                                     , 6843-6853. <a href="https://doi.org/10.1021/acs.jmedchem.8b01985" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01985</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01985%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BMacrocycle%252BDesign%252Bin%252BSmall-Molecule%252BDrug%252BDiscovery%252Band%252BSimple%252BMetrics%252BTo%252BIdentify%252BOpportunities%252Bfor%252BMacrocyclization%252Bof%252BSmall-Molecule%252BLigands%26aulast%3DCummings%26aufirst%3DMaxwell%2BD.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D18122018%26date%3D22032019%26date%3D12032019%26volume%3D62%26issue%3D15%26spage%3D6843%26epage%3D6853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul M.  Scola</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Keith D.  Combrink</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Campbell</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Yong  Tu</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Sing-Yuen  Sit</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Anthony  Cocuzza</span>, <span class="hlFld-ContribAuthor ">Donna M.  Bilder</span>, <span class="hlFld-ContribAuthor ">Stanley  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Barbara  Zheng</span>, <span class="hlFld-ContribAuthor ">Piyasena  Hewawasam</span>, <span class="hlFld-ContribAuthor ">Min  Ding</span>, <span class="hlFld-ContribAuthor ">Jan  Thuring</span>, <span class="hlFld-ContribAuthor ">Jianqing  Li</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Guangzhi  Zhai</span>, <span class="hlFld-ContribAuthor ">Amy K.  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Chaoqun  Chen</span>, <span class="hlFld-ContribAuthor ">Min S.  Lee</span>, <span class="hlFld-ContribAuthor ">Diana  Barry</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Wenying  Li</span>, <span class="hlFld-ContribAuthor ">Yong-Hae  Han</span>, <span class="hlFld-ContribAuthor ">Susan  Jenkins</span>, <span class="hlFld-ContribAuthor ">Christoph  Gesenberg</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Michael W.  Sinz</span>, <span class="hlFld-ContribAuthor ">Kenneth S.  Santone</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Richard J.  Colonno</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Grasela</span>, <span class="hlFld-ContribAuthor ">Eric  Hughes</span>, <span class="hlFld-ContribAuthor ">Caly  Chien</span>, <span class="hlFld-ContribAuthor ">Stephen  Adams</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Jialong  Zhu</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, and <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1708-1729. <a href="https://doi.org/10.1021/jm401840s" title="DOI URL">https://doi.org/10.1021/jm401840s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401840s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401840s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BEarly%252BClinical%252BEvaluation%252Bof%252BBMS-605339%25252C%252Ba%252BPotent%252Band%252BOrally%252BEfficacious%252BTripeptidic%252BAcylsulfonamide%252BNS3%252BProtease%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DScola%26aufirst%3DPaul%2BM.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D27112013%26date%3D20022014%26date%3D13032014%26volume%3D57%26issue%3D5%26spage%3D1708%26epage%3D1729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul M.  Scola</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Sing-Yuen  Sit</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Anthony  Cocuzza</span>, <span class="hlFld-ContribAuthor ">Donna M.  Bilder</span>, <span class="hlFld-ContribAuthor ">Stanley V.  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Barbara  Zheng</span>, <span class="hlFld-ContribAuthor ">Piyasena  Hewawasam</span>, <span class="hlFld-ContribAuthor ">Yong  Tu</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Steven  Levine</span>, <span class="hlFld-ContribAuthor ">Chaoqun  Chen</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Amy K.  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Guangzhi  Zhai</span>, <span class="hlFld-ContribAuthor ">Diana  Barry</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Yong-Hae  Han</span>, <span class="hlFld-ContribAuthor ">Richard  Schartman</span>, <span class="hlFld-ContribAuthor ">Maria  Donoso</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Michael W.  Sinz</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Tredup</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Luciano  Mueller</span>, <span class="hlFld-ContribAuthor ">Richard J.  Colonno</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Grasela</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Adams</span>, <span class="hlFld-ContribAuthor ">James  Loy</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Huabin  Sun</span>, <span class="hlFld-ContribAuthor ">Hong  Shi</span>, <span class="hlFld-ContribAuthor ">Lucy  Sun</span>, <span class="hlFld-ContribAuthor ">William  Warner</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Jialong  Zhu</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, and <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1730-1752. <a href="https://doi.org/10.1021/jm500297k" title="DOI URL">https://doi.org/10.1021/jm500297k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500297k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500297k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252BAsunaprevir%252B%252528BMS-650032%252529%25252C%252BAn%252BOrally%252BEfficacious%252BNS3%252BProtease%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DScola%26aufirst%3DPaul%2BM.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D24022014%26date%3D05032014%26date%3D13032014%26date%3D24022014%26volume%3D57%26issue%3D5%26spage%3D1730%26epage%3D1752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jih Ru  Hwu</span>, <span class="hlFld-ContribAuthor ">Shu-Yu  Lin</span>, <span class="hlFld-ContribAuthor ">Shwu-Chen  Tsay</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Pieter  Leyssen</span>, and <span class="hlFld-ContribAuthor ">Johan  Neyts</span>  . </span><span class="cited-content_cbyCitation_article-title">Coumarin−Purine Ribofuranoside Conjugates as New Agents against Hepatitis C Virus. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (7)
                                     , 2114-2126. <a href="https://doi.org/10.1021/jm101337v" title="DOI URL">https://doi.org/10.1021/jm101337v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm101337v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm101337v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCoumarin%2525E2%252588%252592Purine%252BRibofuranoside%252BConjugates%252Bas%252BNew%252BAgents%252Bagainst%252BHepatitis%252BC%252BVirus%26aulast%3DHwu%26aufirst%3DJih%2BRu%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D15102010%26date%3D04032011%26date%3D14042011%26volume%3D54%26issue%3D7%26spage%3D2114%26epage%3D2126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Danling  Huang</span>, <span class="hlFld-ContribAuthor ">Min  Liao</span>, <span class="hlFld-ContribAuthor ">Tianyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Shuyan  You</span>, <span class="hlFld-ContribAuthor ">Yun‐Feng  Zhou</span>, <span class="hlFld-ContribAuthor ">Yong‐Xian  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Fungicidal Activity of Novel 2‐aryl‐thiazole Derivatives Containing Saccharin Motif. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (42)
                                     , 13179-13182. <a href="https://doi.org/10.1002/slct.202003616" title="DOI URL">https://doi.org/10.1002/slct.202003616</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202003616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202003616%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BFungicidal%252BActivity%252Bof%252BNovel%252B2%2525E2%252580%252590aryl%2525E2%252580%252590thiazole%252BDerivatives%252BContaining%252BSaccharin%252BMotif%26aulast%3DHuang%26aufirst%3DDanling%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D42%26spage%3D13179%26epage%3D13182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Rong  Guan</span>, <span class="hlFld-ContribAuthor ">Zi-Ming  Liu</span>, <span class="hlFld-ContribAuthor ">Qin  Wan</span>, <span class="hlFld-ContribAuthor ">Ming-Wu  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot four-component synthesis of polysubstituted thiazoles via cascade Ugi/Wittig cyclization starting from odorless Isocyano(triphenylphosphoranylidene)-acetates. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (15)
                                     , 131101. <a href="https://doi.org/10.1016/j.tet.2020.131101" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131101%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DOne-pot%252Bfour-component%252Bsynthesis%252Bof%252Bpolysubstituted%252Bthiazoles%252Bvia%252Bcascade%252BUgi%25252FWittig%252Bcyclization%252Bstarting%252Bfrom%252Bodorless%252BIsocyano%252528triphenylphosphoranylidene%252529-acetates%26aulast%3DGuan%26aufirst%3DZhi-Rong%26date%3D2020%26volume%3D76%26issue%3D15%26spage%3D131101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed A. M.  Ahmed</span>, <span class="hlFld-ContribAuthor ">Ahmed E. M.  Mekky</span>, <span class="hlFld-ContribAuthor ">Ahmed H. M.  Elwahy</span>, <span class="hlFld-ContribAuthor ">Sherif M. H.  Sanad</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis and characterization of novel benzo-fused macrocyclic dicarbonitriles and pyrazolo-fused macrocycles containing thiazole subunits. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2020,</strong> <em>50 </em>
                                    (6)
                                     , 796-804. <a href="https://doi.org/10.1080/00397911.2019.1689269" title="DOI URL">https://doi.org/10.1080/00397911.2019.1689269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2019.1689269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2019.1689269%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DFacile%252Bsynthesis%252Band%252Bcharacterization%252Bof%252Bnovel%252Bbenzo-fused%252Bmacrocyclic%252Bdicarbonitriles%252Band%252Bpyrazolo-fused%252Bmacrocycles%252Bcontaining%252Bthiazole%252Bsubunits%26aulast%3DAhmed%26aufirst%3DAhmed%2BA.%2BM.%26date%3D2020%26date%3D2020%26volume%3D50%26issue%3D6%26spage%3D796%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">2-Aminothiazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 284-320. <a href="https://doi.org/10.1002/9781118686263.ch8" title="DOI URL">https://doi.org/10.1002/9781118686263.ch8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch8%26sid%3Dliteratum%253Aachs%26atitle%3D2-Aminothiazoles%26date%3D2018%26date%3D2018%26spage%3D284%26epage%3D320%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Jin  Wu</span>, <span class="hlFld-ContribAuthor ">Bingwei V.  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Five-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 267-291. <a href="https://doi.org/10.1016/B978-0-08-096805-6.00009-7" title="DOI URL">https://doi.org/10.1016/B978-0-08-096805-6.00009-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-096805-6.00009-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-096805-6.00009-7%26sid%3Dliteratum%253Aachs%26atitle%3DFive-Membered%252BRing%252BSystems%26aulast%3DWu%26aufirst%3DYong-Jin%26date%3D2011%26spage%3D267%26epage%3D291%26pub%3DElsevier%26date%3D2011%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Y.-J.  Wu</span>, <span class="hlFld-ContribAuthor ">Bingwei V.  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Five-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 259-307. <a href="https://doi.org/10.1016/S0959-6380(11)22009-9" title="DOI URL">https://doi.org/10.1016/S0959-6380(11)22009-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0959-6380(11)22009-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0959-6380%2811%2922009-9%26sid%3Dliteratum%253Aachs%26atitle%3DFive-Membered%252BRing%252BSystems%26aulast%3DWu%26aufirst%3DY.-J.%26date%3D2011%26spage%3D259%26epage%3D307%26pub%3DElsevier%26date%3D2011%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900524b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Inhibitors of HCV NS3/4A protease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900524b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Molecular model of carbamate <b>2</b> (green) superimposed with oxadiazole <b>4</b> (a, blue) and thiazole <b>5</b> (b, yellow) in the context of NS3-4A active site (gray)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and helicase domain (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900524b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Oxadiazole Derivative <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900524b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) EDCI·HCl, Boc-NHNH<sub>2</sub>, DCM; (ii) TFA, DCM. (b) Dioxane. (c) (i) POCl<sub>3</sub>, 80 °C; (ii) LiOH, THF/H<sub>2</sub>O. (d) TBTU, DCM. (e) Zhan 1 catalyst, 1,2-DCE, 80 °C. (f) (i) Pd/C, H<sub>2</sub>, EtOH; (ii) LiOH, THF/H<sub>2</sub>O; (iii) <b>13A</b>, TBTU, DIPEA, DMF.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Thiazole Derivative <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900524b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CH<sub>2</sub>N<sub>2</sub>, Et<sub>2</sub>O, then aq HBr, 0 °C. (b) NaSCN, CH<sub>3</sub>CN. (c) Methyl valinate, dioxane, 50 °C. (d) (i) LiOH, THF, H<sub>2</sub>O; (ii) <b>10A</b>, EDCI·HCl, HOBt, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, DCM. (e) (i) <b>10A</b>, TBTU, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, DMF; (ii) HCl, dioxane. (f) (i) Fmoc-SCN, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, DCM, 0 °C, then 20% piperidine in MeOH. (g) <b>14a</b>, dioxane, 60 °C. (h) (i) Zhan 1 catalyst, 1,2-DCE, 80 °C. (l) (i) Pd/C, H<sub>2</sub>, MeOH; (ii) LiOH THF, H<sub>2</sub>O; (iii) <b>13A</b>, TBTU, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, DMF.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Modular Approach to the Synthesis of Macrocyclic Aminothiazole Analogues <b>47</b>−<b>60</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/large/jm-2009-00524b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900524b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) EDCI·HCl, HOBt, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, DCM; (ii) HCl/dioxane. (b) Fmoc-SCN, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, DCM, 0 °C, then 20% piperidine in MeOH. (c) <b>14a</b>−<b>c</b>, dioxane, 60 °C. (d) Zhan 1 catalyst, 1,2-DCE, 80 °C. (e) Pd/C, H<sub>2</sub>, MeOH; (f) (i) LiOH, THF, H<sub>2</sub>O; (ii) <b>13A</b> or <b>13B</b>, EDCI·HCl, HOBt, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, DCM. (g) (COCl)<sub>2</sub>, cat. DMF, DCM. (h) CH<sub>2</sub>N<sub>2</sub>, Et<sub>2</sub>O; then aq HBr, 0 °C; <i>E</i>-db = <i>E</i>-double bond; sat = saturated.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67887" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67887" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">World Health Organization (WHO)</span><span class="NLM_x">. </span>Initiative for Vaccine Research. Hepatitis C.<a href="http://www.who.int/vaccine_research/diseases/viral_cancers/en/index2.html" class="extLink">http://www.who.int/vaccine_research/diseases/viral_cancers/en/index2.html</a></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health+Organization+%28WHO%29.+Initiative+for+Vaccine+Research.+Hepatitis+C.http%3A%2F%2Fwww.who.int%2Fvaccine_research%2Fdiseases%2Fviral_cancers%2Fen%2Findex2.html"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DInitiative%2520for%2520Vaccine%2520Research.%2520Hepatitis%2520C." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hoofnagle, J. H.</span><span> </span><span class="NLM_article-title">Course and outcome of hepatitis C</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">S21</span><span class="NLM_x">–</span> <span class="NLM_lpage">S29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1002%2Fhep.1840360704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=12407573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A280%3ADC%252BD38nkslWntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=S21-S29&author=J.+H.+Hoofnagle&title=Course+and+outcome+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Course and outcome of hepatitis C</span></div><div class="casAuthors">Hoofnagle Jay H</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Baltimore, Md.)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5 Suppl 1</span>),
    <span class="NLM_cas:pages">S21-9</span>
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    </div><div class="casAbstract">The hepatitis C virus (HCV) is a small enveloped RNA virus belonging to the family flaviviridae and genus hepacivirus.  The HCV RNA genome is 9,600 nucleotides in length and encodes a single polyprotein that is post-translationally cleaved into 10 polypeptides including t3 structural (C, E1, and E2) and multiple nonstructural proteins ([NS] NS2 to NS5).  The NS proteins include enzymes necessary for protein processing (proteases) and viral replication (RNA polymerase).  The virus replicates at a high rate in the liver and has marked sequence heterogeneity.  There are 6 genotypes and more than 90 subtypes of HCV, the most common in the United States being 1a and 1b (approximately 75%), 2a and 2b (approximately 15%), and 3 (approximately 7%).  Acute hepatitis C is marked by appearance of HCV RNA in serum within 1 to 2 weeks of exposure followed by serum alanine aminotransferase (ALT) elevations, and then symptoms and jaundice.  Antibody to HCV (anti-HCV) tends to arise late.  In acute resolving hepatitis, HCV RNA is cleared and serum ALT levels fall to normal.  However, 55% to 85% of patients do not clear virus, but develop chronic hepatitis C.  Chronic hepatitis C is often asymptomatic, but is usually associated with persistent or fluctuating elevations in ALT levels.  The chronic sequelae of hepatitis C include progressive hepatic fibrosis, cirrhosis, and hepatocellular carcinoma.  Extra-hepatic manifestations include sicca syndrome, cryoglobulinemia, glomerulonephritis, and porphyria cutanea tarda.  Knowledge of the course and outcome of hepatitis C is important in developing approaches to management and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUup51yhOB770AGQpJZWpJfW6udTcc2eak2rieFd6WU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38nkslWntw%253D%253D&md5=dd5c88eaad10bd81cc98ab2e344aab71</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1002%2Fhep.1840360704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.1840360704%26sid%3Dliteratum%253Aachs%26aulast%3DHoofnagle%26aufirst%3DJ.%2BH.%26atitle%3DCourse%2520and%2520outcome%2520of%2520hepatitis%2520C%26jtitle%3DHepatology%26date%3D2002%26volume%3D36%26spage%3DS21%26epage%3DS29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liang, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, T.</span><span> </span><span class="NLM_article-title">Pathogenesis of hepatitis C—associated hepatocellular carcinoma</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">S62</span><span class="NLM_x">–</span> <span class="NLM_lpage">S71</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=S62-S71&author=T.+J.+Liangauthor=T.+Heller&title=Pathogenesis+of+hepatitis+C%E2%80%94associated+hepatocellular+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DT.%2BJ.%26aulast%3DHeller%26aufirst%3DT.%26atitle%3DPathogenesis%2520of%2520hepatitis%2520C%25E2%2580%2594associated%2520hepatocellular%2520carcinoma%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D127%26spage%3DS62%26epage%3DS71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Rustgi, V. K.</span><span> </span><span class="NLM_article-title">The epidemiology of hepatitis C infection in the United States</span> <span class="citation_source-journal">J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1007%2Fs00535-007-2064-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=17653645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A280%3ADC%252BD2svjt1altg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=513-21&issue=7&author=V.+K.+Rustgi&title=The+epidemiology+of+hepatitis+C+infection+in+the+United+States"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The epidemiology of hepatitis C infection in the United States</span></div><div class="casAuthors">Rustgi Vinod K</div><div class="citationInfo"><span class="NLM_cas:title">Journal of gastroenterology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">513-21</span>
        ISSN:<span class="NLM_cas:issn">0944-1174</span>.
    </div><div class="casAbstract">BACKGROUND:  The prevalence of hepatitis C virus (HCV) infection in the United States has remained constant from 1988 through 2002, although the peak age of infection has increased.  While the number of new HCV cases is declining, the rates of HCV-associated morbidity and mortality are increasing.  We reviewed the risk factors for HCV infection, the laboratory methods used to diagnose it, the dynamics of disease progression, and the natural history of HCV infection.  METHODS:  Medline searches were performed using the key word HCV, together with incidence, risk factors, demographics, diagnostic methods, disease progression, natural history, normal alanine aminotransferase (ALT), fibrosis, and hepatocellular carcinoma (HCC).  RESULTS:  Three characteristics-abnormal serum ALT, history of injection drug use, and blood transfusion before 1992-identified 85% of HCV-positive individuals 20-59 years old.  About 75%-85% of acutely infected individuals progress to chronic infection, with up to 20% developing liver cirrhosis over 20-25 years, putting them at increased risk for end-stage liver disease and/or HCC.  HCV-associated cirrhosis is the leading cause of liver transplantation in the United States.  Rates of infection are higher in non-Hispanic blacks than in non-Hispanic whites and Mexican Americans and higher in men than in women.  In the United States, over 70% of HCV-infected individuals are infected with genotype 1.  CONCLUSIONS:  HCV infection is more prevalent than human immunodeficiency virus or hepatitis B virus infection and is particularly common among certain demographic groups.  Individual rates of fibrosis progression vary, but identification of host and viral characteristics associated with disease progression may reveal the mechanisms of HCV-associated hepatic fibrosis/cirrhosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSbTKo3W8ZBP6xYuD7tu2XfW6udTcc2ea_TaRBqXFxL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svjt1altg%253D%253D&md5=d8def6b8a9631953e8c5210b7800f53c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs00535-007-2064-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00535-007-2064-6%26sid%3Dliteratum%253Aachs%26aulast%3DRustgi%26aufirst%3DV.%2BK.%26atitle%3DThe%2520epidemiology%2520of%2520hepatitis%2520C%2520infection%2520in%2520the%2520United%2520States%26jtitle%3DJ.%2520Gastroenterol.%26date%3D2007%26volume%3D42%26issue%3D7%26spage%3D513%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Di Bisceglie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoofnagle, J. H.</span><span> </span><span class="NLM_article-title">Optimal therapy of hepatitis C</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">S121</span><span class="NLM_x">–</span> <span class="NLM_lpage">S127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=S121-S127&author=A.+M.+Di+Bisceglieauthor=J.+H.+Hoofnagle&title=Optimal+therapy+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BBisceglie%26aufirst%3DA.%2BM.%26aulast%3DHoofnagle%26aufirst%3DJ.%2BH.%26atitle%3DOptimal%2520therapy%2520of%2520hepatitis%2520C%26jtitle%3DHepatology%26date%3D2002%26volume%3D36%26spage%3DS121%26epage%3DS127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fried, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goncales, F. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haussinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diago, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carosi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhumeaux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craxi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span> </span><span class="NLM_article-title">Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1056%2FNEJMoa020047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=12324553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=975-982&issue=13&author=M.+W.+Friedauthor=M.+L.+Shiffmanauthor=K.+R.+Reddyauthor=C.+Smithauthor=G.+Marinosauthor=F.+L.+Goncalesauthor=D.+Haussingerauthor=M.+Diagoauthor=G.+Carosiauthor=D.+Dhumeauxauthor=A.+Craxiauthor=A.+Linauthor=J.+Hoffmanauthor=J.+Yu&title=Peginterferon+alfa-2a+plus+ribavirin+for+chronic+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</span></div><div class="casAuthors">Fried, Michael W.; Shiffman, Mitchell L.; Reddy, K. Rajender; Smith, Coleman; Marinos, George; Goncales, Fernando L., Jr.; Haussinger, Dieter; Diago, Moises; Carosi, Giampiero; Dhumeaux, Daniel; Craxi, Antonio; Lin, Amy; Hoffman, Joseph; Yu, Jian</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">975-982</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Treatment with peginterferon alfa-2a alone produces significantly higher sustained virol. responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) infection.  We compared the efficacy and safety of peginterferon alfa-2a plus ribavirin, interferon alfa-2b plus ribavirin, and peginterferon alfa-2a alone in the initial treatment of chronic hepatitis C.  Methods: A total of 1121 patients were randomly assigned to treatment and received at least one dose of study medication, consisting of 180 μg of peginterferon alfa-2a once weekly plus daily ribavirin (1000 or 1200 mg, depending on body wt.), weekly peginterferon alfa-2a plus daily placebo, or 3 million units of interferon alfa-2b thrice weekly plus daily ribavirin for 48 wk.  Results: A significantly higher proportion of patients who received peginterferon alfa-2a plus ribavirin had a sustained virol. response (defined as the absence of detectable HCV RNA 24 wk after cessation of therapy) than of patients who received interferon alfa-2b plus ribavirin (56 % vs. 44 %, P<0.001) or peginterferon alfa-2a alone (56 % vs. 29 %, P<0.001).  The proportions of patients with HCV genotype 1 who had sustained virol. responses were 46 %, 36 %, and 21 %, resp., for the three regimens.  Among patients with HCV genotype 1 and high base-line levels of HCV RNA, the proportions of those with sustained virol. responses were 41 %, 33 %, and 13 %, resp.  The overall safety profiles of the three treatment regimens were similar; the incidence of influenza-like symptoms and depression was lower in the groups receiving peginterferon alfa-2a than in the group receiving interferon alfa-2b plus ribavirin.  Conclusions: In patients with chronic hepatitis C, once-weekly peginterferon alfa-2a plus ribavirin was tolerated as well as interferon alfa-2b plus ribavirin and produced significant improvements in the rate of sustained virol. response, as compared with interferon alfa-2b plus ribavirin or peginterferon alfa-2a alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqblwkeNXWJzbVg90H21EOLACvtfcHk0ljS8bwFKbKEig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D&md5=2fd959d790b9505384fbd26ef44b2963</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa020047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa020047%26sid%3Dliteratum%253Aachs%26aulast%3DFried%26aufirst%3DM.%2BW.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DMarinos%26aufirst%3DG.%26aulast%3DGoncales%26aufirst%3DF.%2BL.%26aulast%3DHaussinger%26aufirst%3DD.%26aulast%3DDiago%26aufirst%3DM.%26aulast%3DCarosi%26aufirst%3DG.%26aulast%3DDhumeaux%26aufirst%3DD.%26aulast%3DCraxi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26atitle%3DPeginterferon%2520alfa-2a%2520plus%2520ribavirin%2520for%2520chronic%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26issue%3D13%26spage%3D975%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Feld, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoofnagle, J. H.</span><span> </span><span class="NLM_article-title">Mechanism of action of interferon and ribavirin in treatment of hepatitis C</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x"> (</span><span class="NLM_issue">7053</span><span class="NLM_x">) </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">972</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=967-972&issue=7053&author=J.+J.+Feldauthor=J.+H.+Hoofnagle&title=Mechanism+of+action+of+interferon+and+ribavirin+in+treatment+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeld%26aufirst%3DJ.%2BJ.%26aulast%3DHoofnagle%26aufirst%3DJ.%2BH.%26atitle%3DMechanism%2520of%2520action%2520of%2520interferon%2520and%2520ribavirin%2520in%2520treatment%2520of%2520hepatitis%2520C%26jtitle%3DNature%26date%3D2005%26volume%3D436%26issue%3D7053%26spage%3D967%26epage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Strader, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeffm, L. B.</span><span> </span><span class="NLM_article-title">Diagnosis, management, and treatment of hepatitis C</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1147</span><span class="NLM_x">–</span> <span class="NLM_lpage">1171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2004&pages=1147-1171&issue=4&author=D.+B.+Straderauthor=T.+Wrightauthor=D.+L.+Thomasauthor=L.+B.+Seeffm&title=Diagnosis%2C+management%2C+and+treatment+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrader%26aufirst%3DD.%2BB.%26aulast%3DWright%26aufirst%3DT.%26aulast%3DThomas%26aufirst%3DD.%2BL.%26aulast%3DSeeffm%26aufirst%3DL.%2BB.%26atitle%3DDiagnosis%252C%2520management%252C%2520and%2520treatment%2520of%2520hepatitis%2520C%26jtitle%3DHepatology%26date%3D2004%26volume%3D39%26issue%3D4%26spage%3D1147%26epage%3D1171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornberg, M.</span><span> </span><span class="NLM_article-title">Treating viral hepatitis C: efficacy, side effects, and complications</span> <span class="citation_source-journal">Gut</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1350</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2006&pages=1350-1359&issue=9&author=M.+P.+Mannsauthor=H.+Wedemeyerauthor=M.+Cornberg&title=Treating+viral+hepatitis+C%3A+efficacy%2C+side+effects%2C+and+complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DCornberg%26aufirst%3DM.%26atitle%3DTreating%2520viral%2520hepatitis%2520C%253A%2520efficacy%252C%2520side%2520effects%252C%2520and%2520complications%26jtitle%3DGut%26date%3D2006%26volume%3D55%26issue%3D9%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><div class="note"><p class="first last">Reviewed in </p></div><span class="NLM_contrib-group">Moradpour, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, M. C.</span><span> </span><span class="NLM_article-title">Replication of hepatitis C virus</span> <span class="citation_source-journal">Nat. Rev. Microb.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1038%2Fnrmicro1645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=17487147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlSqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=453-463&issue=6&author=D.+Moradpourauthor=F.+Peninauthor=M.+C.+Rice&title=Replication+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of hepatitis C virus</span></div><div class="casAuthors">Moradpour, Darius; Penin, Francois; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">453-463</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Exciting progress has recently been made in understanding the replication of hepatitis C virus, a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma worldwide.  The development of complete cell-culture systems should now enable the systematic dissection of the entire viral life-cycle, providing insights into the hitherto difficult-to-study early and late steps.  These efforts have already translated into the identification of novel antiviral targets and the development of new therapeutic strategies, some of which are currently undergoing clin. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreB87JperiIrVg90H21EOLACvtfcHk0ljoiaPHwtYSNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlSqtb8%253D&md5=be020cc05a67e7256779b1c0ce797089</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1645%26sid%3Dliteratum%253Aachs%26aulast%3DMoradpour%26aufirst%3DD.%26aulast%3DPenin%26aufirst%3DF.%26aulast%3DRice%26aufirst%3DM.%2BC.%26atitle%3DReplication%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DNat.%2520Rev.%2520Microb.%26date%3D2007%26volume%3D5%26issue%3D6%26spage%3D453%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="note"><p class="first last">Reviewed in: </p></div><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span> </span><span class="NLM_article-title">Peptidomimetic Therapeutic Agents Targeting the Protease Enzyme of the Human Immunodeficiency Virus and Hepatitis C Virus</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1252</span><span class="NLM_x">–</span> <span class="NLM_lpage">1263</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar8000519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=1252-1263&issue=10&author=Y.+S.+Tsantrizos&title=Peptidomimetic+Therapeutic+Agents+Targeting+the+Protease+Enzyme+of+the+Human+Immunodeficiency+Virus+and+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1021%2Far8000519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far8000519%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DPeptidomimetic%2520Therapeutic%2520Agents%2520Targeting%2520the%2520Protease%2520Enzyme%2520of%2520the%2520Human%2520Immunodeficiency%2520Virus%2520and%2520Hepatitis%2520C%2520Virus%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26issue%3D10%26spage%3D1252%26epage%3D1263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carfi, A.</span><span> </span><span class="NLM_article-title">Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1242</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2007&pages=1242-1262&issue=12&author=R.+De+Francescoauthor=A.+Carfi&title=Advances+in+the+development+of+new+therapeutic+agents+targeting+the+NS3-4A+serine+protease+or+the+NS5B+RNA-dependent+RNA+polymerase+of+the+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DCarfi%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520the%2520development%2520of%2520new%2520therapeutic%2520agents%2520targeting%2520the%2520NS3-4A%2520serine%2520protease%2520or%2520the%2520NS5B%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520the%2520hepatitis%2520C%2520virus%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2007%26volume%3D59%26issue%3D12%26spage%3D1242%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><div class="note"><p class="first last">Reviewed in </p></div><span class="NLM_contrib-group">Gale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foy, E. M.</span><span> </span><span class="NLM_article-title">Evasion of intracellular host defence by hepatitis C virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x"> (</span><span class="NLM_issue">7053</span><span class="NLM_x">) </span> <span class="NLM_fpage">939</span><span class="NLM_x">–</span> <span class="NLM_lpage">945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=939-945&issue=7053&author=M.+Galeauthor=E.+M.+Foy&title=Evasion+of+intracellular+host+defence+by+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGale%26aufirst%3DM.%26aulast%3DFoy%26aufirst%3DE.%2BM.%26atitle%3DEvasion%2520of%2520intracellular%2520host%2520defence%2520by%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2005%26volume%3D436%26issue%3D7053%26spage%3D939%26epage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinkuhler, C.</span><span> </span><span class="NLM_article-title">Structure and function of the hepatitis C virus NS3-NS4A serine proteinase</span> <span class="citation_source-journal">Curr. Top. Microbiol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">242</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=242&publication_year=2000&pages=149-169&author=R.+De+Francescoauthor=C.+Steinkuhler&title=Structure+and+function+of+the+hepatitis+C+virus+NS3-NS4A+serine+proteinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DSteinkuhler%26aufirst%3DC.%26atitle%3DStructure%2520and%2520function%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3-NS4A%2520serine%2520proteinase%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2000%26volume%3D242%26spage%3D149%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deziel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2724</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=2719-2724&issue=19&author=M.+Llinas-Brunetauthor=M.+Baileyauthor=R.+Dezielauthor=G.+Fazalauthor=V.+Gorysauthor=S.+Gouletauthor=T.+Halmosauthor=R.+Mauriceauthor=M.+Poirierauthor=M.+A.+Poupartauthor=J.+Rancourtauthor=D.+Thibeaultauthor=D.+Wernicauthor=D.+Lamarre&title=Studies+on+the+C-terminal+of+hexapeptide+inhibitors+of+the+hepatitis+C+virus+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DDeziel%26aufirst%3DR.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DMaurice%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DPoupart%26aufirst%3DM.%2BA.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DWernic%26aufirst%3DD.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DStudies%2520on%2520the%2520C-terminal%2520of%2520hexapeptide%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26issue%3D19%26spage%3D2719%26epage%3D2724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Steinkuhler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biasiol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span> </span><span class="NLM_article-title">Product inhibition of the hepatitis C virus NS3 protease</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">8899</span><span class="NLM_x">–</span> <span class="NLM_lpage">8905</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi980313v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=8899-8905&issue=25&author=C.+Steinkuhlerauthor=G.+Biasiolauthor=M.+Brunettiauthor=A.+Urbaniauthor=U.+Kochauthor=R.+Corteseauthor=A.+Pessiauthor=R.+De+Francesco&title=Product+inhibition+of+the+hepatitis+C+virus+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fbi980313v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi980313v%26sid%3Dliteratum%253Aachs%26aulast%3DSteinkuhler%26aufirst%3DC.%26aulast%3DBiasiol%26aufirst%3DG.%26aulast%3DBrunetti%26aufirst%3DM.%26aulast%3DUrbani%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DPessi%26aufirst%3DA.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26atitle%3DProduct%2520inhibition%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26issue%3D25%26spage%3D8899%26epage%3D8905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bös, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. George, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span> </span><span class="NLM_article-title">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1038%2Fnature02099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=14578911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=186-189&author=D.+Lamarreauthor=P.+C.+Andersonauthor=M.+Baileyauthor=P.+Beaulieuauthor=G.+Bolgerauthor=P.+Bonneauauthor=M.+B%C3%B6sauthor=D.+R.+Cameronauthor=M.+Cartierauthor=M.+G.+Cordingleyauthor=A.-M.+Faucherauthor=N.+Goudreauauthor=S.+H.+Kawaiauthor=G.+Kukoljauthor=L.+Lagac%C3%A9author=S.+R.+LaPlanteauthor=H.+Narjesauthor=M.-A.+Poupartauthor=J.+Rancourtauthor=R.+E.+Sentjensauthor=R.+St.+Georgeauthor=B.+Simoneauauthor=G.+Steinmannauthor=D.+Thibeaultauthor=Y.+S.+Tsantrizosauthor=S.+M.+Weldonauthor=C.-L.+Yongauthor=M.+Llin%C3%A0s-Brunet&title=An+NS3+protease+inhibitor+with+antiviral+effects+in+humans+infected+with+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span></div><div class="casAuthors">Lamarre, Daniel; Anderson, Paul C.; Bailey, Murray; Beaulieu, Pierre; Bolger, Gordon; Bonneau, Pierre; Boes, Michael; Cameron, Dale R.; Cartier, Mireille; Cordingley, Michael G.; Faucher, Anne-Marie; Goudreau, Nathalie; Kawai, Stephen H.; Kukolj, George; Lagace, Lisette; LaPlante, Steven R.; Narjes, Hans; Poupart, Marc-Andre; Rancourt, Jean; Sentjens, Roel E.; St. George, Roger; Simoneau, Bruno; Steinmann, Gerhard; Thibeault, Diane; Tsantrizos, Youla S.; Weldon, Steven M.; Yong, Chan-Loi; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6963</span>),
    <span class="NLM_cas:pages">186-189</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide with more than 170 million infected individuals at risk of developing significant morbidity and mortality.  Current interferon-based therapies are suboptimal esp. in patients infected with HCV genotype 1, and they are poorly tolerated, highlighting the unmet medical need for new therapeutics.  The HCV-encoded NS3 protease is essential for viral replication and has long been considered an attractive target for therapeutic intervention in HCV-infected patients.  Here we identify a class of specific and potent NS3 protease inhibitors and report the evaluation of BILN 2061, a small mol. inhibitor biol. available through oral ingestion and the first of its class in human trials.  Administration of BILN 2061 to patients infected with HCV genotype 1 for 2 days resulted in an impressive redn. of HCV RNA plasma levels, and established proof-of-concept in humans for an HCV NS3 protease inhibitor.  Our results further illustrate the potential of the viral-enzyme-targeted drug discovery approach for the development of new HCV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnVapDO21RLVg90H21EOLACvtfcHk0liijC7_Fh6A4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D&md5=36db818d5af257d3ebeef1a061ca68cb</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1038%2Fnature02099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02099%26sid%3Dliteratum%253Aachs%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DB%25C3%25B6s%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DSt.%2BGeorge%26aufirst%3DR.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DWeldon%26aufirst%3DS.%2BM.%26aulast%3DYong%26aufirst%3DC.-L.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DAn%2520NS3%2520protease%2520inhibitor%2520with%2520antiviral%2520effects%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2003%26volume%3D426%26spage%3D186%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grand-Maître, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapeyre-Paquette, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhéaume, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1608</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0342414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1605-1608&author=M.+Llin%C3%A0s-Brunetauthor=M.+D.+Baileyauthor=G.+Bolgerauthor=C.+Brochuauthor=A.-M.+Faucherauthor=J.+M.+Ferlandauthor=M.+Garneauauthor=E.+Ghiroauthor=V.+Gorysauthor=C.+Grand-Ma%C3%AEtreauthor=T.+Halmosauthor=N.+Lapeyre-Paquetteauthor=F.+Liardauthor=M.+Poirierauthor=M.+Rh%C3%A9aumeauthor=Y.+S.+Tsantrizosauthor=D.+Lamarre&title=Structure%E2%88%92Activity+Study+on+a+Novel+Series+of+Macrocyclic+Inhibitors+of+the+Hepatitis+C+Virus+NS3+Protease+Leading+to+the+Discovery+of+BILN+2061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fjm0342414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0342414%26sid%3Dliteratum%253Aachs%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DFerland%26aufirst%3DJ.%2BM.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGrand-Ma%25C3%25AEtre%26aufirst%3DC.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLapeyre-Paquette%26aufirst%3DN.%26aulast%3DLiard%26aufirst%3DF.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRh%25C3%25A9aume%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DStructure%25E2%2588%2592Activity%2520Study%2520on%2520a%2520Novel%2520Series%2520of%2520Macrocyclic%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%2520Leading%2520to%2520the%2520Discovery%2520of%2520BILN%25202061%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1605%26epage%3D1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3−4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.-P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+hepatitis+C+virus+NS3%E2%88%924A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%25E2%2588%25924A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span> </span><span class="NLM_article-title">Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Infect. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.2174%2F187152606776056706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=16787300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=3-16&author=C.+Linauthor=A.+D.+Kwongauthor=R.+B.+Perni&title=Discovery+and+development+of+VX-950%2C+a+novel%2C+covalent%2C+and+reversible+inhibitor+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3•4A serine protease</span></div><div class="casAuthors">Lin, C.; Kwong, A. D.; Perni, R. B.</div><div class="citationInfo"><span class="NLM_cas:title">Infectious Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-16</span>CODEN:
                <span class="NLM_cas:coden">IDDTAD</span>;
        ISSN:<span class="NLM_cas:issn">1871-5265</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The hepatitis C virus (HCV) NS3•4A protease, which is essential for viral replication, is considered one of the most attractive targets for developing novel anti-HCV therapies.  However, discovery of potent and selective small-mol. inhibitors of HCV NS3•4A protease as oral drug candidates has been hampered by the shallow substrate-binding groove of the protease.  Serine trap warheads have been used to covalently anchor inhibitor scaffolds and to increase their affinity to the protease.  This review will examine the evolution of covalent inhibitors of the HCV NS3•4A protease from early aldehyde mols. to α-ketoamide inhibitors.  Kinetic and structural studies of α-ketoacid and α-ketoamide inhibitors revealed an unusual mechanism of binding in the catalytic site.  Optimization of α-ketoamide scaffolds by scientists at Vertex and Eli Lilly led to the discovery of VX-950, a novel, potent, selective inhibitor of HCV NS3•4A protease.  VX-950 possesses excellent antiviral activity in both HCV replicon cells and human fetal hepatocytes infected with HCV-pos. patient sera.  In addn., VX-950 exhibits a favorable pharmacokinetic profile in several animal species and demonstrates potent inhibition of the HCV NS3•4A protease activity in a mouse model.  In a recent phase 1b clin. trial, VX-950 was able to rapidly reduce the plasma viral load of patients chronically infected with genotype 1 HCV by a mean ∼3 log10 in 2 days.  The median viral load redn. was 4.4 log10 for the best dose group after 14 days of dosing.  The preclin. profile and early clin. data of VX-950 will be discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOA6Gspx5Jv7Vg90H21EOLACvtfcHk0li_iUZpY3mXaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7k%253D&md5=dbf5706a5d351aabf722d88216d88b78</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.2174%2F187152606776056706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152606776056706%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26atitle%3DDiscovery%2520and%2520development%2520of%2520VX-950%252C%2520a%2520novel%252C%2520covalent%252C%2520and%2520reversible%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DInfect.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2006%26volume%3D6%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broske, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisson, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prelusky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korfmacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdanowich-Knipp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery of (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6074</span><span class="NLM_x">–</span> <span class="NLM_lpage">6086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agrawalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=V.+Madisonauthor=L.+Broskeauthor=X.+Cuiauthor=K.-C.+Chengauthor=Y.+Hsiehauthor=J.-M.+Brissonauthor=D.+Preluskyauthor=W.+Korfmacherauthor=R.+Whiteauthor=S.+Bogdanowich-Knippauthor=A.+Pavlovskyauthor=P.+Bradleyauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-Amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+Selective%2C+Potent%2C+Orally+Bioavailable+Hepatitis+C+Virus+NS3+Protease+Inhibitor%3A+A+Potential+Therapeutic+Agent+for+the+Treatment+of+Hepatitis+C+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DBroske%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DBrisson%26aufirst%3DJ.-M.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogdanowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DBradley%26aufirst%3DP.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-Amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520Selective%252C%2520Potent%252C%2520Orally%2520Bioavailable%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%2520Inhibitor%253A%2520A%2520Potential%2520Therapeutic%2520Agent%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6074%26epage%3D6086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Prongay, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosise, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taremi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarosh-Tomaine, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senior, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span> </span><span class="NLM_article-title">Discovery of the HCV NS3/4A Protease Inhibitor (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (SCH 503034). Key Steps in Structure-Based Optimization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2310</span><span class="NLM_x">–</span> <span class="NLM_lpage">2318</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060173k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2310-2318&author=A.+J.+Prongayauthor=Z.+Guoauthor=N.+Yaoauthor=J.+Pichardoauthor=T.+Fischmannauthor=C.+Stricklandauthor=J.+Myersauthor=P.+C.+Weberauthor=B.+M.+Beyerauthor=R.+Ingramauthor=Z.+Hongauthor=W.+W.+Prosiseauthor=L.+Ramanathanauthor=S.+S.+Taremiauthor=T.+Yarosh-Tomaineauthor=R.+Zhangauthor=M.+Seniorauthor=R.-S.+Yangauthor=B.+Malcolmauthor=A.+Arasappanauthor=F.+Bennettauthor=S.+L.+Bogenauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+G.+Loveyauthor=A.+K.+Saksenaauthor=S.+Venkatramanauthor=V.+Girijavallabhanauthor=F.+G.+Njorogeauthor=V.+Madison&title=Discovery+of+the+HCV+NS3%2F4A+Protease+Inhibitor+%281R%2C5S%29-N-%5B3-Amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29.+Key+Steps+in+Structure-Based+Optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fjm060173k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060173k%26sid%3Dliteratum%253Aachs%26aulast%3DProngay%26aufirst%3DA.%2BJ.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DFischmann%26aufirst%3DT.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMyers%26aufirst%3DJ.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26aulast%3DIngram%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DProsise%26aufirst%3DW.%2BW.%26aulast%3DRamanathan%26aufirst%3DL.%26aulast%3DTaremi%26aufirst%3DS.%2BS.%26aulast%3DYarosh-Tomaine%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DSenior%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DR.-S.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%2BG.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DMadison%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520the%2520HCV%2520NS3%252F4A%2520Protease%2520Inhibitor%2520%25281R%252C5S%2529-N-%255B3-Amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529.%2520Key%2520Steps%2520in%2520Structure-Based%2520Optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2310%26epage%3D2318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, Å.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvador-Oden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wähling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickström, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pille, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Structure−activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">–</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4853-4858&author=P.+Raboissonauthor=H.+De+Kockauthor=%C3%85.+Rosenquistauthor=M.+Nilssonauthor=L.+Salvador-Odenauthor=T.+Linauthor=N.+Roueauthor=V.+Ivanovauthor=H.+W%C3%A4hlingauthor=K.+Wickstr%C3%B6mauthor=E.+Hamelinkauthor=M.+Edlungauthor=L.+Vrangauthor=S.+Vendevilleauthor=W.+V.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=C.+Bouttonauthor=O.+Lenzauthor=F.+Delouvroyauthor=G.+Pilleauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=B.+Samuelssonauthor=K.+Simmen&title=Structure%E2%88%92activity+relationship+study+on+a+novel+series+of+cyclopentane-containing+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease+leading+to+the+discovery+of+TMC435350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DDe%2BKock%26aufirst%3DH.%26aulast%3DRosenquist%26aufirst%3D%25C3%2585.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DSalvador-Oden%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DRoue%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DW%25C3%25A4hling%26aufirst%3DH.%26aulast%3DWickstr%25C3%25B6m%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DEdlung%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%2BV.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DBoutton%26aufirst%3DC.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DPille%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DStructure%25E2%2588%2592activity%2520relationship%2520study%2520on%2520a%2520novel%2520series%2520of%2520cyclopentane-containing%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520TMC435350%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4853%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lin, T.-I.; Lenz, O.; Fanning, G.; Verbinnen, T.; Delouvroy, F.; Scholliers, A.; Vermeiren, K.; Rosenquist, Å.; Edlund, M.; Samuelsson, B.; Vrang, L.; de Kock, H.; Wigerinck, P.; Raboisson, P.; Simmen, K.</span><span> </span><span class="NLM_article-title">In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor</span>.  <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span>− <span class="NLM_lpage">1385</span>; New Data on Tibotec Investigational Hepatitic C Compounds being Presented at EASL. Press releases at the Tibotec homepage: <a href="http://www.tibotec.com/news/detail.jhtml?action=view&amp;itemname=news_60" class="extLink">http://www.tibotec.com/news/detail.jhtml?action=view&itemname=news_60</a> (accessed Jul 2009).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=1377-1385&author=T.-I.+Lin&author=O.+Lenz&author=G.+Fanning&author=T.+Verbinnen&author=F.+Delouvroy&author=A.+Scholliers&author=K.+Vermeiren&author=%C3%85.+Rosenquist&author=M.+Edlund&author=B.+Samuelsson&author=L.+Vrang&author=H.+de+Kock&author=P.+Wigerinck&author=P.+Raboisson&author=K.+Simmen&title=In+Vitro+Activity+and+Preclinical+Profile+of+TMC435350%2C+a+Potent+Hepatitis+C+Virus+Protease+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DT.-I.%26atitle%3DIn%2520Vitro%2520Activity%2520and%2520Preclinical%2520Profile%2520of%2520TMC435350%252C%2520a%2520Potent%2520Hepatitis%2520C%2520Virus%2520Protease%2520Inhibitor%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D1377%26epage%3D1385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Manns, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reesink, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamous, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horsmans, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusheiko, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flisiak, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyvisch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van’t Klooster, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verloes, R.</span><span> </span><span class="NLM_article-title">Opera-1 Trial: Interim Analysis Of Safety and Antiviral Activity of TMC435 in Treatment-Naïve Genotype 1 HCV Patients</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">S7</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=S7&author=M.+Mannsauthor=H.+Reesinkauthor=C.+Morenoauthor=T.+Bergauthor=Y.+Benhamousauthor=Y.+Horsmansauthor=G.+Dusheikoauthor=R.+Flisiakauthor=P.+Meyvischauthor=O.+Lenzauthor=V.+Sekarauthor=G.+Van%E2%80%99t+Kloosterauthor=K.+Simmenauthor=R.+Verloes&title=Opera-1+Trial%3A+Interim+Analysis+Of+Safety+and+Antiviral+Activity+of+TMC435+in+Treatment-Na%C3%AFve+Genotype+1+HCV+Patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%26aulast%3DReesink%26aufirst%3DH.%26aulast%3DMoreno%26aufirst%3DC.%26aulast%3DBerg%26aufirst%3DT.%26aulast%3DBenhamous%26aufirst%3DY.%26aulast%3DHorsmans%26aufirst%3DY.%26aulast%3DDusheiko%26aufirst%3DG.%26aulast%3DFlisiak%26aufirst%3DR.%26aulast%3DMeyvisch%26aufirst%3DP.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DSekar%26aufirst%3DV.%26aulast%3DVan%25E2%2580%2599t%2BKlooster%26aufirst%3DG.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DVerloes%26aufirst%3DR.%26atitle%3DOpera-1%2520Trial%253A%2520Interim%2520Analysis%2520Of%2520Safety%2520and%2520Antiviral%2520Activity%2520of%2520TMC435%2520in%2520Treatment-Na%25C3%25AFve%2520Genotype%25201%2520HCV%2520Patients%26jtitle%3DJ.%2520Hepatol.%26date%3D2009%26volume%3D50%26spage%3DS7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, P. T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoycheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L. M.</span><span> </span><span class="NLM_article-title">Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4432-4441&issue=12&author=S.+D.+Seiwertauthor=S.+W.+Andrewsauthor=Y.+Jiangauthor=V.+Serebryanyauthor=H.+Tanauthor=K.+Kossenauthor=P.+T.+R.+Rajagopalanauthor=S.+Misialekauthor=S.+K.+Stevensauthor=A.+Stoychevaauthor=J.+Hongauthor=S.+R.+Limauthor=X.+Qinauthor=R.+Riegerauthor=K.+R.+Condroskiauthor=H.+Zhangauthor=M.+G.+Doauthor=C.+Lemieuxauthor=G.+P.+Hingoraniauthor=D.+P.+Hartleyauthor=J.+A.+Joseyauthor=L.+Panauthor=L.+Beigelmanauthor=L.+M.+Blatt&title=Preclinical+characteristics+of+the+hepatitis+C+virus+NS3%2F4A+protease+inhibitor+ITMN-191+%28R7227%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DKossen%26aufirst%3DK.%26aulast%3DRajagopalan%26aufirst%3DP.%2BT.%2BR.%26aulast%3DMisialek%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DStoycheva%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%2BR.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DRieger%26aufirst%3DR.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDo%26aufirst%3DM.%2BG.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DHingorani%26aufirst%3DG.%2BP.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DPreclinical%2520characteristics%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520inhibitor%2520ITMN-191%2520%2528R7227%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26issue%3D12%26spage%3D4432%26epage%3D4441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Blatt, L. M.; Wenglowsky, S. M.; Andrews, S. W.; Jiang, Y.; Kennedy, A. L.; Condroski, K. R.; Josey, J. A.; Stengel, P. J.; Madduru, M. R.; Doherty, G. A.; Woodard, B. T.</span><span> </span><span class="NLM_article-title">Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication</span>. PCT Int. Appl. WO 2005/037214, <b>2005</b>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Blatt%2C+L.+M.%3B+Wenglowsky%2C+S.+M.%3B+Andrews%2C+S.+W.%3B+Jiang%2C+Y.%3B+Kennedy%2C+A.+L.%3B+Condroski%2C+K.+R.%3B+Josey%2C+J.+A.%3B+Stengel%2C+P.+J.%3B+Madduru%2C+M.+R.%3B+Doherty%2C+G.+A.%3B+Woodard%2C+B.+T.+Macrocyclic+carboxylic+acids+and+acylsulfonamides+as+inhibitors+of+HCV+replication.+PCT+Int.+Appl.+WO+2005%2F037214%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DMacrocyclic%2520carboxylic%2520acids%2520and%2520acylsulfonamides%2520as%2520inhibitors%2520of%2520HCV%2520replication" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Marchetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ontoria, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span> </span><span class="NLM_article-title">Synthesis of Two Novel Cyclic Biphenyl Ether Analogs of an Inhibitor of HCV NS3 Protease</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">S1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1000</span><span class="NLM_x">–</span> <span class="NLM_lpage">1002</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=S1&publication_year=1999&pages=1000-1002&author=A.+Marchettiauthor=J.+M.+Ontoriaauthor=V.+G.+Matassa&title=Synthesis+of+Two+Novel+Cyclic+Biphenyl+Ether+Analogs+of+an+Inhibitor+of+HCV+NS3+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetti%26aufirst%3DA.%26aulast%3DOntoria%26aufirst%3DJ.%2BM.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26atitle%3DSynthesis%2520of%2520Two%2520Novel%2520Cyclic%2520Biphenyl%2520Ether%2520Analogs%2520of%2520an%2520Inhibitor%2520of%2520HCV%2520NS3%2520Protease%26jtitle%3DSynlett%26date%3D1999%26volume%3DS1%26spage%3D1000%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Activity of <i>m</i>-Tyrosine-Based 16- and 17-Membered Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">6229</span><span class="NLM_x">–</span> <span class="NLM_lpage">6235</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050323b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6229-6235&issue=20&author=K.+X.+Chenauthor=F.+G.+Njorogeauthor=J.+Pichardoauthor=A.+Prongayauthor=N.+Butkiewiczauthor=N.+Yaoauthor=V.+Madisonauthor=V.+Girijavallabhan&title=Design%2C+Synthesis%2C+and+Biological+Activity+of+m-Tyrosine-Based+16-+and+17-Membered+Macrocyclic+Inhibitors+of+Hepatitis+C+Virus+NS3+Serine+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fjm050323b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050323b%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Activity%2520of%2520m-Tyrosine-Based%252016-%2520and%252017-Membered%2520Macrocyclic%2520Inhibitors%2520of%2520Hepatitis%2520C%2520Virus%2520NS3%2520Serine%2520Protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D20%26spage%3D6229%26epage%3D6235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span> </span><span class="NLM_article-title">Potent 7-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid-Based Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050520a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=567-574&issue=2&author=K.+X.+Chenauthor=F.+G.+Njorogeauthor=J.+Pichardoauthor=A.+Prongayauthor=N.+Butkiewiczauthor=N.+Yaoauthor=V.+Madisonauthor=V.+Girijavallabhan&title=Potent+7-Hydroxy-1%2C2%2C3%2C4-tetrahydroisoquinoline-3-carboxylic+Acid-Based+Macrocyclic+Inhibitors+of+Hepatitis+C+Virus+NS3+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjm050520a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050520a%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26atitle%3DPotent%25207-Hydroxy-1%252C2%252C3%252C4-tetrahydroisoquinoline-3-carboxylic%2520Acid-Based%2520Macrocyclic%2520Inhibitors%2520of%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D2%26spage%3D567%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span> </span><span class="NLM_article-title">P2−P4 Macrocyclic inhibitors of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">3960</span><span class="NLM_x">–</span> <span class="NLM_lpage">3965</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3960-3965&issue=15&author=A.+Arasappanauthor=F.+G.+Njorogeauthor=K.+X.+Chenauthor=S.+Venkatramanauthor=T.+N.+Parekhauthor=H.+Guauthor=J.+Pichardoauthor=N.+Butkiewiczauthor=A.+Prongayauthor=V.+Madisonauthor=V.+Girijavallabhan&title=P2%E2%88%92P4+Macrocyclic+inhibitors+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DParekh%26aufirst%3DT.%2BN.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26atitle%3DP2%25E2%2588%2592P4%2520Macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D15%26spage%3D3960%26epage%3D3965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Molecular modeling based approach to potent P2−P4 macrocyclic inhibitors of hepatitis C NS3/4a protease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4607</span><span class="NLM_x">–</span> <span class="NLM_lpage">4609</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFygur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=J.+W.+Butcherauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.-S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=B.-L.+Wanauthor=D.+B.+Olsenauthor=J.+P.+Vacca&title=Molecular+modeling+based+approach+to+potent+P2%E2%88%92P4+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4a+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Modeling Based Approach to Potent P2-P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease</span></div><div class="casAuthors">Liverton, Nigel J.; Holloway, M. Katharine; McCauley, John A.; Rudd, Michael T.; Butcher, John W.; Carroll, Steven S.; DiMuzio, Jillian; Fandozzi, Christine; Gilbert, Kevin F.; Mao, Shi-Shan; McIntyre, Charles J.; Nguyen, Kevin T.; Romano, Joseph J.; Stahlhut, Mark; Wan, Bang-Lin; Olsen, David B.; Vacca, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4607-4609</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. modeling of inhibitor bound full length HCV NS3/4A protease structures proved to be a valuable tool in the design of a new series of potent NS3 protease inhibitors.  Optimization of initial compds. provided 25a.  The in vitro activity and selectivity as well as the rat pharmacokinetic profile of 25a compare favorably with the data for other NS3/4A protease inhibitors currently in clin. development for the treatment of HCV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppYenMBNqdeLVg90H21EOLACvtfcHk0lg3rQ6XVGZzhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFygur8%253D&md5=5e7bb98bdb19c30bebb30f03a702838d</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520modeling%2520based%2520approach%2520to%2520potent%2520P2%25E2%2588%2592P4%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4a%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4607%26epage%3D4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. W.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Bismacrocyclic inhibitors of hepatitis C NS3/4a protease</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">47</span><span class="NLM_x">) </span> <span class="NLM_fpage">9104</span><span class="NLM_x">–</span> <span class="NLM_lpage">9107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=9104-9107&issue=47&author=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=K.+T.+Nguyenauthor=C.+J.+McIntyreauthor=J.+J.+Romanoauthor=K.+J.+Bushauthor=S.+L.+Vargaauthor=C.+W.+Rossauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=T.+A.+Lyleauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Bismacrocyclic+inhibitors+of+hepatitis+C+NS3%2F4a+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DVarga%26aufirst%3DS.%2BL.%26aulast%3DRoss%26aufirst%3DC.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DBismacrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4a%2520protease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26issue%3D47%26spage%3D9104%26epage%3D9107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Scola, P. M.; Campbell, J. A.; Sin, N.; Sun, L.; Wang, X. A.</span>Preparation of peptides as hepatitis C virus inhibitors. PCT Int. Appl. WO 2005/051410,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=P.+M.+Scola&author=J.+A.+Campbell&author=N.+Sin&author=L.+Sun&author=X.+A.+Wang&title=Preparation+of+peptides+as+hepatitis+C+virus+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DScola%26aufirst%3DP.%2BM.%26jtitle%3DPreparation%2520of%2520peptides%2520as%2520hepatitis%2520C%2520virus%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">McCauley, J. A.; Rudd, M. T.; McIntyre, C. J.; Nguyen, K. T.; Romano, J. J.; Butcher, J. W.; Holloway, M. K.; Wan, B.; Carroll, S. S.; DiMuzio, J. M.; Graham, D. J.; Ludmerer, S. W.; Mao, S.; Stahlhut, M.; Fandozzi, C.; Trainor, N.; Olsen, D. B.; Vacca, J. P.; Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-7009:a novel macrocyclic HCV NS3/4A protease inhibitor</span>.  <span class="citation_source-book">Abstracts of Papers, 235th ACS National Meeting</span>, <span class="NLM_conf-loc">New Orleans, LA</span>, <span class="NLM_conf-date">April 6−10</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+A.+McCauley&author=M.+T.+Rudd&author=C.+J.+McIntyre&author=K.+T.+Nguyen&author=J.+J.+Romano&author=J.+W.+Butcher&author=M.+K.+Holloway&author=B.+Wan&author=S.+S.+Carroll&author=J.+M.+DiMuzio&author=D.+J.+Graham&author=S.+W.+Ludmerer&author=S.+Mao&author=M.+Stahlhut&author=C.+Fandozzi&author=N.+Trainor&author=D.+B.+Olsen&author=J.+P.+Vacca&author=N.+J.+Liverton&title=Abstracts+of+Papers%2C+235th+ACS+National+Meeting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520MK-7009%253Aa%2520novel%2520macrocyclic%2520HCV%2520NS3%252F4A%2520protease%2520inhibitor%26btitle%3DAbstracts%2520of%2520Papers%252C%2520235th%2520ACS%2520National%2520Meeting%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span>Reviewed in <span class="NLM_contrib-group">Patani, G. A.; LaVoie, E. J.</span><span> </span><span class="NLM_article-title">Bioisosterism: A rational approach in drug design</span>.  <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">3147</span>− <span class="NLM_lpage">3176</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/cr950066q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADyaK28XntFSitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1996&pages=3147-3176&author=G.+A.+Patani&author=E.+J.+LaVoie&title=Bioisosterism%3A+A+rational+approach+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Bioisosterism: A rational approach in drug design</span></div><div class="casAuthors">Patani, George A.; LaVoie, Edmond J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3147-3176</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with 191 refs., on bioisosteres that incorporates sufficient detail to enable the reader to understand the concepts being delineated.  Classical bioisosteres, such as monovalent atoms and groups, divalent isosteres, trivalent atoms and groups, tetra substituted atoms, and ring equiv., and non-classical bioisosteres, such as cyclic vs. non-cyclic non-classical bioisosteric replacements and non-classical bioisosteric replacements of functional groups, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrADeNoRGbU9LVg90H21EOLACvtfcHk0liq4Uu41uXDpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntFSitLg%253D&md5=4b3ec55087feabc53e0490ebd5a3ddcd</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fcr950066q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr950066q%26sid%3Dliteratum%253Aachs%26aulast%3DPatani%26aufirst%3DG.%2BA.%26atitle%3DBioisosterism%253A%2520A%2520rational%2520approach%2520in%2520drug%2520design%26jtitle%3DChem.%2520Rev.%26date%3D1996%26volume%3D96%26spage%3D3147%26epage%3D3176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Thompson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eppley, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darcy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszek, T. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanoff, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternberg, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petteway, S. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, J. G.</span><span> </span><span class="NLM_article-title">Synthesis and antiviral activity of a novel class of HIV-1 protease inhibitors containing a heterocyclic P<sub>1</sub>′−P<sub>2</sub>′ amide bond isostere</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2441</span><span class="NLM_x">–</span> <span class="NLM_lpage">2446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=2441-2446&author=S.+K.+Thompsonauthor=A.+M.+Eppleyauthor=J.+S.+Frazeeauthor=M.+G.+Darcyauthor=R.+T.+Lumauthor=T.+A.+Tomaszekauthor=L.+A.+Ivanoffauthor=J.+F.+Morrisauthor=E.+J.+Sternbergauthor=D.+M.+Lambertauthor=A.+V.+Fernandezauthor=S.+R.+Pettewayauthor=T.+D.+Meekauthor=B.+W.+Metcalfauthor=J.+G.+Gleason&title=Synthesis+and+antiviral+activity+of+a+novel+class+of+HIV-1+protease+inhibitors+containing+a+heterocyclic+P1%E2%80%B2%E2%88%92P2%E2%80%B2+amide+bond+isostere"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DS.%2BK.%26aulast%3DEppley%26aufirst%3DA.%2BM.%26aulast%3DFrazee%26aufirst%3DJ.%2BS.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DLum%26aufirst%3DR.%2BT.%26aulast%3DTomaszek%26aufirst%3DT.%2BA.%26aulast%3DIvanoff%26aufirst%3DL.%2BA.%26aulast%3DMorris%26aufirst%3DJ.%2BF.%26aulast%3DSternberg%26aufirst%3DE.%2BJ.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DFernandez%26aufirst%3DA.%2BV.%26aulast%3DPetteway%26aufirst%3DS.%2BR.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DMetcalf%26aufirst%3DB.%2BW.%26aulast%3DGleason%26aufirst%3DJ.%2BG.%26atitle%3DSynthesis%2520and%2520antiviral%2520activity%2520of%2520a%2520novel%2520class%2520of%2520HIV-1%2520protease%2520inhibitors%2520containing%2520a%2520heterocyclic%2520P1%25E2%2580%25B2%25E2%2588%2592P2%25E2%2580%25B2%2520amide%2520bond%2520isostere%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26spage%3D2441%26epage%3D2446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Di Marco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colarusso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollazzo, M.</span><span> </span><span class="NLM_article-title">Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">7152</span><span class="NLM_x">–</span> <span class="NLM_lpage">7157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=7152-7157&issue=10&author=S.+Di+Marcoauthor=M.+Rizziauthor=C.+Volpariauthor=M.+A.+Walshauthor=F.+Narjesauthor=S.+Colarussoauthor=R.+De+Francescoauthor=V.+G.+Matassaauthor=M.+Sollazzo&title=Inhibition+of+the+hepatitis+C+virus+NS3%2F4A+protease.+The+crystal+structures+of+two+protease-inhibitor+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMarco%26aufirst%3DS.%26aulast%3DRizzi%26aufirst%3DM.%26aulast%3DVolpari%26aufirst%3DC.%26aulast%3DWalsh%26aufirst%3DM.%2BA.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DColarusso%26aufirst%3DS.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DSollazzo%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease.%2520The%2520crystal%2520structures%2520of%2520two%2520protease-inhibitor%2520complexes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26issue%3D10%26spage%3D7152%26epage%3D7157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cicero, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbato, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingallinella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardi, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinkuhler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazzo, R..</span><span> </span><span class="NLM_article-title">Structural Characterization of the Interactions of Optimized Product Inhibitors with the N-terminal Proteinase Domain of the Hepatitis C Virus (HCV) NS3 Protein by NMR and Modelling Studies</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=385-396&issue=2&author=D.+O.+Ciceroauthor=G.+Barbatoauthor=U.+Kochauthor=P.+Ingallinellaauthor=E.+Bianchiauthor=M.+C.+Nardiauthor=C.+Steinkuhlerauthor=R.+Corteseauthor=V.+Matassaauthor=R.+De+Francescoauthor=A.+Pessiauthor=R..+Bazzo&title=Structural+Characterization+of+the+Interactions+of+Optimized+Product+Inhibitors+with+the+N-terminal+Proteinase+Domain+of+the+Hepatitis+C+Virus+%28HCV%29+NS3+Protein+by+NMR+and+Modelling+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCicero%26aufirst%3DD.%2BO.%26aulast%3DBarbato%26aufirst%3DG.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DIngallinella%26aufirst%3DP.%26aulast%3DBianchi%26aufirst%3DE.%26aulast%3DNardi%26aufirst%3DM.%2BC.%26aulast%3DSteinkuhler%26aufirst%3DC.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DMatassa%26aufirst%3DV.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DPessi%26aufirst%3DA.%26aulast%3DBazzo%26aufirst%3DR..%26atitle%3DStructural%2520Characterization%2520of%2520the%2520Interactions%2520of%2520Optimized%2520Product%2520Inhibitors%2520with%2520the%2520N-terminal%2520Proteinase%2520Domain%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520%2528HCV%2529%2520NS3%2520Protein%2520by%2520NMR%2520and%2520Modelling%2520Studies%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1999%26volume%3D289%26issue%3D2%26spage%3D385%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plouffe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">NMR Structural Characterization of Peptide Inhibitors Bound to the Hepatitis C Virus NS3 Protease: Design of a New P2 Substituent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0303002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=123-132&issue=1&author=N.+Goudreauauthor=D.+R.+Cameronauthor=P.+Bonneauauthor=V.+Gorysauthor=C.+Plouffeauthor=M.+Poirierauthor=D.+Lamarreauthor=M.+Llinas-Brunet&title=NMR+Structural+Characterization+of+Peptide+Inhibitors+Bound+to+the+Hepatitis+C+Virus+NS3+Protease%3A+Design+of+a+New+P2+Substituent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1021%2Fjm0303002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0303002%26sid%3Dliteratum%253Aachs%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DPlouffe%26aufirst%3DC.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DNMR%2520Structural%2520Characterization%2520of%2520Peptide%2520Inhibitors%2520Bound%2520to%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%253A%2520Design%2520of%2520a%2520New%2520P2%2520Substituent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D1%26spage%3D123%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Grubbs, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, G. C.</span><span> </span><span class="NLM_article-title">Ring-closing metathesis and related processes in organic synthesis</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">446</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar00059a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADyaK2MXosl2ns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1995&pages=446-452&issue=11&author=R.+H.+Grubbsauthor=S.+J.+Millerauthor=G.+C.+Fu&title=Ring-closing+metathesis+and+related+processes+in+organic+synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Ring-Closing Metathesis and Related Processes in Organic Synthesis</span></div><div class="casAuthors">Grubbs, Robert H.; Miller, Scott J.; Fu, Gregory C.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">446-52</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 45 refs. including, e.g. molybdenum-based alkylidenes, ruthenium-based alkylidenes and new catalysts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkuIuELXHEALVg90H21EOLACvtfcHk0lhv7MUCu4pZ6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXosl2ns70%253D&md5=c65649fd9d2582338f816a0b23ecc142</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Far00059a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far00059a002%26sid%3Dliteratum%253Aachs%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26aulast%3DMiller%26aufirst%3DS.%2BJ.%26aulast%3DFu%26aufirst%3DG.%2BC.%26atitle%3DRing-closing%2520metathesis%2520and%2520related%2520processes%2520in%2520organic%2520synthesis%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D1995%26volume%3D28%26issue%3D11%26spage%3D446%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grubbs, R. H.</span><span> </span><span class="NLM_article-title">Olefin metathesis catalysts for the preparation of molecules and materials (Nobel Lecture)</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3760</span><span class="NLM_x">–</span> <span class="NLM_lpage">3765</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=3760-3765&author=R.+H.+Grubbs&title=Olefin+metathesis+catalysts+for+the+preparation+of+molecules+and+materials+%28Nobel+Lecture%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26atitle%3DOlefin%2520metathesis%2520catalysts%2520for%2520the%2520preparation%2520of%2520molecules%2520and%2520materials%2520%2528Nobel%2520Lecture%2529%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D3760%26epage%3D3765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Saegusa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span> </span><span class="NLM_article-title">Reaction of 1,3,4-oxadiazolones with free <span class="smallcaps smallerCapital">l</span>-α-amino acids: a facile synthesis of novel 3,5-disubstituted hydantoins</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">742</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1990&pages=739-742&issue=3&author=Y.+Saegusaauthor=S.+Haradaauthor=S.+Nakamura&title=Reaction+of+1%2C3%2C4-oxadiazolones+with+free+l-%CE%B1-amino+acids%3A+a+facile+synthesis+of+novel+3%2C5-disubstituted+hydantoins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaegusa%26aufirst%3DY.%26aulast%3DHarada%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DS.%26atitle%3DReaction%2520of%25201%252C3%252C4-oxadiazolones%2520with%2520free%2520l-%25CE%25B1-amino%2520acids%253A%2520a%2520facile%2520synthesis%2520of%2520novel%25203%252C5-disubstituted%2520hydantoins%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1990%26volume%3D27%26issue%3D3%26spage%3D739%26epage%3D742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Di Francesco, M. E.; Nizi, E.; Pace, P.; Summa, V.</span><span> </span><span class="NLM_article-title">Preparation of peptidyl macrocyclic compounds as antiviral agents</span>. PCT Int. Appl. WO 2007/131966,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+E.+Di+Francesco&author=E.+Nizi&author=P.+Pace&author=V.+Summa&title=Preparation+of+peptidyl+macrocyclic+compounds+as+antiviral+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFrancesco%26aufirst%3DM.%2BE.%26atitle%3DPreparation%2520of%2520peptidyl%2520macrocyclic%2520compounds%2520as%2520antiviral%2520agents%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="note"><p class="first last">The Zhan ruthenium metathesis catalyst RC-301, Zhan catalyst 1, dichloro(5-chloro-2-isopropoxybenzylidene)(1,3-dimethylimidazolidin-2-ylidene)ruthenium), is available from Strem, catalogue no. 44-0082.<span class="NLM_inline-graphic"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm900524b/production/images/medium/jm-2009-00524b_0009.tif.gif" alt="" /></img></span></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Wang, X. A.; Sun, L.-Q.; Sit, S.-Y.; Sin, N.; Scola, P. M.; Hewawasam, P.; Good, A. C.; Chen, Y.; Campbell, J. A.</span><span> </span><span class="NLM_article-title">Hepatitis C Virus Inhibitors</span>. U.S. Patent 6,995,174,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=X.+A.+Wang&author=L.-Q.+Sun&author=S.-Y.+Sit&author=N.+Sin&author=P.+M.+Scola&author=P.+Hewawasam&author=A.+C.+Good&author=Y.+Chen&author=J.+A.+Campbell&title=Hepatitis+C+Virus+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BA.%26atitle%3DHepatitis%2520C%2520Virus%2520Inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Holloway, M. K.; Liverton, N. J.; Ludmerer, S. W.; McCauley, J. A.; Olsen, D. B.; Rudd, M. T.; Vacca, J. P.</span><span> </span><span class="NLM_article-title">Preparation of macrocyclic compounds as HCV NS3 protease inhibitors</span>. PCT Int. Appl. WO 2006/119061,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+K.+Holloway&author=N.+J.+Liverton&author=S.+W.+Ludmerer&author=J.+A.+McCauley&author=D.+B.+Olsen&author=M.+T.+Rudd&author=J.+P.+Vacca&title=Preparation+of+macrocyclic+compounds+as+HCV+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26atitle%3DPreparation%2520of%2520macrocyclic%2520compounds%2520as%2520HCV%2520NS3%2520protease%2520inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Holloway, M. K.; Liverton, N. J.; Ludmerer, S. W.; Mccauley, J. A.; Olsen, D. B.; Rudd, M. T.; Vacca, J. P.; Mcintyre, C. J.</span><span> </span><span class="NLM_article-title">Preparation of macrocyclic compounds as HCV NS3 protease inhibitors</span>. <span class="NLM_patent"></span>US 2007/027071,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+K.+Holloway&author=N.+J.+Liverton&author=S.+W.+Ludmerer&author=J.+A.+Mccauley&author=D.+B.+Olsen&author=M.+T.+Rudd&author=J.+P.+Vacca&author=C.+J.+Mcintyre&title=Preparation+of+macrocyclic+compounds+as+HCV+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26atitle%3DPreparation%2520of%2520macrocyclic%2520compounds%2520as%2520HCV%2520NS3%2520protease%2520inhibitors%26jtitle%3DUS%25202007%252F027071%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Butcher, J.; Di Filippo, M.; Ferrara, M.; Di Francesco, M. E.; Harper, S.; Rudd, M.; Summa, V.; Romano, J.; Liverton, N.; Mccauley, J.</span><span> </span><span class="NLM_article-title">Macrocyclic compounds as antiviral agents</span>. PCT Int. Appl. WO 2009/010804,<span class="NLM_x"> </span><span class="NLM_year">2009.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009.&author=J.+Butcher&author=M.+Di+Filippo&author=M.+Ferrara&author=M.+E.+Di+Francesco&author=S.+Harper&author=M.+Rudd&author=V.+Summa&author=J.+Romano&author=N.+Liverton&author=J.+Mccauley&title=Macrocyclic+compounds+as+antiviral+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DButcher%26aufirst%3DJ.%26atitle%3DMacrocyclic%2520compounds%2520as%2520antiviral%2520agents%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span> </span><span class="NLM_article-title">A time-resolved, internally quenched fluorescence assay to characterize inhibition of hepatitis C virus nonstructural protein 3−4A protease at low enzyme concentrations</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2008&pages=1-8&author=S.-S.+Maoauthor=J.+DiMuzioauthor=C.+McHaleauthor=C.+Burleinauthor=D.+Olsenauthor=S.+S.+Carroll&title=A+time-resolved%2C+internally+quenched+fluorescence+assay+to+characterize+inhibition+of+hepatitis+C+virus+nonstructural+protein+3%E2%88%924A+protease+at+low+enzyme+concentrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DMcHale%26aufirst%3DC.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DOlsen%26aufirst%3DD.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26atitle%3DA%2520time-resolved%252C%2520internally%2520quenched%2520fluorescence%2520assay%2520to%2520characterize%2520inhibition%2520of%2520hepatitis%2520C%2520virus%2520nonstructural%2520protein%25203%25E2%2588%25924A%2520protease%2520at%2520low%2520enzyme%2520concentrations%26jtitle%3DAnal.%2520Biochem.%26date%3D2008%26volume%3D373%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, J.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theilmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1126%2Fscience.285.5424.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=10390360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=110-113&author=V.+Lohmannauthor=F.+Kornerauthor=J.-O.+Kochauthor=U.+Herianauthor=L.+Theilmannauthor=R.+Bartenschlager&title=Replication+of+subgenomic+hepatitis+C+virus+RNAs+in+a+hepatoma+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span></div><div class="casAuthors">Lohmann, V.; Korner, F.; Koch, J.-O.; Herian, U.; Theilmann, L.; Bartenschlager, R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">5424</span>),
    <span class="NLM_cas:pages">110-113</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">An estd. 170 million persons worldwide are infected with hepatitis C virus (HCV), a major cause of chronic liver disease.  Despite increasing knowledge of genome structure and individual viral proteins, studies on virus replication and pathogenesis have been hampered by the lack of reliable and efficient cell culture systems.  A full-length consensus genome was cloned from viral RNA isolated from an infected human liver and used to construct subgenomic selectable replicons.  Upon transfection into a human hepatoma cell line, these RNAs replicated to high levels, permitting metabolic radiolabeling of viral RNA and proteins.  This work defines the structure of HCV replicons functional in cell culture and provides the basis for a long-sought cellular system that should allow detailed mol. studies of HCV and the development of antiviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7X754RT8y1LVg90H21EOLACvtfcHk0liT8bz6uy_qKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D&md5=b075621b316209ecf4498c9b5b33e4b5</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1126%2Fscience.285.5424.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.285.5424.110%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DKorner%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DJ.-O.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DTheilmann%26aufirst%3DL.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DReplication%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNAs%2520in%2520a%2520hepatoma%2520cell%2520line%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span>More than 10 analogues featuring the oxadiazole moiety in P4 were prepared bearing combinations of the various P2 cores and P3 residues. Overall they proved to be inferior to the corresponding aminothiazoles, in analogy with the findings described for analogue <b>4</b>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=More+than+10+analogues+featuring+the+oxadiazole+moiety+in+P4+were+prepared+bearing+combinations+of+the+various+P2+cores+and+P3+residues.+Overall+they+proved+to+be+inferior+to+the+corresponding+aminothiazoles%2C+in+analogy+with+the+findings+described+for+analogue+4."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ingallinella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingenito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinkuehler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessi, A.</span><span> </span><span class="NLM_article-title">Potent Peptide Inhibitors of Human Hepatitis C Virus NS3 Protease Are Obtained by Optimizing the Cleavage Products</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">8906</span><span class="NLM_x">–</span> <span class="NLM_lpage">8914</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi980314n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=8906-8914&issue=25&author=P.+Ingallinellaauthor=S.+Altamuraauthor=E.+Bianchiauthor=M.+Talianiauthor=R.+Ingenitoauthor=R.+Corteseauthor=R.+De+Francescoauthor=C.+Steinkuehlerauthor=A.+Pessi&title=Potent+Peptide+Inhibitors+of+Human+Hepatitis+C+Virus+NS3+Protease+Are+Obtained+by+Optimizing+the+Cleavage+Products"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.1021%2Fbi980314n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi980314n%26sid%3Dliteratum%253Aachs%26aulast%3DIngallinella%26aufirst%3DP.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DBianchi%26aufirst%3DE.%26aulast%3DTaliani%26aufirst%3DM.%26aulast%3DIngenito%26aufirst%3DR.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DSteinkuehler%26aufirst%3DC.%26aulast%3DPessi%26aufirst%3DA.%26atitle%3DPotent%2520Peptide%2520Inhibitors%2520of%2520Human%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%2520Are%2520Obtained%2520by%2520Optimizing%2520the%2520Cleavage%2520Products%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26issue%3D25%26spage%3D8906%26epage%3D8914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laplante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Peptide-based inhibitors of the hepatitis C virus serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">1713</span><span class="NLM_x">–</span> <span class="NLM_lpage">1718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=1713-1718&issue=13&author=M.+Llinas-Brunetauthor=M.+Baileyauthor=G.+Fazalauthor=S.+Gouletauthor=T.+Halmosauthor=S.+Laplanteauthor=R.+Mauriceauthor=M.+Poirierauthor=M.+Poupartauthor=D.+Thibeaultauthor=D.+Wernicauthor=D.+Lamarre&title=Peptide-based+inhibitors+of+the+hepatitis+C+virus+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLaplante%26aufirst%3DS.%26aulast%3DMaurice%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DPoupart%26aufirst%3DM.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DWernic%26aufirst%3DD.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DPeptide-based%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26issue%3D13%26spage%3D1713%26epage%3D1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span> </span><span class="NLM_article-title">A Systematic Approach to the Optimization of Substrate-Based Inhibitors of the Hepatitis C Virus NS3 Protease: Discovery of Potent and Specific Tripeptide Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">6584</span><span class="NLM_x">–</span> <span class="NLM_lpage">6594</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0494523" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6584-6594&issue=26&author=M.+Llinas-Brunetauthor=M.+D.+Baileyauthor=E.+Ghiroauthor=V.+Gorysauthor=T.+Halmosauthor=M.+Poirierauthor=J.+Rancourtauthor=N.+Goudreau&title=A+Systematic+Approach+to+the+Optimization+of+Substrate-Based+Inhibitors+of+the+Hepatitis+C+Virus+NS3+Protease%3A+Discovery+of+Potent+and+Specific+Tripeptide+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm0494523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0494523%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DGoudreau%26aufirst%3DN.%26atitle%3DA%2520Systematic%2520Approach%2520to%2520the%2520Optimization%2520of%2520Substrate-Based%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%253A%2520Discovery%2520of%2520Potent%2520and%2520Specific%2520Tripeptide%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D26%26spage%3D6584%26epage%3D6594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">2267</span><span class="NLM_x">–</span> <span class="NLM_lpage">2270</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2267-2270&issue=20&author=M.+Llinas-Brunetauthor=M.+Baileyauthor=G.+Fazalauthor=E.+Ghiroauthor=V.+Gorysauthor=S.+Gouletauthor=T.+Halmosauthor=R.+Mauriceauthor=M.+Poirierauthor=M.-A.+Poupartauthor=J.+Rancourtauthor=D.+Thibeaultauthor=D.+Wernicauthor=D.+Lamarre&title=Highly+potent+and+selective+peptide-based+inhibitors+of+the+hepatitis+C+virus+serine+protease%3A+towards+smaller+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DMaurice%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DWernic%26aufirst%3DD.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DHighly%2520potent%2520and%2520selective%2520peptide-based%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520serine%2520protease%253A%2520towards%2520smaller%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26issue%3D20%26spage%3D2267%26epage%3D2270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit37b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Poupart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span> </span><span class="NLM_article-title">Solid-Phase Synthesis of Peptidomimetic Inhibitors for the Hepatitis C Virus NS3 Protease</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">4743</span><span class="NLM_x">–</span> <span class="NLM_lpage">4751</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo010164d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=4743-4751&issue=14&author=M.+Poupartauthor=D.+R.+Cameronauthor=C.+Chabotauthor=E.+Ghiroauthor=N.+Goudreauauthor=S.+Gouletauthor=M.+Poirierauthor=Y.+S.+Tsantrizos&title=Solid-Phase+Synthesis+of+Peptidomimetic+Inhibitors+for+the+Hepatitis+C+Virus+NS3+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=10.1021%2Fjo010164d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo010164d%26sid%3Dliteratum%253Aachs%26aulast%3DPoupart%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DSolid-Phase%2520Synthesis%2520of%2520Peptidomimetic%2520Inhibitors%2520for%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26issue%3D14%26spage%3D4743%26epage%3D4751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Bartels, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcial, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigges, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adiwijaya, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieffer, T. L.</span><span> </span><span class="NLM_article-title">Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3−4A protease inhibitors in treatment-naive subjects</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">198</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">800</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1086%2F591141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=18637752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFygs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2008&pages=800-807&issue=6&author=D.+J.+Bartelsauthor=Y.+Zhouauthor=E.+Z.+Zhangauthor=M.+Marcialauthor=R.+A.+Byrnauthor=T.+Pfeifferauthor=A.+M.+Tiggesauthor=B.+S.+Adiwijayaauthor=C.+Linauthor=A.+D.+Kwongauthor=T.+L.+Kieffer&title=Natural+prevalence+of+hepatitis+C+virus+variants+with+decreased+sensitivity+to+NS3%E2%88%924A+protease+inhibitors+in+treatment-naive+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3·4A protease inhibitors in treatment-naive subjects</span></div><div class="casAuthors">Bartels, Doug J.; Zhou, Yi; Zhang, Eileen Z.; Marcial, Michelle; Byrn, Randal A.; Pfeiffer, Thomas; Tigges, Ann M.; Adiwijaya, Bambang S.; Lin, Chao; Kwong, Ann D.; Kieffer, Tara L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">800-807</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Background: The prevalence and clin. implications of naturally occurring variants that are resistant to hepatitis C virus (HCV) protease inhibitors in treatment-naive patients has not been reported.  We report here the prevalence of such variants and their effect on clin. response.  Methods: Population sequence anal. of the NS3.4A protease was conducted in 570 treatment-naive subjects.  Results: Most subjects (98%) had wild-type virus.  The remaining subjects had the following variants present in significant proportions (∼100%): V36M, 0.9%; R155K, 0.7%; V170A, 0.2%; and R109K, 0.2%.  The V36M, R109K, and V170A substitutions confer low-level resistance (<7-fold) to protease inhibitors in replicon cells.  The R155K substitution confers low-level resistance to telaprevir (TVR) and boceprevir and confers high-level resistance (>70-fold) to BILN 2061 and ITMN-191.  Five subjects with the V36M or R109K variant were treated with 8-24 wk of TVR and peginterferon-α2a (P) with or without ribavirin (R).  Four achieved a sustained viral response, and 1 was lost to follow-up.  In subjects with the R155K variant, TVR/PR provided greater antiviral activity than PR alone; however, the antiviral response was lower than that obsd. in subjects with wild-type virus.  Conclusion: High levels of naturally occurring protease inhibitor-resistant variants were uncommon (<1% each) in HCV treatment-naive patients.  TVR/PR efficiently inhibited V36M and R109K variants and contributed partial antiviral activity against the R155K variant.  As new HCV agents are evaluated in clin. trials, it will be important to monitor the effect of baseline variants on sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU_M2kPrlZHrVg90H21EOLACvtfcHk0lhJ0-hLdukrEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFygs7rE&md5=531ae93d91433667dc8c46c3a08cbc28</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1086%2F591141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F591141%26sid%3Dliteratum%253Aachs%26aulast%3DBartels%26aufirst%3DD.%2BJ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DE.%2BZ.%26aulast%3DMarcial%26aufirst%3DM.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DPfeiffer%26aufirst%3DT.%26aulast%3DTigges%26aufirst%3DA.%2BM.%26aulast%3DAdiwijaya%26aufirst%3DB.%2BS.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DKieffer%26aufirst%3DT.%2BL.%26atitle%3DNatural%2520prevalence%2520of%2520hepatitis%2520C%2520virus%2520variants%2520with%2520decreased%2520sensitivity%2520to%2520NS3%25E2%2588%25924A%2520protease%2520inhibitors%2520in%2520treatment-naive%2520subjects%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2008%26volume%3D198%26issue%3D6%26spage%3D800%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span> <span class="citation_source-book">MacroModel Version 7.0</span>; <span class="NLM_publisher-name">Schroedinger Inc.</span>: <span class="NLM_publisher-loc">Portland, OR</span>; <a href="http://www.schrodinger.com/Products/macromodel.html" class="extLink">http://www.schrodinger.com/Products/macromodel.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MacroModel+Version+7.0%3B+Schroedinger+Inc.%3A+Portland%2C+OR%3B+http%3A%2F%2Fwww.schrodinger.com%2FProducts%2Fmacromodel.html."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMacroModel%2520Version%25207.0%26pub%3DSchroedinger%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Halgren, T. A.</span><span> </span><span class="NLM_article-title">Potential energy functions</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1016%2F0959-440X%2895%2980077-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm900524b&amp;key=7648322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADyaK2MXlvVOrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=205-210&author=T.+A.+Halgren&title=Potential+energy+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Potential energy functions</span></div><div class="casAuthors">Halgren, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-10</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review, with 52 refs.  When energy is a crit. quantity, accurate biomol. simulations rest in substantial part on accurate potential energy functions (force fields).  Improvements in methodol. for detg. parameters - particularly, in the systematic use of computational data obtained from quantum chem. calcns. - and enhancements in functional form are leading to better potential energy functions.  New calcns. have been developed for water (including calcns. that incorporate electronic polarizability to take account of the degree to which a mol. can be polarized), proteins, nucleic acids, carbohydrates, lipids, and general org. mols.  Most notably, two new biomol. force fields have recently been derived and significant redetns. of the parameters of two existing biomol. force fields have been carried out.  Some progress has also been made in incorporating polarizability into potential energy functions for mols. in general and in improving the treatment of metal-ligand interactions in systems of biomol. interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTetENh3B15LVg90H21EOLACvtfcHk0lhJ0-hLdukrEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlvVOrtr4%253D&md5=2bae4682983c94bdf12b4d8801c9a546</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2F0959-440X%2895%2980077-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0959-440X%252895%252980077-8%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26atitle%3DPotential%2520energy%2520functions%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D1995%26volume%3D5%26spage%3D205%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Halgren, T. A.</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">586</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm900524b&amp;key=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm900524b&amp;key=1%3ACAS%3A528%3ADyaK28XhvVGmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Halgren%2C+T.+A.J.+Comput.+Chem.+1996%2C+17%2C+490%E2%80%93586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94</span></div><div class="casAuthors">Halgren, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5 & 6</span>),
    <span class="NLM_cas:pages">490-519</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">This article introduces MMFF94, the initial published version of the Merck mol. force field (MMFF).  It describes the objectives set for MMFF, the form it takes, and the range of systems to which it applies.  This study also outlines the methodol. employed in parameterizing MMFF94 and summarizes its performance in reproducing computational and exptl. data.  Though similar to MM3 in some respects, MMFF94 differs in ways intended to facilitate application to condensed-phase processes in mol.-dynamics simulations.  Indeed, MMFF94 seeks to achieve MM3-like accuracy for small mols. in a combined "org./protein" force field that is equally applicable to proteins and other systems of biol. significance.  A second distinguishing feature is that the core protion of MMFF94 has primarily been derived from high-quality computational data-ca. 500 mol. structures optimized at the HF/6-31G* level, 475 structures optimized at the MP2/6-31G* level, 380 MP2/6-31* structures evaluated at a defined approxn. to the MP4SDQ/TZP level, and 1450 structures partly derived from MP2/6-31G* geometries and evaluated at the MP2/TZP level.  A third distinguishing feature is that MMFF94 has been parameterized for a wide variety of chem. systems of interest to org. and combinations of functional groups for which little, if any, useful exptl. data are available.  The methodol. used in parameterizing MMFF94 represents a fourth distinguishing feature.  Rather than using the common "functional group" approach, nearly all MMFF parameters have been detd. in a mutually consistent fashion from the full set of available computational data.  MMFF94 reproduces the computational data used in its parameterization very well.  In addn., MMFF94 reproduces exptl. bond lengths (0.014 Å root mean square [rms]), bond angles (1.2° rms), vibrational frequencies (61 cm-1 rms), conformational energies (0.38 kcal/mol rms), and rotational barriers (0.39 kcal/mol rms) very nearly as well as does MM3 for comparable systems.  MMFF94 also describes intermol. interactions in hydrogen-bonded systems in a way that closely parallels that given by the highly regarded OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAzCYfKnN83rVg90H21EOLACvtfcHk0lhJ0-hLdukrEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvVGmsbk%253D&md5=56fb073477b4f49d1dfbd786fc56a480</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%2528199604%252917%253A5%252F6%253C490%253A%253AAID-JCC1%253E3.0.CO%253B2-P%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1996%26volume%3D17%26spage%3D490%26epage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i53"><a href="/doi/suppl/10.1021/jm900524b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_81125"></div></div></div></div></div><hr /></hr><p class="last">Characterization data for intermediates <b>14</b>, <b>20</b>, <b>21</b>, <b>23</b>−<b>30</b>, <b>32</b>−<b>38</b>, and <b>39</b>−<b>46</b>; additional characterization data for compounds <b>4</b>, <b>5</b>, <b>51</b>, <b>55</b>, <b>57</b>, <b>59</b>, and <b>60</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900524b/suppl_file/jm900524b_si_001.pdf">jm900524b_si_001.pdf (630.26 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm900524b&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm900524b%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm900524b" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679aba408b203bec","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
